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 I feel honoured to be invited to introduce the publication ‚Refinement and 
standardization of storage procedures for clonal crops – Collective Action for the 
Rehabilitation of Global Public Goods Phase 2‛. I am grateful to the authors of this 
publication, in particular to Nicolas Roux, coordinator of centres’ in vitro conservation 
specialist community. 
The impact of the International Agricultural Research Centres’ work towards 
sustainable development largely depends on the centres’ genebanks, which hold the 
world’s most complete collections of plant diversity for food and agriculture. Four 
centres (Bioversity International, CIAT, CIP, and IITA) maintain over 28,000 ex situ 
accessions of bananas, plantains, cassava, potatoes, sweet potatoes, Andean roots and 
tubers and yams. From this total, 85% are also held as in vitro collections under slow 
growth conditions, and 10% of these have been placed under cryopreservation. The 
conservation of clonal material poses additional and unique challenges, especially 
when in vitro conservation methods are implemented.  
Although the feasibility of using in vitro culture methods for plant genetic resources 
conservation was advocated in the mid to late 1970’s (e.g. by the late G Henshaw and 
his group), it was only in the 1980’s that the International Board for Plant Genetic 
Resources (IBPGR) established a working group of specialists, with the coordination of 
T Williams and L Withers, to look at critical aspects of in vitro plant conservation. As a 
follow-up, the IBPGR-CIAT project was implemented in 1987-89 to assess the technical 
and logistical aspects of establishing and running an in vitro active genebank using 
cassava as a model. In order to realize the potential of in vitro conservation at the 
CGIAR system and global levels, one lesson learned indicated that generic 
conservation quality standards should be developed. Early contributions towards 
these objectives included the IBPGR status report on in vitro conservation techniques 
by S Ashmore in 1997, and the technical guidelines for the management of field and in 
vitro collections by B Reed et al. in 2004. 
A milestone of the centres’ long history of working together on genetic resources 
issues was the creation of the System-wide Genetic Resources Programme (SGRP) in 
1994. Based on two external reviews, commissioned by the SGRP in 1995 and 1998, an 
investment plan was developed with World Bank funding; the plan comprised a two-
phase programme. The programme’s first project ‚Global Public Goods Rehabilitation 
Project‛, Phase 1 (GPG1) in 2003-06, raised the standards, and upgraded the operations 
of CGIAR genebanks. Centres holding clonal collections in vitro made substantial 
impact on accessions backlog processing, advanced the preparation of safety backups, 
and improved the health status of collections.  
The second project, ‚Collective Action for the Rehabilitation of Global Public 
Goods‛, Phase 2 (GPG2) aimed at enhancing the security and stewardship of the 
genetic resources held in trust in CGIAR genebanks. This project is the central topic of 
this publication which presents the outcomes, lessons learned, and points out key 
 challenges involved in furthering the GPG2 activity ‚Refinement and standardization 
of storage procedures for clonal crops‛, sub-activity ‚Review of in vitro protocols 
applied to clonal crops‛.  
The GPG2 Project (2007-09) successfully promoted collective actions for the 
conservation of clonal genetic resources, specifically to increase their security, to use 
best practices across genebank processes needing validation, third party accreditation 
and risk management. In this context, the evolving role for germplasm curators was 
envisioned to satisfy stakeholders’ demands in meeting high standards in storage 
procedures (including in vitro slow growth and cryopreservation), to provide access to 
taxonomic and trait-related information, to develop modern genebank inventory 
systems for storage and delivery of accession data, and to develop high throughput 
screening techniques for new traits (such as abiotic stress, micronutrient and health-
related phytochemical content).  
In pursuing the collective actions for implementing system-wide priorities, 
attention should be placed on the use of best practices for raising the quality standards 
in the management for clonal collections, and on seeking qualification by International 
Standard Organization accreditation, e.g. the recent certification of CIPs’ genebank 
with ISO 17025. Maintenance of third party certifications will require continuous, 
rigorous controls, processes and validations within and between centres. 
To successfully move ahead in implementing the GPG2 objectives, key challenges 
requiring collective attention still need to be tackled. These include:  
a) establishing practical risk-amelioration strategies for in vitro genebanks, especially 
in disaster-prone areas;  
b) developing simple, low cost, conservation protocols to expand the in vitro 
genebanks in developing countries;  
c) linking fundamental and applied research in in vitro conservation, for expanding 
the range of cryoresponse in the germplasm, for increasing the subculture interval 
of slow growth, and improving the efficiency of disease-indexing techniques at in 
vitro level, and  
d) developing high throughput screening techniques for relevant new traits, such as 
abiotic stress, micronutrient and health-related phytochemical content.  
 
 
William Roca 
Consultant 
Genetic Resources and Biotechnology 
Lima, Peru 
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 These multi-crop, in vitro conservation guidelines have been produced as part of the 
CGIAR’s System-wide Genetic Resources Programme (SGRP) project ‚Collective 
Action for the Rehabilitation of Global Public Goods Phase 2‛ (GPG2). The project’s 
development goal is ‚Crop genetic resources and associated biodiversity are put to use in 
developing countries to fight poverty, enhance food security and health and protect the 
environment‛. The GPG2 Project will facilitate CGIAR’s contribution to securing global 
plant genetic resources by upgrading genebank operations through the collective 
development of best practices. These are consolidated by adopting system-wide 
performance indicators, risk management procedures, protocol validation and quality 
assurance measures. The GPG2 collaborative activity 1.2: ‚Refinement and 
standardization of storage procedures for clonal crops‛ is mandated, through the CGIAR’s 
Clonal Crop Task Force, to produce multi-crop guidelines for the medium and long-term 
storage of germplasm. The overarching aims of this activity are the collation of 
information to support the validation of best practices and the production of multi-
crop best practice guidelines. Three outputs have been compiled to aid this process:  
 Part I. Project landscape and general status of clonal crop in vitro conservation 
technologies; 
 Part II. Status of in vitro conservation technologies for Andean root and tuber crops, 
cassava, Musa, potato, sweetpotato and yam; 
 Part III. Multi-crop guidelines for developing in vitro conservation best practices for 
clonal crops. 
 
This document comprises Part III, which has been constructed using information 
collated from: (1) a review of state-of-the-art slow growth and cryopreservation in the 
wider community of practice (Part I) and (2) a survey and workshop, which assessed 
CGIAR’s in vitro genebanks’ activities for their mandate clonal crops (Part II). 
Commonly held best practices and standards are core to high quality bioresources 
stewardship, these guidelines are therefore based on best practices from both plant 
(Genebank Standards 1994; Engels and Visser 2003; Reed et al. 2004) and other 
bioresource communities (OECD 2001, 2007; Coecke et al. 2005; ISBER 2005, 2008; NCI 
2007; Benson 2008; Betsou 2008). The Office of Economic Co-operation and 
Development guidelines for biorepositories (OECD 2007) have been used as the main 
exemplar for their construction.  
 The Clonal Crop Task Force (CCTF) representing the CGIAR’s in vitro genebanks, 
Bioversity, CIAT, CIP and IITA, hold in trust the genetic resources of Musa, cassava, 
potato, sweetpotato, yam and Andean root and tuber crops (ARTCs). These genebanks 
are cooperating in the GPG2 Activity 1.2: ‚Refinement and standardization of storage 
procedures for clonal crops‛. A survey of their conservation activities was conducted, 
followed by clarification of survey returns at a workshop, hosted by CIP in Lima, Peru 
in 2007. In addition, experiences gained from conserving potato, yam and cassava have 
been scrutinized with a view to using the lessons learned to help conserve yam, sweet 
potato and ARTCs. This has been undertaken by evaluating the survey returns and 
reviewing: (1) crop-specific technical guidelines of the CGIAR’s in vitro genebanks and 
(2) the status of the wider in vitro conservation community of practice. The 
development of best practices and quality systems for safeguarding biological 
resources is advancing rapidly in many bioresources communities and this document 
is informed by their wider experiences. This collective knowledge provides the 
foundation for developing these multi-crop best practice guidelines. They are 
compiled in two parts. Section I comprises general operational guidelines for in vitro 
plant genebanks. Section II provides generic, multi-crop technical guidelines for the 
medium-term (slow growth) and long-term (cryopreservation) storage of crop 
germplasm held in In vitro active genebanks (IVAGs) and In vitro base genebanks 
(IVBGs) respectively. The format is structured to harmonize with GPG2’s Knowledge 
base, best practices, risk management templates and performance indicators. The 
guidelines place emphasis on conserving clonal plant germplasm in infrastructures 
that are aspiring to develop quality management systems.  
 Conserving clonal crops presents unique challenges not encountered in other types of 
genetic resources management, for which seed storage is often the preferred 
conservation method. This approach is not feasible for germplasm from clonal crops 
which are vegetatively propagated and/or do not produce seeds. Special genetic 
combinations must also be preserved through clonal means, as heterozygosity does 
not maintain their desired characteristics. Clonal plant genetic resources can be 
preserved in field genebanks and as dormant vegetative (e.g. tubers, buds) propagules 
conserved in cold stores. However, these approaches are limited by efficiency, security 
and the costs of long-term maintenance. In vitro conservation is a complementary 
strategy that has the advantage of safe germplasm transfer under contained (i.e. in 
vitro) phytosanitary control. Medium-term storage (MTS) extends subculture intervals 
and reduces processing costs by arresting growth. Long-term storage (LTS) is achieved 
by cryopreservation and theoretically it secures viable germplasm longevity for 
centuries.  
The realization of best practices and external accreditation requires considerable 
time and resources and it is more practical to aspire to their development whilst 
capacity building progresses. Within this context, the generic guidelines in Section I 
may be best utilized as a road map to facilitate stepwise progress that are in line with 
the goals of high standard stewardship. In working towards best practices, some 
cautionary points need consideration (Genebank Standards 1994; OECD 2007). These 
include fixing best practices in a point in time, and the inability of some institutions to 
attain and maintain them. Therefore, developing best practices and quality systems 
should be considered evolutionary processes that keep in step with future 
technological advancements and the needs and capabilities of end users. Where 
constraints occur, institutions may need to moderate the development of their best 
practices to make them amenable to local circumstances. It is hoped this approach will 
support best practices development in the wider global plant conservation community. 
1.1 Aims, scope and structure 
The aim of these guidelines is to enable the continued development of quality services 
in the CGIAR’s clonal crop IVGBs. They have been constructed in accordance with the 
fundamental principles and responsibilities common to all biorepositories, which are:  
 Purity: freedom from contaminating organisms 
 Authenticity: correct identity 
 Stability: fit-for-purpose and trueness-to-type. 
 
These guidelines are modelled on existing plant conservation guides (Genebank 
Standards 1994; Engels and Visser 2003; Reed et al. 2004). However, they have been 
extended to incorporate generic best practices from other bioresources communities 
(i.e. sectors dependent upon the safe conservation of biological resources) that have 
 already developed quality systems (Stacey and Doyle 1998, Stacey et al. 1999; OECD 
2001, 2007; Coecke et al. 2005; ISBER 2005, 2008; Stacey 2004; Stacey and Day 2007). The 
scope of this document constitutes generic principles applicable to multiple crops and 
it is constructed within the remit of the GPG2 Project’s Knowledge base and Risk 
management activities. The technical scope of these guidelines specifically concerns in 
vitro storage, albeit for continuity associated practices are also considered. More 
detailed coverage of phytosanitary regulations, registration and authentication are 
addressed by other activities of the GPG2 Project. These guidelines comprise two 
parts: Section I offers general operational guidelines for in vitro genebanks; Section II 
provides generic, multi-crop technical guidelines for medium-term (slow growth) and 
long-term (cryopreservation) storage. Crop-specific protocols and technical guidelines 
of CGIAR’s clonal genebanks have already been compiled (IPGRI-CIAT 1994; Panis 
and Thinh 2001; Panis et al. 2005; Panta et al. 2007; IITA 2007a, b; Mafla et al. 2007; 
Panis 2009) or, are in progress.  
1.2 Quality systems for clonal crop in vitro genebanks  
The In vitro genebank (IVGB) as defined by Genebank Standards (1994) comprises two 
components: (1) the In vitro base genebank (IVBG) and (2) the In vitro active genebank 
(IVAG). The attributes of the IVBG are germplasm is preserved for the long-term and 
not normally distributed directly to users. Ideally, a base collection represents a 
comprehensive genepool of the crop or species and because of the longevity of viable 
germplasm held in cryobanks at liquid nitrogen (LN) temperatures (to -196°C) they are 
usually designated IVBGs. The IVAG holds accessions that are immediately available 
for multiplication and distribution and the cyclic flow of material is their key feature. 
The IVAG operates by successive subculturing and tissue cultures are maintained in 
conditions that retard their growth. This increases the efficient use of resources and 
staff time, and reduces the likely hood of contamination and operator errors. 
Developing best practices for protecting clonal food crops is an ongoing remit for 
CGIAR’s genebanks responsible for conserving potato, sweetpotato, Musa, yam, 
cassava and ARTCs. Their activities include the collective development of protocols 
and best practices and their validation as well as risk management for the safe 
conservation of germplasm held in trust. High standards of stewardship require 
compliance with overarching regulations regarding germplasm acquisitions, material 
transfers, ownership and phytosanitary legislation. These are drivers for developing 
quality management systems and they are underpinned by common best practices that 
may be modified to meet local conditions and needs. 
 
 These general guidelines underpin technical best practices and standards and they are 
core to high quality genetic resources stewardship. Cross-cutting operations are 
common to all biorepositories and genebanks and they provide the operational 
infrastructure for the multi-crop technical guidelines presented in Section II.  
In vitro crop plant genebanks should operate in compliance with institutional national 
and international regulations and provide sustainable infrastructures and/or 
alternative measures to ensure the security of their germplasm holdings and their safe 
transfer to other repositories, researchers, end users and beneficiaries. Information 
sources on national and international regulations are provided in the ‘Useful websites’ 
section of this document. If possible, the genebank’s overarching organization should 
aspire towards operating within a formalized quality framework. A glossary of terms 
related to quality systems and best practices is provided in the ‘Technology 
terminology’ section of this document.  
1.1 Management and organizational requirements 
Management responsibilities and operations include delegation and overseeing of 
administrative, technical, regulatory, safety, quality and training activities, as 
appropriate to qualified and new staff, visitors, students, end users and beneficiaries. 
The IVGB Director is required to formulate an organizational chart that clearly 
identifies and delineates the different functional relationships of the IVGB, and how 
they interact with respect to responsibilities and processes. The Director, together with 
appropriate staff oversees personnel supervision and training, approves and maintains 
job descriptions and ensures the capacities and capabilities of staff to undertake 
genebank operations. Clear and explicit procedures should be in place for 
documenting and archiving staff lists, duties and protocols, including inventories of 
biological holdings, associated passport and regulatory information. Senior 
Management has responsibility for implementing, as appropriate, accreditation 
standards and support efficient bilateral communications across all levels to ensure 
system effectiveness. This is usually undertaken by leadership team meetings, group 
meetings and team and sectional meetings.  
1.1.1 Technical management  
A Technical Manager is responsible for overseeing the management of practical and 
technical aspects of individual work areas in the IVGB and works in liaison with the 
Quality Manager. Duties of the Technical Manager are the implementation, 
 maintenance and improvement of the technical management system. Responsibilities 
may include, providing resources to support quality analyses within genebanks that 
are aspiring to external accreditation, Technical Managers are assisted by locally 
identified Accreditation Coordinators, who have the responsibility of the day-to-day 
maintenance of quality, and accreditation procedures (see section 7). Technical 
management includes the supervision and training of personnel and trainees by staff 
that are fully trained and authorized to undertake protocols and procedures and to 
assess test results (see sections 1.3 and 1.4). As necessary, Technical Managers should 
have the support, authority and resources to satisfy external third party accreditation 
standards. They should be empowered to identify departures from their management 
system or testing procedures, and put in place corrective and preventative actions to 
address them. Staff should be appointed to deputize for absent Technical Managers.  
1.1.2 Quality management 
A Quality Manager should normally be appointed to ensure that the IVGB complies 
with appropriate quality standards (see section 7) and provide guidance and 
information to staff concerning the maintenance and improvement of standards. A 
Deputy Quality Manager should be appointed for absentee coverage. In the case of 
organizations aspiring to, or maintaining third party external accreditation, an overall 
responsibility of the Quality Manager is to ensure that the requirements of the external 
body are met (e.g. for ISO certification). The Quality Manager heads the Quality 
Systems Team and together they are responsible for implementing and maintaining the 
Quality Management System. This includes actions at the technical level and in the 
administration of quality control procedures and internal audits (see section 7). The 
Quality Manager and Quality Systems Team liaises with the external accreditation 
body, carries out performance and proficiency testing, responds to follow-ups and 
complaints and corrects non-conforming work (see section 1.2.1.1). In addition, the 
Quality Manager and Quality Team ensure technical managers (see section 1.1.1) and 
their personnel are informed of changes to the accreditation standard and the policies 
and procedures of the accreditation body, including updates to its publications. 
Further responsibilities are document control, the production and administration of 
quality handbooks and technical guides and archiving copies of amended manuals 
(see section 1.3). The Quality Manager and Quality Team are tasked to ensure that 
IVGB personnel are aware of the importance and relevance of their activities, and how 
they contribute to the overall management system. 
1.2 In vitro genebank quality management systems 
The purpose of a quality system is to ensure IVGBs are operating to the highest 
standards in compliance with their regulatory, safety and service obligations. An 
overarching Quality Assurance Programme (see section 7) or Quality Management 
System (termed ‘QMS’) ensures that biorepositories operate in full accordance with 
their best practices. The Quality Manager (see section 1.1) represents the IVGB on 
quality matters with partner institutes, external contractors and suppliers, auditors, 
 regulatory bodies and end users, in compliance with risk management and regulatory 
obligations. Processes in a QMS should provide the opportunity to improve the system 
and support actions to prevent and correct non-conforming work (see section 1.2.1.1) or 
deviations and departures from technical procedures and protocols.  
1.2.1 Quality manuals 
Policies and procedures of a QMS should be defined in a Quality manual, which 
provides the overarching objective of the quality policy statement. The Quality manual 
describes the roles of personnel and their responsibilities and the genebank’s facilities 
and infrastructures. The range and scope of operations should be defined within the 
context of the genebank’s quality policy. The manual should include the protocols, 
Standard Operating Procedures (SOPs) and methods that need to be in place to ensure 
that quality policy objectives are satisfied. Personnel should understand and be able to 
comply with the Quality manual, which should be assessed annually in a management 
review. Any changes made to the Quality manual should be undertaken in a 
controlled manner (see section 1.3.1). The review and update process should involve 
regular meetings with all staff concerned and take into account statutory and 
regulatory requirements. The Quality manual should be maintained as an electronic 
document and published as a workbench hard copy that is available to all staff.  
Personnel should conform to the procedures in the quality manual and its associated 
documentation and report to the Quality Manager and Quality Team any issue or 
factor that influences their ability and capacity to comply. In cases where staff have not 
conformed to documented procedures and to work accredited by an external third 
party, the Technical and Quality Managers and Quality Team are to be informed 
immediately and the significance of the non-conforming work assessed. Such an 
occurrence is recorded as non-conforming work and the Quality Manager and Quality 
Team should take corrective action in a timely manner. This includes analysis allowing 
the root cause to be identified and rectified; corrective actions are monitored for their 
efficacy. Should non-conforming work cast doubt on work and procedures carried out, 
the Quality Manager should ensure that an audit is carried out to confirm the efficacy 
of corrective actions. In association with the Quality Manager, the Technical Manager 
should be responsible for authorizing the continuation of work. Preventative actions 
should be put in place to avert the risk of future non-conforming work and to improve 
the quality of the system and technical processes. 
1.3 Documentation and records 
Documents provide, publish and disseminate factual and material information. Records 
are registered information, or pieces of recorded evidence that are permanent, 
traceable points of reference. Records are systematically archived and accessed for 
regulatory and institutional inspection, and as such, they have an important role in 
quality management systems. 
 1.3.1 Controlled and uncontrolled documents 
Controlled documents are verified for accuracy by internal and/or external quality 
audits. Uncontrolled documents have not been through this process and they may be 
designated as drafts under revision, or non-verified, un-validated documents. A full 
list of controlled information required for germplasm processing, starting from 
registration and progressing to storage and safe transfer should be available in IVGBs. 
Alterations to best practices and core documents should be indelible, explained, dated, 
and signed by the operator, supervisor and endorsed by the Quality Manager. Copies 
of quality manuals, best practices, and technical handbooks should be clearly marked 
as ‘controlled’ and designated with a version number, issue date and authorization 
name. If controlled documents are usually maintained electronically, printed copies 
should be marked as uncontrolled; controlled documents are available at point of use. 
Procedures for verification of general/passport documentation and accompanying 
germplasm registration should be in place, including confirmation of safety status for 
quarantine and phytosanitary regulations, special and regulatory documents and other 
Intellectual Property (IP) restrictions such as (Standard) Material Transfer Agreements 
([S]MTAs). Lists of technical documents, safety and operational manuals provided by 
equipment manufacturers’ and chemical suppliers’ Material Safety Data Sheets 
(MSDS) should be recorded and their access points made known to the personnel 
using them. Staff, visitors and students should adhere to internal documentation. 
Departures from SOPs and best practices should be agreed upon and confirmed with 
written justification by the Quality Manager. 
There are two basic types of errors: (1) where work has not been carried out in 
accordance with documented procedures and (2) where documentation of a procedure 
is incorrect, for both cases corrective action is required. Where mistakes and deviations 
detected in documents are due to inaccuracies in language translation, 
misinterpretation or misdirection, the error should be identified, rectified and, if 
required personnel re-training implemented. A Quality Manager should ensure that 
documents are in order, updated, amended and changes properly documented with 
the agreement of personnel, supervisors and Technical Managers.  
1.3.2 Records  
The records chain extends from germplasm acquisition, registration to storage and 
dispatch, inclusive of supporting practices such as phytosanitary control. The Quality 
Manager should be responsible for ensuring records are in place for records retention, 
archiving, security, confidentiality and destruction. Records should be accessible for 
inspection by authorized personnel as required for quality, regulatory, health and 
safety audits and inspections. 
 1.4 Regulatory issues  
In addition to institutional, national and international regulations, these include 
observance of the Convention on Biological Diversity, the Standard material transfer 
agreement (SMTA), regarding plant genetic resources exchange, the International 
Plant Protection Convention and regulations concerning biosafety, phytosanitary 
control and quarantine. Genebank and biorepository personnel should be familiar 
with and have access to the regulatory guidelines and laws that are relevant to their 
work (for examples see Stacey and Doyle 1998; Stacey 2004).  
1.5 Training and personnel competencies  
Proper training underpins quality systems and it is essential for implementing best 
practices; in some countries, it can be mandatory for safety regulations. Procedures 
and personnel should be in place for coordinating, supervising and delivering training, 
this is particularly important as IVGBs are becoming increasingly multidisciplinary 
and depend on different types and levels of expertise. Personnel should only be 
allocated to, and held responsible for work for which they have been appropriately 
trained. Each staff member should be trained according to documented job 
descriptions and their development needs reviewed regularly and where appropriate 
training should be linked to specific objectives and measures of competence. Trained 
staff should also undertake the training and assessment process.  
1.5.1 Training programmes 
Staff should be fully informed of and trained in the quality systems and best practices 
used in their IVGB and are aware of the principles of quality issues and their role and 
importance in delivering quality services. It is the responsibility of all staff to 
familiarize themselves with best practice guidelines, documented protocols and the 
policies and procedures appropriate for their work. It is management’s responsibility 
to ensure staff, visitors and students are provided with appropriate quality documents. 
A four stage training procedure is recommended:  
1. Read documentation. 
2. Witness of operation by trained staff. 
3. Carrying out of an operation under supervision. 
4. Undergo periodic assessment and produce objective evidence of competence. 
 
Periodic re-evaluations, updates and audits of personnel can also be included in 
training programmes; mentoring is advisable to ensure personnel understand and are 
able to comply with their Quality System obligations. Staff training should be a 
formalized procedure, ideally reviewed on a regular basis in line with personal career 
development. Personnel should be supported by training when new procedures, 
protocols, instruments and equipment are introduced, until they demonstrate 
confidence and competency. Authorization to use specialist and high-risk equipment 
should be provided after appropriate training in their safe use by a suitably 
 experienced and qualified user or instructor. This may include staff training by the 
instrument/product manufacturer at the time of installation. Training can also be 
provided by formal courses, workshops and through academic qualifications.  
1.6 Technology transfer  
Formalized procedures for technology transfers should be coordinated with current 
best practices and quality systems. These can entail: (1) documented monitoring of 
technology transfer; (2) evidence based consensus as to whether the technology will, or 
will not be adopted; (3) impact assessment of the technology on current and projected 
operations; (4) risk and safety assessments; (5) cost/benefit and efficiency analyses and 
(6) staff training in new technologies. Distinctions between research development, 
technology transfer, internal verification, validation and best practices should be made 
clear to personnel. Technology transfers may be implemented via workshops, research 
collaboration, technical visits, Web-based posting of methods, SOPs and training 
attachments; these usually involve non-validated skills training. Critical point 
assessment of technology transfers help to identify problems and they are 
recommended before implementing a validation exercise and, on its completion. In 
this context, a critical point is a factor or issue that can affect the successful outcome of 
a procedure or protocol.  
1.7 Validation  
A formally validated in vitro conservation protocol should be sufficiently robust to 
translate into a best practice that can be used by different genebanks, over a reasonable 
period, by different staff. It can involve: 
1. Reproducibility testing: comparing results for a protocol replicated several times, 
ideally with several genotypes if possible.  
2. Reliability testing: comparing several methods which have the same application.  
3. Blind testing: to prevent outcomes being influenced by laboratory/genebank 
bias.  
 
1.7.1 The validation process 
Validation is the process by which a protocol or method is ensured to be fit for 
purpose. Optimally, external validation is calibrated and corroborated by validators 
with different levels of expertise across different institutions. This approach tests the 
quality of supporting information, guidance and experimental designs and helps to 
ensure a robust best practice is the outcome.  
Storage protocol validation typically involves reaching consensus on a common 
experimental design which is applied within the same time frame across several 
institutes, using an identical test culture from a sole source. The first stage requires 
detailed consensus planning as to how the validation will be undertaken. Lead in time 
 is necessary to dispatch test cultures to different validators, on their receipt, the 
cultures should be checked for morphogenetic competency and health. Test cultures 
should be cultivated using the same growth media across participating laboratories 
and cross-checks are advised so that cultures continue to grow within expected 
performance criteria. It is preferable that test cultures have a proven amenability to the 
protocol being used. This should have been developed, tested and verified by at least 
one participating partner who usually takes the lead.  
Identical handbooks and clear, unambiguous, complete technical instructions should 
be provided to all validators and scrutinized for accuracy, understanding and 
language translation. Precise details of solution preparation, calculations and technical 
detail should be checked, preferably by more than one person (see section 2.4.6). 
Adjunct training, workshops and phone/video-conferences are recommended, 
especially if validation is concomitant with technology transfer to personnel unfamiliar 
with the procedures.  
Genebank infrastructures should include any special design elements necessary for the 
security and safety of germplasm holdings and the personnel charged with their 
stewardship. The facility should adhere to obligations as required by law and/or other 
regulatory bodies and the operating environment and equipment should conform to 
relevant national and international standards and safety regulations.  
2.1 Institutional facilities  
These comprise basic facilities (lighting, heating and air conditioning) and essential 
services (water, power, emergency), communications, computers, Information 
Technology (IT) support and any special requirement for bioresources conservation 
and management.  
2.1.1 Environmental services 
Environmental control of ambient temperature and humidity in laboratories, 
operational areas and computer systems is a quality assurance factor. Critical 
environmental limits should be identified to ensure the appropriate control of 
temperature, humidity and light in growth rooms. Adequate air conditioning is 
advisable to prevent excessive loads on computers, refrigerators, freezers, incubators 
and cold rooms, for which regular maintenance is important to extend equipment 
lifespan and offset breakdowns. It is important to replace equipment prior to its 
failure, therefore upgrading older equipment and keeping the older equipment as a 
back-up is critical. Operating conditions for optimal use and lifetime of mechanical 
refrigerators, freezers and temperature-controlled equipment should be in accordance 
with manufacturers’ recommendations. Regular defrosting and cleaning should be 
undertaken in accordance with manufacturers’ recommendations. Service ventilation 
 systems should conform to health and safety requirements for the use of solvents, 
irritants, LN and other harmful substances. Lighting should be adequate for safe 
working, particularly where samples are stored; care is required for protecting light 
sensitive materials and germplasm. Appendix II provides examples of equipment 
calibration and maintenance for routine technical and safety operations within IVGBs.  
2.1.2 Work place design  
Laboratories and work areas should be conducive to high standards of cleanliness, 
optimally doors and windows ought to be close-fitting, and wall and floor surfaces 
sealed with even and smooth curved wall-to-floor junctions. Bench surfaces should be 
made of fabrics that provide smooth, contained surfaces to facilitate cleaning. Physical 
infrastructures should be designed to aid secure germplasm movement through a self-
contained, process chain. For example: (1) receipt/registration and storage of incoming 
germplasm accessions; (2) phytosanitary control; (3) preparation, regeneration and 
processing; (4) in vitro and cryogenic storage; (5) duplication/backups; (6) germplasm 
recovery; (7) germplasm transfers/dispatch and (8) decontamination, cleaning and 
waste processing.  
Operations and workspace design should be planned so that germplasm and materials 
do not become contaminated, lost or misplaced. Logistically this may be achieved by 
the physical delineation of clean and dirty areas and offsetting the timing of ‘dirty’, 
clean-up and sterile manipulations by having an area designated for the quarantine of 
new cultures. Using the laboratory on the ‚no way back‛ principle ensures that samples 
progress one-way through increasing levels of cleanliness and security.  
2.2 Computer and IT support 
In addition to usual computer usage, computers, electronic data management and 
storage inventories are integrated with modern analytical equipment and digital 
barcoding systems. Therefore, robust and efficient IT support should be provided, 
inclusive of a safe, anti-surge power supply and provisions should be made for the 
regular back-up of data and IT support. For specialist equipment (e.g. LN auto-supply 
tanks) contingencies should be made in the event of computer and power failure.  
2.3 General laboratory services  
Full and proper instructions explaining how general laboratory equipment is safely 
used should be written down and manufacturers’ handbooks annexed as required. 
Equipment usage, calibration, testing and maintenance should confirm fitness for 
purpose and servicing should be undertaken proficiently and regularly documented 
by a Laboratory or Facility Manager. Qualified personnel and/or external 
maintenance engineers, (i.e. endorsed by equipment providers) should carry out 
servicing and the calibration of general equipment (see Appendix II). These activities 
 should be in the care of the Quality and Technical Managers and records made 
available for internal/external auditors.  
2.3.1 Water quality 
Fit-for-purpose high quality water should be continuously available and stored as 
required. Water processing systems should be regularly cleaned and serviced and the 
microbial, chemical and physical quality of water routinely checked. 
2.4 Basic in vitro genebank operations 
These include facilities and operations dedicated to the routine culture and in vitro 
maintenance of crop germplasm. Actions involve the regular servicing, maintenance, 
cleaning and calibration of basic laboratory equipment: e.g. autoclaves, pH meters, 
light meters, balances, stirrers, water baths, automatic pipettes, microscopes, 
centrifuges, laminar airflows (e.g. flow checks and filter changes) should be scheduled 
by rota for competent staff and verified by a check-list (see Appendix II).  
2.4.1 Laboratory cleanliness  
Staff should be trained in aseptic technique and culture facility hygiene should be 
observed by regular cleaning. Stringent measures are necessary to ensure asepsis 
control and the avoidance of procedures that might potentially introduce pathogens, 
nuisance microflora, adventitious organisms, pests and mites into culture areas. 
Ideally, different washing-up areas are delineated into clean and dirty zones equipped 
with sufficient sinks and space for automatic and manual washing; provisions should 
be made for special washing treatments and rinses. An area holding dedicated 
disposal containers is designated for safe recycling and/or disposal of organic and 
inorganic chemicals, solvents, spent media, plant wastes, broken glass, sharps and 
paper. Strict containment should be maintained throughout all culture operations, and 
as required, in positive pressure, self-contained, limited access clean rooms. Plant 
culture rooms, growth chambers and cabinets should be under regular, checklist 
surveillance and made secure from contamination risks by routine, regular cleaning.  
2.4.2 Sterilization  
Staff should be trained and competent in the safe use of autoclaves and filter-sterilizing 
units and they should understand why and how the different types of sterilization 
procedures are applied. Autoclaves and sterilizing equipment should be routinely 
serviced and checked for function and safety. In some countries it is a statutory health 
and safety obligation for external (third party) checks to be undertaken on autoclaves. 
This procedure may also include the certification of the audit and the withdrawal of 
autoclaves from use if they do not comply with safety standards.  
2.4.3 Tissue culture use 
Procedures should be in place explaining how different types of cultures are acquired, 
used and by whom. Process and supply chains should be monitored for their intended 
purpose in: (1) slow growth and cryogenic storage; (2) research; (3) phytosanitary and 
 molecular diagnostics; (4) for training and technology transfer and (5) black box 
duplication. Good practices should be instigated for culling and disposing of cultures 
when they are no longer needed. For example: (1) deemed unsuitable for intended 
purpose; (2) withdrawal from storage collections; (3) redundancy on completion of 
research projects and training programmes. Evidence of removal and safe disposal 
should be clearly documented.  
2.4.4 Laboratory procedures  
Procedures should contain full instructions, including basic preparatory steps that 
explain how reagents, solutions and culture media are made, these should provide 
details of formulae, dispensing weights and volumes. Calculations and formulae 
should be meticulously verified by more than one operator and ideally witnessed for 
accuracy before being incorporated into controlled, best practices, technical guidelines 
and laboratory handbooks. Such documents may need to be available for internal and 
external quality auditors (see sections 1.2 and 7).  
2.4.5 Media and reagents 
The accurate preparation, labelling and proper storage of culture media and analytical 
reagents are key issues in quality control. The IVGB should have well defined 
standards, documents and procedures explaining how to prepare and store chemicals, 
reagents and materials used in tissue culture, storage and associated analytical and 
molecular procedures. Reagents and chemicals should be sourced from a reliable 
supplier and their grade and purity (including water quality) should be appropriate to 
application. Inventories of chemicals, reagents and their suppliers, including details of 
shelf life, expiry dates, minimum safe storage temperatures and special requirements 
(e.g. light sensitivity) should be compiled and collated by the Laboratory Manager or 
Technical Manager, with the aid of supplier MSDS and manufacturers’ product 
information. Creating and updating chemical and reagent inventories are components 
of risk management best practice (see section 4).  
2.4.6 Explicit technical details 
Explicit technical guidance (e.g. in SOPs) should be provided explaining how to 
prepare solutions using different types of formulation e.g. percentage, Molar, parts per 
million (ppm) and with clarification explaining how solutions are made up on a % 
weight/volume (w/v) or % volume/volume (v/v) basis. This process should take into 
account volumetric dispensing adjustments for specific gravity and the accurate 
gravimetric dispensing of viscous liquids (e.g. for cryoprotective additives). 
Preparation of analytical reagents and culture media should include details that 
describe how to precision-measure weights and volumes, prepare buffers, make pH 
adjustment and use solvents, acids and bases for solubilising additives. Clear 
instructions should be provided regarding the appropriate choice of sterilizing 
procedure (e.g. filter or autoclave) and the type of storage (e.g. refrigerated, dark).  
 2.4.7 Media and reagent stock control  
Media batches and working solutions should be made using standard documents and 
templates. Culture media, analytical reagents and solutions can be formulated from 
constituent chemicals, pre-prepared packs or stock solutions and these should be 
double-checked for shelf-life expiry, diluent concentration and numerical accuracy. Final 
solutions should be dispensed into clearly labelled, storage vessels, dated for expiry and 
with the name/operator coded. Stock-controls and storage inventories should be 
carefully documented; ideally solutions/media should be labelled in a bar-coded 
inventory system. Traceability of records should be assured for the entire process, from 
basic reagents and stock solutions, to culture media preparation, sterilization and batch 
storage. For example, a binder of every sheet used to make media should be kept so that 
it is possible to refer back to records if issues arise and each item should be checked off 
as it is added during media/solution preparation. Exact comments as to how calculations 
are used to make up solutions and stocks should be included (see section 2.4.6).  
2.5 General in vitro facilities 
Physical infrastructures, housing and general storage facilities should be safe, secure 
and environmentally controlled. Documented procedures for surveillance, alarms, 
regular inspections and maintenance (see Appendix II) should be in place and vigilance 
checks undertaken for contamination/pest infestations. Mechanical freezers, 
refrigerators, incubators and walk-in environmental cold rooms holding critically 
important materials should ideally operate with dual or back-up compressors. 
Calibrated temperature and light regimes should comply with storage requirements 
and range settings should take into account normal (acceptable) operating variations 
and max-min differentials. When thermal probes are used for calibration and 
surveillance they should be positioned at different locations to identify hot/cold spots 
and condensation points and actions should be taken to reduce their effects. A 
temperature profile should be constructed for environmentally controlled facilities 
prior to using and after servicing in order to identify areas that are not conforming to 
requirements. Optimally, continuous monitoring should be undertaken using an 
environmental monitor-data logger, noting that capacity loading in static mechanical 
refrigerators and freezers can change thermal characteristics compared to empty 
chambers. Provisions should be made for containment when growth rooms/cold 
storage facilities require defrosting, servicing, maintenance or for breakdown or 
emergency contingencies (see section 2.6.1).  
2.6 In vitro genebank equipment  
Manipulations should be undertaken in regularly serviced, routinely checked laminar 
airflow cabinets with specification grade-clean filters. Environmental support systems, 
air conditioning units and positive pressure rooms should be checked for optimal 
performance.  
 2.6.1 Servicing and breakdowns 
Specialist analytical, instrumentation, diagnostic and molecular biology equipment 
should be regularly calibrated and routinely checked by appropriately trained staff 
(see Appendix II). Ideally, spare and replacement parts should be held in store to ensure 
continuity of operations. Qualified maintenance engineers should service culture 
rooms, incubators and growth chambers regularly. Service records should be 
maintained and equipment failure incidents and correction procedures recorded 
methodically. The personnel that operate equipment should be kept informed about its 
status by means of a user log to verify functionality and personnel should be notified 
of outcomes of emergency interventions before planning to use equipment. In some 
countries, certain materials and equipment (e.g. pressurized cryogenic gases, radiation, 
and autoclaves) are regulated and they require mandatory safety inspections (see 
Appendix II). Procedures should be in place to ensure these comply with 
manufacturers’ health and safety specifications, the Quality and Technical Managers 
and Safety Officer should cooperate in undertaking these measures. 
A policy should be in place for the repair and replacement of equipment, working on 
the principles of preventative maintenance, availability of replacement parts, 
depreciation, and using optimal environmental conditions in the area in which the 
equipment is used and or/stored. Documented long-term replacement plans should 
ideally be developed that account for expected, safe lifetimes of essential equipment, 
based on manufacturers’ recommendations and usage and replacement needs.  
2.7 Suppliers and contracted services 
Suppliers of chemicals, equipment and materials should be reputable, reliable and 
providers of proven quality products, ideally contracted services should be quality 
assured by accredited certification. Copies of purchase orders, maintenance and, 
servicing contracts should be held on file and documented as part of the quality audit. 
Suppliers and external contracted services should provide support in full compliance 
with the IVGB’s safety regulations, best practices and quality assurance systems.  
 Well-documented procedures are core to quality assured management, inclusive of 
both hard copy and electronic information. Templates should be used for record 
management and documentation should be securely stored and backed up as 
authenticated and validated information and data (see section 1.2). Standard 
terminology and formats should be used for germplasm registration data, general data 
management and exchange of best practice protocols and procedures. Where possible, 
common standards should be in place for data transmission and sharing across 
federated networks at the local, domain, regional and global levels. This should take 
into account existing data processing and inventory systems and the need to review 
regularly IT services in line with new developments. Regular updating and archiving 
of information is part of a robust knowledge and information management system.  
3.1 Inventory procedures  
Depositors and registrars should ensure IVGB inventory systems and procedures 
comply with best practices and that quality assured information is associated with the 
biological material entering the genebank for registration. This should be: (a) verified 
and (b) accompanied by all the required regulatory and legal documents.  
3.1.1 Data entry, labelling and barcoding 
Manual, hard copy labelling should be avoided, when necessary it should be accurate, 
legible and witnessed as authentic to ensure correct transfers of label information, this 
is especially important when several operators are involved in the process over 
extended periods. Electronic barcoding systems are not infallible and measures should 
be taken to ensure the accurate input of electronic data, such as duplicate readings of 
barcodes prior to data being uploaded.  
3.1.2 Data quality control  
Control measures should ensure identification and correction of errors accumulated in 
the electronic inventory over time. Optimally, each record should comprise a 
minimum data set, a recommended data set and a full data set with language-specific 
spell checks for every field built-in to avoid cumulative errors. A standard approach 
should be applied for scientific symbols, abbreviations, and alternatives to symbols 
that cannot be entered into electronic inventories (e.g. ° for temperature, Greek letters, 
subscripts/superscripts). Unfamiliar data entries should be cross-checked for ontology 
and scientific names by using authorized lists to prevent errors and the miss-typing of 
complex or unfamiliar names and nomenclature. A procedure to detect manual, hand 
written and electronic data entries for transcription errors is critical to quality 
information management. Data quality and consistency of data handling procedures 
should be documented as a best practice and appropriately described e.g. as archived, 
currently existing and newly entered data (see section 1.2).  
 3.2 Sample traceability 
The genebank inventory should be sufficiently robust to allow trouble-free sample 
location and traceability of germplasm accessions held in store, together with their 
accompanying passport, regulatory and crop-specific information. It should be 
possible to track germplasm with precision and efficiency as it passes through 
different IVGB processes and phytosanitary treatments.  
3.3 Database content and access 
Inventory and informatics systems should be constructed in a standard format 
enabling linkages across appropriate facilities within the local IVGB and as required in 
federated genetic resources networks. Ideally, databases should contain all the relevant 
information for germplasm requisitions and depositors and inform on germplasm 
holdings status, including identification of duplicated/redundant accessions and/or 
inventories. Data should remain active so long as the germplasm remains viable, loss 
or purposeful removal of an accession should be recorded and documented (date, 
person responsible and reason) and the entry removed, indicating that it is no longer 
available; this information may also be archived or placed in reserve for future 
reference.  
3.4 Safeguarding data  
Informatics and IT staff should cooperate with IVGB personnel to ensure regular 
backups and off-site duplicate data storage for high-risk institutions. Back-up files and 
electronic storage devices should be stored in secure, locked and fireproof cabinets. 
Data archives, including procedures and manuals should be reviewed for redundancy, 
obsolescence, omissions and information loss. Documented standards and quality 
systems should be used to ensure data systems operate to best practices. Information 
should only be accessed by authentic users by means of ID and passwords and when 
necessary confidential data or information should be protected using encryption and 
restricted IP addresses.  
3.5 Accessibility and publication 
As appropriate, the IVBG makes data available externally regarding their biological 
holdings, in accordance with organizational principles and regulations. When 
required, users of restricted or confidential data should be authenticated and 
passwords provided to allow access to different domains, validity of identifiers and 
passwords should be checked. Publication of data and information, including on 
websites should comply with international copyright laws, regulations and be 
appropriately accompanied by authorship credits, acknowledgements, disclaimers and 
copyright permissions. Updating websites regularly includes auditing the material on 
a yearly basis depending on the type of material [protocols (less frequent) or data on 
accessions (more frequent)].  
 All IVGB personnel should be aware of their own responsibility towards genebank 
safety, the importance of audited risk management and its regulation. In some 
countries it is a statutory requirement for institutions to have robust risk management 
and safety procedures that are subjected to internal and external audits. Regulations 
governing safety are under the jurisdiction of diverse institutional, regional, national 
and international regulatory controls. Management, administration and the IVGB 
Safety Officer should be cognizant of all potential threats and hazards to personnel, 
germplasm holdings and operations. These can be broadly categorized into chemical 
electrical, biological, physical, radiological and fire. Non-adherence to regulations is 
also a risk. Protective facilities (airflow benches, containment cabinets) should be used 
for hazardous substances and organisms and cleaned appropriately after use to avoid 
subsequent contamination. Equipment and operations should be formally assessed 
and audited for risk and risk mitigation. Personal protective clothing and equipment 
(PPC and PPE), safety alarms and healthcare measures (e.g. vaccinations, oxygen 
monitors) should be supplied to personnel as appropriate.  
4.1 Risk management infrastructure 
Usually the Director or other designated senior member of staff holds primary 
responsibility for safety and risk management in an institution; however, staff are also 
responsible for the safety of operations in which they are involved. It is usual to 
appoint a Safety Committee which assigns a Safety Officer to administer and oversee risk 
management and safety programmes. The Safety Officer, in cooperation with the 
Safety Committee establishes risk management plans, runs safety training, monitors 
and maintains adherence to procedures, coordinates and delivers regular and spot-
check monitoring (including checking safety equipment (first-aid kits, bioshowers, eye 
wash, fire extinguishers, etc.). This committee also acts on, evaluates and reports 
incidents and injuries and regularly reviews, updates and recommends changes to risk 
management procedures. Ideally, updates should be undertaken no less than annually 
as well as in response to new information and incidents. Safety Officers are usually the 
main point of contact with external health and safety bodies and as such they should 
work closely with supervisors to ensure regulatory compliancy. The Safety Officer 
should be responsible for the safekeeping, updating and archiving of risk management 
documentation and literature, ensuring its accessibility to personnel. Data and 
information associated with safety, regulations and phytosanitary control should be 
retained for traceability, auditing and proof of compliancy with regulatory bodies and 
legal authorities. 
4.1.2 Safety training  
All personnel and visitors participating in practical operations should, as appropriate, 
undertake training in safety, risk assessment and mitigation. Including instruction on 
how to conduct their own risk management exercises using metrics and risk 
 assessment forms. Individuals undertaking specific tasks in their job description and 
related operations should be trained in identifying and mitigating against risks and the 
hazards involved. Correct completion of personnel safety assessments should be 
signed off by supervisors and the Safety Officer, who should retain a copy for 
endorsement by the Safety Committee. Staff should retain copies of risk assessments so 
that information is nearby for reference purposes. Regular training updates in risk 
management should be instigated for personnel. 
4.2 External security 
Genebanks should be made physically secure from break-ins and malicious intruders 
and ideally have an access code and 24 h security system in place for monitoring (e.g. 
security cameras) and limiting admittance to appropriate staff and visitors and 
protecting against intrusion from unauthorized persons. Doors, access points, 
locks/keys should be regulated and as required alarmed. An access policy should be in 
place for visitors, this might include sign-in sheets, logbooks and badges, and only 
authorized persons should be assigned to the genebanks and permitted rights of entry. 
Freezers, cryobanks, growth rooms and storage areas should be secured, if 
appropriate, in locked or restricted areas, taking into account the need to clearly mark 
and maintain emergency exits.  
4.3 Physical security 
The stringency of physical security within an IVGB will depend upon its associated 
activities and requirement for phytosanitary containment. Higher levels of security 
may be necessary for institutes undertaking genetic modification projects, for example, 
when using recombinant DNA technologies the level of biosecurity risk management 
may be expected to be higher. For these cases containment may be governed by 
statutory, national and international obligations for the management of genetically 
modified organisms (see section 4.2). Stringent measures may also be required for the 
containment of notifiable pathogens, in which case delineation into different areas of 
containment may be a mandatory obligation. Containment can range from Level 1, 
general security (negligible to low risk); Level 2, restricted areas (moderate risk) and 
Level 3, high security (high risk). The first demarks the institute from the surrounding 
area and it is the first point of entry and has external access control. Restricted areas in 
Level 2 have an additional area of security and through which only authorized 
personnel pass, optimally this is enclosed on all sides from general areas and without 
shared boundaries with public access. Level 3 areas are encased within a restricted 
area with additional pass security for only authorized personnel. Levels 2 and 3 may 
require intruder alarms and key and/or coded access. Emergency exits and incident 
response plans (see section 4.13) must not be compromised by security and 
containment systems. 
 4.4 Regulatory risks 
The IVGB should ensure its processes are compliant with regulations, agreements and 
international undertakings in the safe storage, movement, transfer and phytosanitary 
control of plant germplasm. Measures, checks, and cross-checks should be 
documented and in place to obviate risks of non-compliance in the regulatory chain. 
This should include timely, responsive updating of regulatory obligations, in line with 
new policies, agendas and laws. The use of the database to tag accessions is critical, 
this involves using a database to tag restrictions per accession which are presented as 
pop-ups which have to be approved when ordering and filling out orders. 
4.5 Phytosanitary risks 
Detailed treatment of phytosanitary aspects of genebank risk management are 
specifically covered by GPG2 Project Activity 2.1. ‚Consolidate, refine, disseminate 
and promote best management practices for collections, including germplasm health 
in storage‛. Therefore, in these guidelines phytosanitary risks will be confined to 
general issues. Compliance with phytosanitary, quarantine, disease diagnostics and 
indexing procedures and regulations is required, including plant health restrictions for 
collection in one country and transfer to another. Introduction of pests and diseases in 
the host country to the IVGB and vice versa should be obviated by accompanying 
incoming material with phytosanitary certification from the country of origin. When 
appropriate, in coming materials should be regenerated in containment facilities, 
quarantined and subject to phytosanitary testing. These include special treatments 
such as thermotherapy, cryotherapy, meristem culture, and health diagnostics (e.g. use 
of microbial media to test for contaminants). Risk assessment and mitigation plans 
should be created for the in vitro detection and testing of pests, pathogens, nuisance 
microorganisms using temperature treatments, meristem excision, culture and 
regeneration and labelling. Incoming germplasm should be delineated from clean in 
vitro materials held in the IVAG and IVBG (including cryotanks) until material is fully 
checked, decontaminated and declared disease, pest and pathogen free. New in vitro 
samples should be checked for microbial flora, systemic infections, endophytes, 
phytoplasmas, viruses and viroids.  
4.6 Transgene and pathogen biosecurity 
For these guidelines, contingencies relate to sources of potential harm arising from 
pathogens, genetically modified organisms (GMOs) and biotoxins held in IVGBs for 
phytopathological research, diagnostics, omics studies and genetic improvement. In 
accord with the Cartagena Protocol on Biosafety (see useful websites) the nature of 
transgenes, their potential for proliferation and spread outside a contained 
environment should be documented; if required, information should be cited as to 
how they can be detected. The IVGB should keep a detailed inventory of all their 
biological materials and identify personnel responsible for their safe storage, use and 
dispatch. A risk assessment should be conducted for the biosecurity required for 
 pathogens and toxins used for research and in vitro diagnostic tests. This should 
include information on infective dose (smallest quantity able to cause infection); 
pathogenicity (disease causing ability) and transmissibility (ease by which a pathogen 
spreads by vector and host).  
4.7 Material safety and germplasm acquisition 
Genebanks should be cognizant of risks associated with failure to collect and preserve 
vulnerable genetic resources under threat in situ. Genetic materials should not be 
collected, acquired and transported by the IVGB without prior knowledge and 
authorization of donor countries and their national control/contact points. Germplasm 
acquisition should comply with national/international procedures for obtaining 
permissions/permits under FAO’s various codes of conduct and the Convention on 
Biodiversity (CBD). Access to and use of germplasm should be verified with donors 
and undertaken in compliance with a Germplasm Acquisition Agreement between 
donors and IVGBs. And, in accord with the Standard International Material Transfer 
Agreement, the CBD’s benefit-sharing provisions and The International Treaty on 
Plant Genetic Resources for Food and Agriculture (ITPGRFA). Best practices should 
underpin collecting missions and representative samples/information should be 
transferred using efficient methods and robust documentation. The IVGB should 
maintain a comprehensive inventory of all bio-materials entering the facility.  
4.8 Safe germplasm shipment and transfers 
Processing of germplasm requests should be in accordance with appropriate risk 
management procedures. Biomaterials should be dispatched using safe transit 
measures and sent to facilities that ensure their continued safety on receipt (see 
section 6). Acquisition request and transfer documentation should be available for 
inspection by appropriate national and international authorities/quality auditors, 
including documented evidence explaining where, which and when external institutes 
have made material requests and if they have been accepted or declined, and for what 
reasons. Transfer and tracking of shipments should be timely and controlled with 
contingencies in place should a shipment go missing, be delayed or diverted, e.g. held 
up in transit and/or at border and customs control points. Materials should be 
appropriately labelled with full details, cautionary notices and regulatory 
documentation to ensure that dispatches are risk-managed effectively (see section 6).  
4.8.1 Safe internal transfers 
High-risk materials should not be left unattended or, outside a high security area. A 
code of practice should be instigated for personnel with custody control of sensitive 
high-risk biomaterials, this should be applied during internal transfers and across 
physical infrastructures with different security and phytosanitary control levels.  
 4.8.2 Safe external transfers 
Adherence to regulatory guidelines is required in the shipment of materials and 
germplasm in accord with the International Air Transport Association (IATA) 
transport of Dangerous Good Regulations and regulations for rail, road and sea 
transfers. Procedures should ensure that all shipment requirements are met and that 
staff undertaking dispatches are fully trained and competent in procedures for 
transferring dangerous and potentially hazardous goods.  
4.9 Safe disposal  
Safe waste disposal measures should be in place for biological and non-biological 
materials, including correct procedures for microbial, toxic and dangerous wastes, 
solvents and acids. Contaminated plant materials should be treated (e.g. autoclaved) 
and discarded safely in accordance with phytosanitary regulations (see section 2.4.1).  
4.10 Duplication and black boxes 
Duplication of germplasm collections held in MTS and LTS in other repositories and 
institutes should be undertaken with formal, reciprocated risk assessments, inclusive 
of transit and black box collections held by partner institute. Risk management 
provisions should be made in the event black box security fails, this may arise in the 
emergency recovery of germplasm held in a black box due to systems failure or a force 
majeure, (e.g. earthquakes, floods, conflict) or the need to contain potentially hazardous 
black box materials.  
4.11 Risk management in the in vitro active genebank 
Loss of in vitro samples due to processing backlogs should be prevented by optimizing 
the extension of cultures held in slow growth. Visible inspections should be 
undertaken regularly to: (1) avoid treatments that cause deleterious stress responses, 
(2) control spoilage due to microbial contamination, especially from covert systemic 
organisms and (3) offset risks of somaclonal variation and deleterious phenotypic and 
epigenetic changes.  
Cooling/air conditioning units in culture rooms should be serviced regularly to 
ensure critical temperatures and lighting for slow growth are maintained. Surveillance 
probes, data loggers and remote sensing devices should be used for risk mitigation 
related to potential environmental control problems (e.g. power surges, equipment 
failure, intermittent faults). Ideally, they should be connected to audio and visual 
alarms should failure occur or a door be left open accidentally. Optimally, a High 
Efficiency Particle-removal Air System (HEPA) should be installed to enhance filter 
efficiency and reduce the risks of contamination. If possible, growth rooms used for 
MTS should be backed up with a dual compressor and power use should be controlled 
to avoid system overload. Ideally, contingency power supplies should be independent 
of the rest of the power circuitry in the IVGB and it is prudent to alternate the testing 
and use of back-up supplies and their compressors with the main supply system as 
 this will ensure both are operating optimally. Personnel working in confined 
refrigerated spaces and cold rooms should be protected (e.g. emergency alarms, inside 
opening) from the risk of being accidentally locked in a low temperature facility.  
4.12 Risk management in the in vitro base genebank (Cryobank) 
Risk assessment of basic tissue culture procedures are common to MTS and LTS 
however special consideration is required for the use of LN and cryogenic equipment 
(see section 4.1).  
4.12.1 Personnel safety 
Cryogenic equipment and LN present special risk management issues as compared to the 
usual hazards to which personnel are exposed in general laboratory operations. Therefore, 
special awareness training is required for staff working in cryobanks, specifically staff 
should be knowledgeable about the hazardous properties of LN and trained in the 
handling of cryogenic gases and made aware of the four main hazards of LN:  
 Frostbite and cold injury.  
 Asphyxiation. 
 Mechanical injury incurred on explosion of a pressurized vessel containing LN 
or non-cryogen resistant instrument or device. 
 Pathological and toxicological injury due to uncontrolled release of a dangerous 
substance from a pressurized cryovial or LN storage vessel.  
Liquid nitrogen, its vapour and any container or implement exposed to it can cause 
severe frostbite and cold burns to skin and eyes. Special cryogenic safety equipment 
and surveillance measures are required when using LN and these can be statutory 
obligations in certain countries. LN-resistant personal protection includes clothing, 
gloves, aprons and face shields/screens, goggles, glasses and resilient, closed toe 
footwear. LN spills can crack ceramic and vinyl tiles, posing safety threats and 
contamination hazards. Only LN-resistant vessels and instruments guaranteed by the 
manufacturer should be exposed to LN and their safety advice adhered to concerning 
differential resistances of their products to LN liquid and vapour phases. Cryogenic 
equipment and cryovials have different tolerances to liquid and vapour states of LN 
and special care is needed when using pressurized vessels that contain, supply and 
transfer LN. Even small passive Dewars can become explosive if ice plugs 
inadvertently pressurize them and LN leakage into cryovials is potentially dangerous 
as the vapour expands rapidly on rewarming and can potentially explode the cryovial.  
Transport of LN with personnel in attendance in enclosed spaces (vehicles, lifts) is 
prohibited where adequate ventilation cannot be ensured and particularly if a Dewar 
or pressurized cryotank ruptures during transit. Special LN storage and delivery 
vessels are often heavy and care in their safe manipulation/transport in accordance 
with manual handling regulations. It is important to avoid personal injury and 
catastrophic breakages if a heavy Dewar is dropped and explodes. Routine safety 
inspection and certification of pressurized LN systems, including pressure gauges and 
 cryotanks is a statutory regulation in certain countries. Asphyxiation due to oxygen 
deficiency in atmospheres flooded with nitrogen gas is potentially lethal making 
adequate ventilation essential. Personnel and laboratory oxygen sensing monitors that 
sound an alarm at critically low levels of oxygen should be supplied, dependent upon 
the handling environment. The provision of these devices and their routine 
servicing/checking is a statutory requirement in certain countries (see Appendix II). 
Stringent rescue procedures should be in place and adhered to in areas where LN is 
dispensed, used and stored.  
4.12.2 Sample safety 
In cases of sample loss, it is necessary to take into account: contamination, mislabelling 
and misidentification in the cryobank and rescue procedures should be in place for 
samples lost in cryotanks. Maintaining LN levels and/or its vapour phase atmosphere is 
critical to the maintenance of storage stability; low-level alarms should be fitted as 
required and frequent operator surveillance and cryogen top-up procedures instigated 
(see Appendix II). Excursions in and out of cryotanks for sample input and retrieval 
causes minor fluctuations in temperature that might potentially damage samples, 
particularly if they are vitrified and stored at temperatures close to their glass transition 
temperatures (Tgs). Over long storage times, multiple rewarming and cooling cycles 
become significant and the inclusion of ‘sentinel cryovials’ is good practice to test the 
stability of samples in cryotanks. It is recommended that cryobanks duplicate their 
cryopreserved genetic resources in a different cryotank and preferably in a different 
location to that of the primary genebank.  
Cryovials are manufactured to withstand cryogenic temperatures and they have to be 
sufficiently robust to prevent penetration of LN, which should it leak into the cryovial 
could pose a containment threat and a potential hazard to the operator. Cryovials 
penetrated by LN become pressurized when vapour is formed, creating the potential 
for explosions on rewarming at rapid rates. Securing cryovials in plastic cryosleeves 
before submerging them in LN and their retention in the same sleeves on rewarming 
can help to contain potential explosions. For germplasm that has not undergone 
phytosanitary treatment, the contents of an exploded cryovial can form pervasive and 
penetrating aerosols, potentially capable of transmitting microorganisms by 
adventitious contamination. Most manufacturers of cryogenic equipment do not advise 
storage of cryovials in liquid phase LN and they only recommend their use in the 
vapour phase. Suppliers make cryovials with special safety features (internal threads, 
silicone ‘O’ rings) but reiterate that they should be used with care and chosen 
appropriately for totally submerged LN storage. Some manufacturers (Benson 2008) 
have developed polyethylene membrane sealants for the safe storing of cryovials in 
liquid phase LN.  
 4.12.3 Cryotransit  
Dry shippers are manufactured for the safe movement of cryopreserved materials and 
manufacturers designate their dry shippers as International Air Transport Association 
(IATA) approved. These vessels are engineered to be durable, lightweight and 
fabricated with adsorbents that hold LN, allowing spill-free safe shipment in the 
vapour phase. Transport in the vapour-phase may compromise glass stability in some 
samples that require their Tgs to be maintained at liquid phase-LN temperature. 
Cleaning of dry shippers is recommended between uses.  
4.13 Emergencies and incident response plans  
As appropriate, the genebank building should be constructed to withstand 
environmental catastrophes such as floods and typhoons and if necessary built to 
earthquake standards; in some cases conflict risks (explosions, artillery fire) may need 
to be considered. Standard checks of genebanks should be undertaken during extreme 
weather, together with regular fire alarm and sprinkler checks and safety drills. A 
check list of key personnel and ‚on call‛ contacts should be provided in the 
eventuality an essential service fails and contingencies for cover need to be made. 
Genebanks should be able to maintain uninterruptible essential services for power, 
water, light and LN supply and in the event of failure contingencies need to be 
activated for backup, power supplies (battery, generators). Ideally, the institute 
Director or Security/Safety Officer(s) should have a direct link to local providers to 
prioritize service restoration. Measures should check emergency services/supplies and 
personnel training, drills and regular practices may be instigated to ensure the 
familiarity and compliance of staff with emergency and crisis procedures. Critical 
storage facilities should be under alarmed surveillance and visual inspections 
undertaken regularly. In case of power failure, portable emergency, lighting should be 
made available for making safe any ongoing operations, back-up facilities need to be 
regularly checked for utility and battery status. Incident response plans should be 
devised in anticipation of potential breaches of security, catastrophes, fires or accidents 
and staff should be trained in incident procedures and know their emergency roles. It 
is precautionary to have alternative back-up, local facilities available for germplasm re-
location if a primary storage facility fails. 
 These guidelines pertain to the registration, verification and authentication of new 
plant materials and their accompanying documentation on genebank entry.  
5.1 Recording and registration  
The IVGB should have a checklist comprising a common, generic template for 
documentation, which is used to register biological materials. This might normally 
comprise information from the donor (and/or collector), legal documents, SMTAs 
germplasm access agreements, phytosanitary certification, quarantine requirements, 
passport data, a germplasm list and its sources; a plant import permit is also a local 
requirement. To avoid duplication, it is best practice to check if material is already in 
the genebank, if this is the case, a new lot of the same accession number is assigned, 
identifying the material as the same accession but from a different source. If the 
germplasm is not in the genebank, it is assigned the next available accession number, 
and is registered with information about the donor and any other relevant information 
is entered into the database, thus making a permanent, complete and accurate record 
of the acquisition. For accuracy purposes all information should be verified with the 
donor and/or collector  
5.2 Explant source and starting material  
A generic procedure should be entered into a standard template describing: 
(1) germplasm source [GPS coordinates, in situ provenance/habitat, field genebank] 
(2) collection time, date and season; (3) donor, mother plant-explant, local name(s) and 
other secondary IDs such as herbarium sheets and images for future reference; (4) in 
vitro/genebank or ex vitro origin; (5) how the material is collected, cleaned, pretreated 
with fumigants, pesticides and antifungal agents; (6) physiological status; (7) 
sterilization solutions and procedures used for culture initiation and (8) axenic status. 
Starting material should be described as one of the following: (1) ex vitro, axillary or 
apical shoots or meristems, buds, dormant/active, zygotic seeds, (orthodox, 
intermediate, recalcitrant); (2) embryos, embryonic axes, or seedling shoots and (3) in 
vitro, plants, apical, axillary or adventitious shoots or meristems; somatic embryos, 
pre-embryogenic masses, totipotent embryogenic callus and cell suspension cultures. 
Special treatments and precautions should be noted e.g. that prevent and reduce 
phenolic and oxidative problems (blackening and browning) on initiation.  
5.3 DNA extraction and storage 
Some germplasm from each accession sample may need to be sequestered as either 
leaf material for DNA extraction or extracted DNA. Lyophilization, low and ultra low 
(cryostorage) temperature storage are preferred long-term conservation options for 
providing stabilized ‘type’ DNA-materials used for authentication and genotypic 
 analysis. DNA banks should be subject to best practice guidelines for documentation, 
storage, regulatory documentation, safety duplication, tracking, inventories and 
recording as for other types of genetic resources. 
5.4 Phytosanitary assessments and procedures 
Conservation activities should interface with the repository’s phytosanitary control 
laboratory and confer with specialist crop health personnel on risk assessments/best 
practices for in vitro plant phytosanitary diagnostics, control, quarantine, disease 
indexing and eradication. No pathogen or pest-infected materials should be placed in 
the IVGB which should be strictly contained from points of infection. Special in vitro 
treatments for thermotherapy, virus eradication, meristem culture and diagnostic tests 
for bacteriological indexing and contamination should be documented as best practices 
for: (1) crop-specific pests and pathogens and (2) generic procedures for detection, 
control and eradication of endophytic, covert and adventitious microbial agents and 
pests (e.g. mites).  
5.5 Verification and authentication 
Verification and authentication of culture identity and genotype should be confirmed for 
new accessions using appropriate phenotypic, genotypic, molecular diagnostic and DNA 
fingerprinting tests. This procedure may also confirm duplicate accession and sample 
status. 
5.6 Monitoring new acquisitions  
Newly acquired in vitro materials or freshly initiated germplasm accessions should be 
carefully monitored for contamination, necrosis, viability and physiological vigour. 
Frequent monitoring should be undertaken during culture establishment and 
following transfer from another IVGB, this helps to preclude covert contamination, 
confirm disease-free status and confirms that cultures are responding effectively to 
their new conditions.  
Common policies and procedures should be in place for distribution and access to the 
genetic resources held by IVGBs, taking into account crop/accession-specific issues. 
These include: (1) deployment practices; (2) policy exemptions, (3) National and 
International laws and regulations, including permits/certificates in countries 
commonly holding the crop; (4) crop-specific phytosanitary regulations; (5) feedback 
to users regarding expected time frame to dispatch and critical factors influencing 
delivery; (6) customer assurance information related to client requests; (7) feedback 
request forms recording the most relevant information required by the donor from the 
customer/client; (8) quantity and status of the germplasm dispatched; (9) any special 
handling requirements for germplasm deployment and receipt and (10) risk 
assessment and mitigation protocols to secure safety of the germplasm supply chain 
 from dispatch to receipt (see section 4). Distribution of materials from IVGBs should be 
undertaken in accordance the phytosanitary guidelines and the safe handling of 
germplasm (see in this document, ‘Useful Websites: Plant Protection’).  
6.1 Distribution records 
Templates of checklist procedures are used to ensure requirements are met to dispatch 
germplasm safely and securely in compliance with regulations, examples include:  
1. Check accession request for availability/stock status 
2. Action steps required if stock is low and requires replenishment 
3. Anticipate any special phytosanitary or biosecurity requirements 
4. Check requirements for material transfer agreements 
5. Register request 
6. Check passport data 
7. Prepare list of accessions available 
8. Generate labels 
9. Label accession containers 
10. Check inventory files and locate germplasm in the IVAG 
11. Remove requested samples from the IVAG 
12. Verify accuracy of labels/confirm authentication of sample labels 
13. Perform any special preparations, pretreatment and growing on procedures  
14. Undertake phytosanitary inspections required before dispatch 
15. Prepare information list to accompany materials for dispatch 
a. Passport data 
b. Phytosanitary certificate 
c. Characterization data to confirm accessions 
d. Cover letter 
e. Material Transfer Agreement information 
f. Any other special requirements. 
6.2 Shipping logs  
Shipping logs should be maintained for germplasm dissemination and receipt, ideally 
these are computerized, interfaced with accession inventories and if required 
connected to other genebank activities to allow for sample tracking. Each shipment 
should be given a unique number/code, possible log examples may include: 
1. Shipment reference number 
2. Consignee responsible for handling the shipment and designation 
3. Names and addresses of sending and receiving organizations 
4. Recipient source and type of organization 
5. Purpose of germplasm request and use 
6. Phytosanitary certificate and reference/code numbers 
7. Export permit reference/code number  
 8. Dates shipped and received 
9. Courier company/name and ID code for their tracking of the shipment 
10. Germplasm description 
11. Reference confirmed for Standard Material Transfer Agreement  
12. Number of samples sent and received 
13. Requirements for stabilizing shipment (temperature, LN, dry ice) 
14. Signature of receiving person 
15. Deviations from the shipping log and the actual shipment 
16. Details of any problems with the shipment. 
6.3 Preparing samples for distribution 
Consignment specifications should be determined by the nature of the germplasm/ 
materials, the transit route and destination of the shipment once it is deployed. The 
consignee should determine which regulatory and legal requirements need to be met, 
the physical conditions required for stabilization and the level of containment required 
for secure dispatch. 
6.3.1 Regulatory issues 
The consignee should be trained in the regulatory, risk and safety procedures required 
to support safe and secure shipment of plant genetic resources. Biological samples to 
be transported should be classified with respect to potential dangers/hazards and 
high-risk consignments should be identified and risk mitigation procedures put in 
place. Any media, cryoprotectants and cryogenic substances used to support cultures 
during transit should be classified in terms of their risk, in compliance with IATA and 
national shipping regulations.  
6.3.2 Temperature  
Temperature tolerance limits (high/low) should be identified for germplasm and for 
chilled/cryopreserved samples, critical temperatures (e.g. Tg for vitrified samples) 
should be specified and actions taken to ensure thermal stability during transit. Dry 
shippers contain LN absorbed in a porous matrix in compliance with IATA safety 
regulations. The stability of LN should be test-calibrated for new dry shippers 
regarding the amount of LN required to fully charge and maintain the temperature of 
the dry shipper over required transit times and conditions. It is best practice to ensure 
refrigerated materials are subjected to cold chain management to ensure that their 
cryogens are in sufficient supply to maintain temperature during a transit period. It is 
prudent to allow at least 24 h for a safety margin for delays in arrival.  
6.3.3 Quality control of shipments 
For precious shipments that are heat sensitive or have critical temperature 
requirements for stability such as Tg stabilization it may be prudent to attach a 
temperature-probe/logger to ensure temperature limits have not been exceeded. For 
these cases, test shipments may be simulated before dispatch of the actual materials. 
 6.3.4 Packaging 
Robust, secure and self-contained culture packages and vessels should be selected for 
optimum dispatch security and spaces between them should be filled with packing to 
prevent movement during transit. Shipment packs should be clearly labelled and 
indelible. The consignee is responsible for safe dispatch and should ensure appropriate 
containment and check all packaging regulations are met.  
6.4 Special shipments 
Special permits may be unique to certain countries and regions with respect to 
phytosanitary regulations, therefore good shipping practices should offset risks of 
delay, loss or confiscation where additional documentation may be required. For 
consignments dispatched outside the usual domains of operation or in regions of 
border dispute and conflict, confirmation of additional requirements should be sought. 
For example, in accord with the Convention on International Trade in Endangered 
Species of Wild Fauna and Flora (CITES). Contingencies should be made for possible 
delays in completing additional paper work, particularly for temperature sensitive 
materials and consignments needing cryogen replenishment. Where delays at customs 
are anticipated, it is wise to build in an additional few days of coolant supply. Special 
shipments should include an institutional letter documenting the content and handling 
requirements attached to the import and phytosanitary permits.  
6.5 Tracking in transit 
Both the consignee and recipient should track the germplasm/materials during their 
transit and confirm dispatch and receipt. The recipient should confirm and send an 
electronic shipping manifest before dispatch, confirming that proper personnel, 
facilities and regulatory support (e.g. plant health inspectors) are available on arrival 
of the materials. The shipper should provide a 24-h emergency contact for packages 
transporting at risk and sensitive goods and transit during holidays/weekends should 
be avoided to ensure a safe supply chain.  
6.5.1 Processing on receipt 
The time between sample arrival and processing of germplasm should be taken into 
account, particularly for chilled and cryogenic shipment and the collection, processing 
and storage times should be assessed by the recipient to ensure successful recovery of 
the germplasm; holidays and weekend absences should be factored into receipts. 
Cooling/warming cycles should be avoided for cryopreserved germplasm and this 
should to be dispatched to the cryobank for immediate receipt. Consideration should be 
given to containment, sterility and the physical stability of the consignment on its 
arrival. On receipt, germplasm should be processed as described in Section I of this 
document, section 5. Guidelines for germplasm registration, verification and processing.
 A quality assurance programme (or system) supports the integrated management of 
best practices and quality issues in the IVGB in compliance with expected performance 
indicators. These may be designated for the different levels of genebank operations:  
1. Registration 
2. Regulation 
3. Documentation 
4. Data recording, collection and management 
5. Accession inventory systems and process tracking 
6. Verification (authentication) 
7. Source material and processing 
8. Basic tissue culture 
9. Conservation strategy 
a. Medium-term storage: Slow growth  
b. Long-term storage: Cryopreservation 
10. Biosafety and security 
a. Containment, contamination, transgenes, stability, security 
11. Phytosanitary procedures and healthcare 
12. Storage monitoring 
13. Regeneration, rejuvenation and recycling 
14. Germplasm testing 
15. Germplasm distribution 
16. Training 
17. Risk management 
18. Technology transfer 
19. Validation 
20. Quality Control (QC). 
7.1 Quality control and performance indicators 
Quality control (QC) is a system devised to check that activities are operating to a level 
of performance against defined standards or performance indicators. Internal quality 
control checks should be in place for documentation and monitoring IVGB operations 
within the overarching quality management infrastructure.  
7.1.1 Key performance indicators 
Optimally, Key performance indicators (KPIs) and metrics are devised to enable and 
verify that IVGBs are meeting their conservation and service obligations and goals. At 
the institutional level this can be assessed by external review procedures of 
 independent panels and timely commissioned impact assessment studies, including 
evaluating the influence of the IVGB on networked and global conservation 
communities, international policies, regulations and agendas.  
At the customer level, KPIs assess and correlate: (1) germplasm requisition 
processing; (2) feedback from client satisfaction surveys and (3) impacts on recipients, 
collaborators and beneficiaries. KPIs also monitor the diversity of genebank holdings, 
their usage by end users/recipients, the purposes for which they are used and their 
impacts on beneficiaries as verified by genebank documentation. Research KPIs 
monitor the use of specific types of germplasm, which is quantified as accession 
requests related for example to omics research. Or, crop specific information can be 
reported in formal scientific outputs as the acknowledged use of germplasm that has 
been provided by an IVGB. Performance of a genebank as a knowledge/information 
source can be verified using dissemination and accessibility information based on web-
user statistics. Operational KPIs can comprise quality assessments of the material 
distributed that is based on recipient/client satisfaction. This can be documented as 
customer feedback surveys that are linked to genebank quality management systems. 
These may be devised to assess the diversity in different types of holdings and ideally 
they are linked to passport data which supplies their genetic, geographic and 
taxonomic distributions. Status information should be available regarding the part of 
the crop’s total diversity held in the IVGB and the proportion of which is readily 
available, held in trust or constrained. For example, in terms of accessibility, e.g. low 
viability or stock and phytosanitary restricted or storage/regeneration recalcitrant. 
These include phytosanitary diagnostics and viability/stability tests that are used to 
assess the practices that ensure disease-free germplasm is held in genebanks with 
acceptable levels of viability. Indicators also include regeneration and functional tests 
following germplasm removal from slow growth and cryopreservation. These metrics 
ideally include an automatic alert that warns if the actual performance falls below a 
critical level. For example, indicating a regeneration backlog due to poorly performing 
accessions, or a containment breach putting germplasm at risk of pandemic infection. 
It is important that technical KPIs are interfaced with risk management and safety and 
security operations and that they include black box collections outside the ‘home’ 
genebank.  
These are devised to ensure that the operational, technical and management best 
practices are cost effective, efficient and that they positively contribute to the long-term 
sustainability of the IVGB and the security of its holdings within any budgetary 
constraints. It is prudent to note that efficient and cost-cutting measures should not 
jeopardize any risk management and mitigation issues and that they should support 
and retain regulatory and legal compliance.  
 7.2 Quality audits 
To maintain QM systems once they have been established, it is important that annual, 
internal audits are carried out to ensure policies and procedures are undertaken in 
accordance with the quality system and its best practices. The programme should cover 
all activities including documentation, supply chains, accessions, databases, germplasm 
acquisition, distribution, training records, equipment, facilities use and maintenance, 
orders supplies, services and complaints. Quality audit procedures should be undertaken 
in cooperation with Management and the Safety Committee (see section 4) to ensure 
continued compliance with regulatory obligations. The production of new and updated 
technical guidelines and handbooks should be processed via internal and ideally 
independent peer review.  
7.2.1 Third party assessment and accreditation 
Third party assessment and accreditation may be an option and IVGBs may wish to 
aspire to (external) third party accreditation status, for which ISO standards and 
certification are one possibility (Betsou et al. 2008). Audits should be undertaken to 
acquire and maintain accreditation status and these will necessarily need to be 
supported by the rigorous upholding of internal quality standards. Translation of 
IVGB standards, best practices and operating guidelines into ISO-compatible formats 
offer useful opportunities to assist the process of accreditation, as is currently the case 
in the wider bioresources community (Betsou et al. 2008; ISBER 2008). However, when 
considering the adoption of third part accreditation, it should be undertaken in a 
management framework that accounts for the additional training and workload that 
the process of external accreditation will generate. Specifically, an accreditation 
process should not detract from ongoing genebank activities (e.g. characterization, 
regeneration, evaluation, collecting missions, database management) but rather, in the 
longer term it should add to the overall efficiency and quality of genebank activities.  
7.3 Developing best practices for clonal crop in vitro conservation  
To ensure parity and the quality control of procedures, processes, data and inventories; 
crop-specific best practice formats should be created by consensus and technically 
verified in house; ideally, the protocols should then be validated across federated 
genebanks. The standardized formatting of methodologies as best practices supports 
quality management systems for which exemplars include: 
1. Title of best practice (BP): to prevent confusion this should be a unique name.  
2. Number: for ease of identification, a unique code, including revision version to 
ensure the most recent update is used. 
3. Date: date the procedure was first created/most recent update and by whom. 
4. Department/personnel: to whom the BP applies.  
5. Safety and protection: details of risk management and mitigation, special safety 
measures and personal protective clothing needed to undertake the BP.  
6. Equipment: list of equipment required to undertake the BP. 
 7. Consumables, reagents, and media: list of supplies needed to undertake the BP. 
8. Special treatments: a list of any special treatments and any processes involved. 
9. Critical points: details of specific technical issues affecting successful outcomes. 
10. Method: step-by-step technical guidance explaining how to undertake the procedure 
or protocol. This should contain sufficient detail to allow the BP to be repeated and 
reproduced by trained, personnel without ambiguity. It is useful to include technical 
explanatory notes, media formulations, and explicit guidance for each step; any 
special conditions and critical factors may also be included. 
The BP format can also be adapted to create specific SOPs. The development of best 
practices for clonal crops and genebanks is facilitated by reaching consensus on generic 
technical guidelines from which future best practices can be developed for specific 
crops and if needed on a genotype basis. To enable this process Section II of these 
guidelines presents generic technical guidelines common to clonal crops. Best practice 
guidelines may also be used to help formulate SOPs within IVGBs and across federated 
genebanks. Sections I and II are supported by Appendix I which comprises bibliographies 
of technical and quality assurance information, literature concerning CGIAR’s 
mandated clonal crops, research and technical publications. 
 
 
 These guidelines should be used in conjunction with Section I ‚General best practice 
guidelines for clonal crop in vitro genebanks‛. The objective of Section II is to provide 
technical information to support the development of multi-crop best practices for 
clonal crop in vitro genebanks within the context of the GPG2 project and CGIAR’s 
clonal crop genebanks. The technical guidelines comprise basic and generic techniques 
and procedures for the tissue culture (including associated manipulations), slow 
growth and shoot meristem cryopreservation of clonally propagated crop plants, as 
well as specific storage protocols.  
The technical guidelines presented in Section II are generated from the results of 
the GPG2 Project CCTF survey and the wider published literature (see Benson et al. 
2011a, b). In sequence, these guidelines first present the technical details of the basic 
equipment, materials and methods that collectively comprise the generic procedures 
(e.g. culture initiation, subculture, pretreatments, encapsulation and cryoprotection 
regimes) that are most commonly used in CGIAR’s clonal crop genebanks (see sections 
1-8; 10 to 10.5). Secondly, particular protocols that are used for the medium-term (slow 
growth) and long-term (cryopreservation) conservation of CGIAR’s clonal crop 
germplasm are described in more specific step-by-step detail (sections 9 and 10.6). 
Critical point factors connected with each component step of a basic procedure or 
storage protocol are highlighted. Section II concludes with general guidelines (see 
sections 10.7 to 10.11) that concern associated practices and troubleshooting issues.  
The technical requirements for executing the manipulations, procedures and 
protocols presented in Section II are based on the minimal requirements for 
propagating tissue cultures in a basic in vitro laboratory (FAO 1985), specialist 
facilities/equipment are noted as required.  
Shoot cultures are initiated from suitable explants (e.g. shoots, tuber spouts, cuttings) 
comprising either ex vitro materials (e.g. from field genebanks, shade or glasshouses) 
or propagated materials from axenic in vitro cultures. The following basic protocols are 
based on the premise that donor plants and explants have already been processed via 
quarantine, phytosanitary testing, disease eradication and virus indexing procedures.  
1.1 Equipment and materials  
 Surface sterilizing solutions: e.g. 70% (v/v) alcohol, 5-10% (v/v) sodium 
hypochlorite [NaClO], prepared from commercial beach [ca. 10-30% NaClO], 
optional wetting agent [Tween 20]. 
 Sterile distilled water dispensed into 20-50 ml bottles for washing tissues. 
  Optional antifungal, antibiotic and antimicrobial agents (e.g. Plant Preservation 
Mixture PPM®). 
 Sterilized dissection instruments, filter papers, Petri dishes. 
 Binocular microscope with a sterile operating surface (i.e. sterile filter papers, open 
sterile Petri dish). 
 Culture medium (crop-specific) dispensed into suitable culture vessels. 
1.2 Procedure 
1.2.1 Non-sterile manipulations 
1. Record all accession details.  
2. Select a sufficient number of explants (e.g. nodes, bud cuttings, apical or axillary 
shoots) for creating a new accession and take into account the potential need to: 
a. Test non-axenic/non-indexed cultures for phytosanitary purposes.  
b. Replenish losses caused by contamination during initiation. 
c. Replenish losses due to latent infections by systemic endophytic flora. 
d. Replenish losses due to lack of or poor growth. 
3. Check ex vitro donor materials for pests, thrips, and mites. 
a. Wash in mild detergent, rinse several times in laboratory tap water to remove 
any contaminating pests.  
4. Cut each explant to a suitable size for sterilization (e.g. nodal bud + 1cm of stem 
either side, one apical bud with sub-basal tissue and non-expanded leaves).  
5. Take care to prevent dehydration of the cuttings.  
6. Use minimal cuts to reduce wound-induced oxidation (browning/blackening).  
1.2.2 Sterile manipulations 
1. These should be undertaken in a laminar airflow bench using aseptic technique. 
2. Soak the explants in 70% (v/v) alcohol, with the duration optimized for 1-5 min. 
3. Optimize surface sterilization by testing explant exposure to 5-10% (v/v) sodium 
hypochlorite solution (with wetting agent as required) for 10-15 min (or longer as 
required).  
4. If necessary, apply a topical or systemic fungicide treatment, concomitantly or 
sequentially with the sodium hypochlorite solution.  
5. Use percentage survival and percentage contamination as performance indicators 
to optimize sterilant concentrations and exposure times.  
6. Using sterile forceps remove explant materials from the sterilant/fungicide and 
wash 3-5 times in sterile distilled water, ensuring that all the surfactant is removed.  
a. For persistent infections, the fungicide may be retained during the first stages of 
culture initiation and re-applied after the washing treatment.  
 7. Place the explant on a sterile surface, (filter paper/open Petri dish) and use a sterile 
scalpel to remove wounded tissue from: (a) the cut edges of a nodal cutting and/or 
(b) the basal tissue and expanded leaves of shoot tips.  
a. Wounded tissue will usually be bleached white or oxidized black/brown.  
8. Optionally, use a binocular microscope to aid the dissection of shoot meristems by 
locating the apical dome, and with the aid of sterile hypodermic needles, or 
scalpels cut away any expanded leaf primordia and tissue subjacent to the apical 
region. 
9. If necessary, blot the explant dry on a sterile filter paper to remove excess water 
and transfer to the appropriate crop-specific culture initiation medium.  
10. Take care that the orientation of the explant is appropriate for shoot growth. 
11. Leaving the ‘planting end’ of a nodal cutting a little longer is a good point of 
reference for positioning the explant correctly in the culture medium.  
12. It is a precautionary measure to place one explant/culture vessel to limit cross-
contamination losses. 
13. Seal culture vessels with ParafilmR, (or equivalent) or cling film may be used as a 
cost effective alternative.  
14. Label clearly, using a standardized format applied either manually or by a data 
logger-barcode, the label should be positioned so that it does not obscure visual 
inspection of the culture.  
15. Transfer the culture to a quarantined environmental control room set at the 
appropriate crop-specific temperature/light regime. 
16. Inspect isolates daily for the first two weeks and remove any contaminated 
cultures; check twice weekly thereafter to remove contaminated cultures and 
isolate growing axillary buds from the original stem. Contaminated isolates should 
be autoclaved prior to opening the tissue culture vessel. 
1.3 Critical points 
 These guidelines are generic, crop-specific best practices include technical details of any 
special and optimal treatments required for successful culture initiation. 
o Examples include: photoperiod, light intensity, temperature, media additives (charcoal, 
plant growth regulators, glucose as an alternative metabolite, antioxidants) and 
crop/genotype specific media. 
 Vigilance limits the risks of contamination occurring during the initiation of cultures from 
field-derived materials, woody perennials and soil-sampled root and tuber explants. 
 Culture initiation should be optimized by taking into account seasonal, physiological and 
developmental factors as these can be critical to successful outcomes. 
 When using antimicrobial agents/antibiotics it is important to limit the risks of microbial 
resistance occurring.  
 Quality control measures should be in place to help identify potential points and sources of 
infection and cross-contamination e.g. from personnel, media and lack of containment. 
  It is good practice to test new cultures for systemic infection 4-6 months after initiation 
using bacteriological indexing procedures.  
 Some wrapping products (e.g. cling film) may produce volatiles such as ethylene that are 
inhibitory to plant growth.  
 Should an adventitious or systemic contamination incident arise it is prudent to develop 
isolation and containment procedures to prevent pandemic losses of germplasm in the 
IVGB. 
Best practices are required for optimizing growth media and culture regimes for 
actively growing cultures as these provide material for slow growth and 
cryopreservation; they are also used in post-storage recovery. Procedures comprise the 
micropropagation of established tissue cultures for the IVAG and IVBG and culture 
dispatch and regeneration. In addition, cultures are used for quality control, stability 
assessments and research. All procedures are performed using aseptic technique 
applied under sterile conditions in a laminar airflow bench. 
2.1 Equipment and materials 
 Cultures to be micropropagated. 
 New culture vessels containing fresh medium. 
 Sterile instruments, filter papers. 
2.2 Procedure 
1. Select established shoot cultures at an optimal time in their subculture cycle.  
2. Check for contamination and physiological status. 
3. Discard any infected materials and unhealthy cultures.  
4. Using aseptic technique, remove a shoot from the culture vessel. 
5. Transfer tissue to a sterile surface e.g. filters paper, Petri dish.  
6. Take micro-cuttings of shoot cultures as required for apical and/or nodal sections 
(e.g. for cryopreservation or slow growth initiation). 
7. For axillary nodes, cut at either side of the stem, ensuring each section contains a 
node and a stem segment, in most cases trim tissues to have half-expanded leaves.  
8. Apices should be undamaged and of an optimal size to support shoot growth.  
9. Transfer nodal cuttings/shoot apices, correctly orientated, to new medium. 
10. It is precautionary to place one explant/culture vessel to limit cross-contamination. 
11. Seal culture vessels with ParafilmR (or equivalent) or cling film may be used as a 
cost effective alternative.  
12. Label clearly using a standardized format either manually or a data logger-barcode. 
13. Transfer to a culture room regulated at the appropriate crop-specific, 
temperature/light regime.  
 2.3 Critical points 
 Micropropagated cultures should be checked regularly for systemic infection, adventitious 
and endophytic contamination, health and vigour following each subculture cycle. 
 Species and genotypes especially susceptible to hyperhydricity, somaclonal variation (SCV), 
loss of totipotency, habituation, in vitro ageing and culture recalcitrance should be 
monitored more carefully and procedures (e.g. culture optimization, regeneration) should be 
developed to prevent or reduce any specific physiological, culture problem. 
 Unambiguous, technically complete protocols should be written for each type of crop-
specific tissue culture, including full details of medium preparation, subculturing practices, 
type of culture vessel, closure and culture room parameters (light regimes [photoperiod, 
quality and intensity], temperature and humidity). 
 Strategies for the rejuvenation and recycling of materials held in active tissue culture 
should be devised to take into account loss of vigour, totipotency and a decline in culture 
performance over long periods of maintenance in vitro. 
 Rejuvenation and regeneration cycles should be especially undertaken for ageing cultures. 
 The risks of adventitious microbial contaminants and instability (e.g. SCV) should be 
assessed on a regular basis particularly in older cultures.  
 Young, vigorous and totipotent cultures should be preferentially selected for slow growth 
and cryopreservation.  
These procedures are used to test initiated explants for systemic and latent infections 
that arise from endophytic or covert bacteria and microbial flora or spores that are 
resilient to standard surface sterilizing procedures.  
3.1 Equipment and materials 
 Tubes containing nutrient enriched (e.g. containing, peptone, yeast extract, glucose) 
broad spectrum, liquid bacteriological test medium made in full or ½ strength 
plant culture medium. 
 Petri dishes containing broad spectrum, semi-solid bacteriological test medium. 
3.2 Procedures 
3.2.1 Screening for systemic contaminants during surface sterilization/initiation 
1. Explants are surface sterilized as described above and transferred to liquid-form 
bacteriological test medium. Contaminated explants will be revealed by the cloudy 
or flocculated growth of microorganisms. 
2. If cultures are contaminated, discard and repeat the surface sterilization procedure 
on a new batch of explants.  
 3. If cultures are not contaminated, proceed to culture initiation and proliferation; 
continue stringent surveillance for the first three months after initiation; longer 
may be required for persistent, endophytic and covert infections. 
3.2.2 Screening of suspect contaminants for quality control 
1. Remove the suspect plants and shoots from standard culture. 
2. Streak the base of the plants on Petri dishes containing broad spectrum, semi-solid 
bacteriological test medium and incubate the culture for 2-14 days at 25°C. 
Alternatively, a stem or node explant can be placed directly onto the bacteriological 
test medium.  
 Noting that it can sometimes take several weeks or longer for covert 
contaminants to be revealed. 
3. Plates should be checked with a hand lens or microscope. 
4. Transfer individual plants/shoots to standard culture medium and retain for the 
results outcome. 
 Plants/shoots that test positive for contaminated streak-plates should be 
discarded and their accessions can be reinitiated if necessary.  
 Plants/shoots that test negative can be reinstated. 
3.3 Critical points 
 Bacterial indexing should be applied as appropriate:  
o on culture initiation, 
o before material is placed in the IVAG and IVBG, 
o as routine quality control checks (e.g. every 3-5 MTS cycles), 
o when covert and endophytic infections are suspected, 
o before the dispatch of cultures, 
o before cultures are used for diagnostic tests and research purposes. 
Newly initiated cultures should be processed in batches and their progress through the 
system monitored, ideally using electronic inventories and barcodes. Only successful 
introductions to the genebank should be entered, although in some cases information 
related to problematic germplasm and unsuccessful initiation may be useful for 
troubleshooting and optimizing new procedures. These types of entry should be 
considered for separate archiving as appropriate.  
4.1 Exemplars of recording data 
 Batch No. 
 Accession No. 
 Date introduced in vitro 
 Number of explants introduced 
  Contamination status 
 Necrosis status 
 Vigour status 
 Dispatched for 1st multiplication cycle 
 Contaminated in 1st multiplication cycle 
 Necrotic in 1st multiplication cycle  
 Vigour loss in 1st multiplication cycle  
 Number of plants, seedlings, proliferating shoots sent to genebank  
 Operator responsible for batch. 
 
Once an accession is newly introduced into the bank, its accession number is 
entered into the database and progress through the system may be recorded, for 
example as follows: 
 Accession No. 
 Date introduced in vitro 
o where there is a replacement accession, previous entries are discarded. 
 Explant type: 
o meristem/nodal cutting/plantlet/ proliferating shoots/tuber sprouts. 
 Phytosanitary status: 
o tested virus-free yes/no, 
o bacteriologically indexed yes/no. 
 Sequential genebank updates (dd/mm/yy) as to status of:  
o progressive subculture cycles, 
o Inventory status:  
 No. tubes going in and out of the bank with a reason given e.g.  
 eliminated due to contamination, vigour loss, necrosis death;  
 dispatched for utility purpose (research, genebanking, duplication, 
multiplication/distribution, diagnostic testing, phytosanitary testing, 
stability, authentication, quality control). 
o Contamination during multiplication cycles. 
o Loss of vigour during multiplication cycles. 
o Necrosis during multiplication cycles. 
o Viability/death. 
 
These common formats are applicable to cultures and germplasm maintained in 
active growth, MTS and LTS.  
 4.2 Critical points 
 A comprehensive record as to the progress and outcomes of newly initiated germplasm in 
relation to accession status in MTS and LTS should be maintained. 
 Ideally, electronic barcoding systems should be used for tracking.  
 Robust recording and inventory systems are needed to ensure the production of accurate, 
safe and secure records for cultures that are held in IVAGs and IVBGs for extended periods. 
 For in vitro collections that have not been systematically documented or characterized, 
procedures should be in place to upgrade records, documentation and inventories. 
o These may need to be authenticated by a field regeneration cycle in which plants are 
grown alongside taxonomic reference accessions for verification using crop descriptors. 
 The issues of variable quality and accuracy of archived and contemporary inventories 
should be addressed and there should be procedures in place for systematically upgrading 
(e.g. by barcoding and electronic inventories) archives that are connected to crop specific 
knowledge bases. These should be hosted by well-maintained websites. 
A standard monitoring template should be devised for cultures maintained in, and 
recovered from active in vitro growth, MTS and LTS and robust performance 
indicators should be developed to assess consistently and accurately culture growth. 
These procedures should be verified by different internal operators and ideally they 
should be validated across federated/collaborating genebanks that hold crops in 
common and use the same storage methods. Assessment scales and metrics need to be 
sufficiently robust to extend over significant time scales and changes in personnel. 
Main monitoring criteria are: (1) plant health, (2) extension of subculture interval (for 
MTS), (3) viability after cryostorage (4) contamination frequency and (5) capacity to 
recover and perform fit-for-purpose after storage stress. The periodic grow-out of 
cultures is advised to ensure that they can still be acclimated to glasshouse conditions 
and are ‚true-to-type‛.  
Monitoring descriptors and performance indicators could utilize computer-based 
image analyses. Where observational descriptive scales are used (e.g. for viability, 
vigour and health status) they should be qualified with visual exemplars and 
quantified, without ambiguity, on point scales (e.g. 1-5) or as a percentage of the 
overall population/explant. Exemplars include (see Reed et al. 1998, 2003): 
6.1 Point scale 
0 = dead, all the plantlet is brown or bleached, no visible indication of growth 
1 =  very poor, doubtful viability, brown, necrotic shoots, with some green 
2 =  poor, mainly brown/bleached, most shoot tips are necrotic, some shoot tips remain green, 
leaves/stems mainly brown, explant base necrotic  
 3 =  acceptable some browning/beaching, some shoot tips necrotic, shoot tips and upper 
leaves green, etiolation present, base green 
4 =  good, elongated shoots, shoot tips generally healthy, green leaves, stem, limited 
etiolation and necrosis 
5 =  excellent, green leaves and shoots, no etiolation, browning or bleaching 
6.2 Percentage scale for monthly assessments of stem necrosis  
100% Lost-dead  
30-70% Bad  
10-30%  Medium  
0-10%  Good  
 
Performance indicators for MTS can also be devised as leaf senescence indexes 
(ratio of green: dead leaves) or micropropagation potential (number of green apical 
shoots, nodes and stems available for subsequent culture and rooting capability). 
Performance indicators for post-cryopreservation recovery are: (1) viability; (2) shoot 
regrowth/multiplication/regeneration, (3) plant regeneration; (4) field-based assess-
ments of development and trueness-to-type using crop descriptors and (5) cytological, 
biochemical, genetic and epigenetic stability assessments.  
6.3 Critical points 
 Abnormal, adventitious and dedifferentiated development should be noted as negative 
performance indicators because:  
o they may indicate compromised genetic stability, however they can be used to assist the 
optimization of recovery protocols (e.g. choice of plant growth regulator). 
 Surveillance of cultures at all stages of processing and storage is critical, regular reviews are 
recommended on a daily or 1-4 monthly basis, dependent upon the crop, and subculture 
cycle extension during MTS. 
 Clear guidance should be provided for making decisions as to discard, rescue and transfer 
cultures falling outside the normally expected limits of germplasm loss. 
o Ideally these should be based on a systematic register of visual and documented 
performance indicators (e.g. using surveys extended over more than one slow growth 
cycle) and performed for all accessions held in the IVGB. 
 On recovery from MTS and LTS phenotypic and genotypic stability assessments should be 
applied as a quality control measure as appropriate. 
o These may be optimally confirmed by performance testing in field trials; more than one 
complete regeneration cycle is recommended for clonal crops/genotypes that are more 
susceptible to SCV and off-types (Scowcroft 1984).  
 A standard format should be developed for the quality control of newly initiated and 
actively growing cultures and germplasm held in and recovered from slow growth and 
cryostorage. Quality control usually comprises four basic checks: (1) contamination/ 
phytosanitary health; (2) physiological stress and vigour; (3) viability and (4) stability. 
Where semi-quantitative descriptors and observational metrics (e.g. good or bad 
scales/numerical codes [1-5 or, 0-100%] or a necrosis index (e.g. colour degree of 
greening, blackening, browning, necrosis, hyperhydricity) for culture health status are 
applied, an image key should be constructed as this provides a comparator between 
different operators. Optimally, observational tools should be aided by computer-based 
imaging systems (e.g. digital photographs). Vigilant and regular contamination checks 
should be undertaken with particular care to detect covert, endophytic infections and 
prevent pandemics arising as a result of delayed microbial proliferation.  
Identity verification should be undertaken as a routine quality control measure across 
the IVGB and in the responsive testing of cultures and regenerants that display 
uncharacteristic growth habits that are not true-to-type for standard descriptors. It is 
prudent to authenticate materials at strategic points for example: (1) for more 
frequently requested accessions (even though all accessions are equally important); 
(2) less frequently requested accessions, which should be targeted to avoid them 
falling through ‘surveillance cracks’; (3) germplasm required for breeding purposes 
and (4) landraces requested for distribution. When differences between 
accessions/clones are observed molecular, genotypic and phenotypic diagnostic tests 
should be applied to ascertain if the differences are due to mislabelling, 
misidentification or instability. Ideally, mislabelled clones should be identified by 
comparing in vitro materials with field-grown clones using descriptors, databases and 
donor supplied information. Genotype verification is best undertaken by a genetic 
quality laboratory/unit which has the capacity to identify duplicates, redundant 
accessions, mislabelling and identification errors. It is also important to confirm the 
stability of plants that display aberrant growth habits before their germplasm is placed 
in storage and following recovery.  
These guidelines pertain to the tissue culture and associated practices that are used to 
extend routine subculturing intervals of in vitro germplasm stored in slow growth in 
the IVAG, noting that detailed technical guidelines for MTS should be produced on a 
crop-specific basis and that microtuber in vitro storage is an alternative method for 
some crops. Inventories should be in place to document the type (e.g. wild species, 
cultivar, landrace, breeding lines) and nature of the explant (in vitro shoots, seedlings, 
 cultures, tubers) that are used to establish MTS collections. The number of replicates 
per accession should be recommended using evidence based knowledge of recovery, 
accession requests, regeneration frequency and the potential for germplasm loss. 
Where possible well-defined performance metrics should be used to assess recovery, 
vigour, contamination, genetic variability and instability (see section 6).  
9.1 Retardation using low temperature and light  
Low temperature and minimal light treatments should be optimized to critical low 
limits of tolerance and as required best practices should be moderated for different 
accessions, species and genotypes.  
9.1.1 Equipment and materials  
 Standard culture medium dispensed into suitable vessels fitted with non-
perishable, robust closures previously checked for deterioration during long-term 
storage (as an alternative, heat sealed vessels i.e. STAR*PACS™ ; AgriStar, Sealy, 
Texas, could be used). 
 Indelible, permanent labels, preferably barcoded. 
 Healthy, axenic and bacteriologically indexed cultures. 
 A secure, growth environment, accurate to light and temperature specifications. 
 Sterile instruments, filter papers. 
9.1.2 Procedure 
1. Prepare standard culture medium and dispense into storage vessels (an increased 
volume may be needed for prolonged storage).  
2. Select explants from actively growing subcultures, ensuring that no selection 
occurs, other than discarding contaminated or unhealthy specimens. 
3. Transfer to storage medium as in vitro plantlets, proliferating shoots, microtubers 
or nodal cuttings. Optimize selection for MTS based on explant type, size, age and 
stage of development.  
4. Record standard performance indicators of cultures before they are placed in MTS. 
Use this data as reference criteria for surveillance, quality control and as a 
comparator for subsequent culture transfers. Digital imaging may help to set a base 
line for the recording procedure.  
5. If necessary, incubate cultures for 1-2 days or longer, under standard growth at 
optimal light/temperature to confirm health status. Then transfer the cultures to 
minimal conditions before they start to proliferate excessively or require 
subculturing or become senescent. 
6. Transfer cultures to appropriate conditions (no light, minimal light and low 
temperature) that have been optimized on a crop and genotype-specific basis (as 
required). For cold tolerant/temperate species these can range from 4°C to 15°C and 
for tropical and chill sensitive species from 16°C to 22°C.  
 7. Optimize light regime for photoperiod (e.g. 16 h light:8 h dark, 12 h:12 h light/dark, 
total darkness). The reduction of Photosynthetic Photon Flux (PPF) usually varies 
from ca. > 5 to 50 μmol m-2 s-1.  
8. Monitor cultures on a weekly basis and check for contamination and deterioration. 
9. Record culture extension periods and deterioration on a genotype basis for future 
reference and use this data to determine the logistics for subculturing, regeneration 
and recovery.  
10. Remove cultures from minimal storage conditions. 
11. Transfer to fresh culture medium, return to optimal light, and temperature regimes.  
12. Test performance and confirm stability (see sections 6, 7 and 10.9). 
13. Micropropagate under standard conditions and use or dispatch as required.  
9.1.3 Critical points 
 Regular surveillance checklists should be used to monitor status and environmental control 
specifications for growth rooms, cold rooms and incubators holding germplasm under low 
light and temperature regimes.  
 Slow growth environmental chambers should be equipped with an alarm in a secured 
location. 
9.2 Retardation using osmotica 
Osmotic agents minimize growth by the osmotic withdrawal of water across semi-
permeable membranes; in effect this process causes growth retardation primarily by 
water limitation. Osmotic agents can be applied singularly or in combination with 
other additives. 
9.2.1 Equipment and materials  
 Culture medium containing osmotic agents at optimized concentration (e.g. 15-
60 g/l mannitol or sorbitol and/or 20-60 g/l sucrose and/or at an increased level of 
agar/gelling agent) dispensed into suitable vessels with non-perishable, robust 
closures previously checked for deterioration during long-term storage. 
 Indelible, permanent labels that are preferably barcoded. 
 Healthy, axenic and bacteriologically indexed cultures. 
 A secure, growth room environment calibrated to an optimal specification. 
 Sterile instruments, filter papers, laminar airflow bench. 
9.2.2 Procedure 
1. Prepare culture medium incorporating osmotic agent(s) the composition of which 
should be optimized on a crop/genotype-specific basis (as appropriate) options 
include mannitol or sorbitol combined with sucrose at growth-limiting levels. 
2. Care should be taken in autoclaving media with sugars and sugar alcohols to avoid 
deleterious heat treatment effects. These include caramelization of sugars, 
hydrolysis of sucrose to glucose and fructose and carbohydrate breakdown 
 exacerbated by interactions between different media components, (particularly Fe-
NaEDTA). Whilst these effects may occur at lower concentrations, they may 
become evident in media enriched with higher levels of sugars (Evans et al. 2003, 
Schenk et al. 1991). The issue of carbohydrate stability during extended autoclave 
cycles may become significant in media where sugars and polyols are applied for 
growth retardation and cryoprotective purposes.  
3. Dispense the medium into storage vessels, noting that an increased volume may be 
needed for prolonged storage.  
4. Select cultures from actively growing subcultures, taking care that no selection 
occurs other than discarding contaminated or unhealthy specimens. 
5. Record standard performance indicators of cultures before they are placed in MTS. 
Use this data as reference criteria for surveillance, quality control and for 
comparisons with subsequent culture transfers.  
6. Transfer to osmotica-supplemented medium as either fully developed in vitro 
plantlets, proliferating shoots, microtubers or nodal cuttings. Optimize explant 
selection for MTS based on explant type, size, age and stage of development.  
7. Transfer cultures to the growth room optimized for light regime, photoperiod and 
temperature. 
8. Monitor cultures on a weekly basis and check for contamination and deterioration. 
9. Record culture extension periods and deterioration on a genotype basis for future 
reference and determine logistics for IVAG subculturing, regeneration cycles and 
recovery.  
10. Remove cultures from minimal storage conditions, transfer to fresh culture 
medium and return to optimal light and temperature regimes.  
11. Test culture performance, confirm stability and micropropagate under standard 
conditions, thereafter dispatch as required.  
9.2.3 Critical points 
 For optimization, a range of osmotica should be tested at different concentrations and 
exposure times for different explant types.  
 Combinations of growth retarding treatments can also be used, these can comprise minimal 
light, low temperature and osmotica and they should be tested in their various permutations 
for enhancing subculture extension.  
9.3 Retardation using inhibitory growth regulators 
Physical (light/temperature) and osmotic growth limitation are the usual choices for 
facilitating slow growth storage. Where these parameters are either sub-optimal or 
deleterious, alternative treatments may be considered as a substitute, or applied in 
combination. This does not necessarily exclude the use of alternative treatments for 
which options include using ancymidol (a growth inhibitor) and/or applying 
acetylsalicylic as an alternative to mannitol (Chau-um and Kirdmanee 2007).  
 9.4 Other minimal growth options 
Reducing the levels of standard growth regulators and hormones in cold-sensitive 
genotypes provides an alternative approach for MTS. Nutrient limitation is usually 
imposed by reducing sucrose and nitrogen in the media (e.g. ½ to ¼ strength).  
9.5 Stress amelioration treatments  
It may be necessary to alleviate the effects of stress (e.g. hyperhydricity, in vitro 
senescence and phenolic production) and the production of morphological 
abnormalities induced by slow growth treatments. Plants maintained in vitro for long 
periods accumulate ethylene and care should be taken in using culture vessels that 
allow gaseous exchange without compromising containment. The production of 
ethylene during slow growth may be attenuated by applying silver thiosulfate and 
other ethylene pathway inhibitors (Roca et al. 1984, 1992; Mafla et al. 2004; Chau-um 
and Kirdmanee 2007). It is cautionary to use minimal growth regimes that do not 
compromise nutritional status to the extent that severe stress is caused and to prevent 
this problem it may be prudent to re-formulate culture media. For example (see Chau-
um and Kirdmanee 2007), this may be achieved by optimizing iron availability, 
changing the chelating agent, calcium supplementation and altering macronutrient 
composition (see section 9.4).  
9.6 Control of contamination in medium-term storage 
Personnel should be fully aware of the special contamination and containment issues 
that can potentially affect germplasm held in MTS:  
1. Greater contamination occurs in explants from soil-derived donors. 
2. Explants from perennials often have complex communities of resident flora.  
3. Surface sterilized material may be non-axenic due to the presence of covert 
infections and systemic endophytes. 
4. Latent infections can be revealed several weeks or even months or years after 
culture initiation. 
5. Latent infection proliferation is exacerbated by stress treatments.  
6. Stresses change the susceptibility of host tissue to microbial spoilage. 
7. Symbiotic/commensal and harmless endophytic bacteria can become opportunistic 
pathogens in stressed tissues.  
8. Physiological stress symptoms may be due to systemic infections and not abiotic or 
sub-optimal treatment factors. 
9. Checks should be undertaken for cultures that are asymptomatic for signs of visual 
infections. 
10. Covert and endophytic contaminants can interfere with molecular diagnostic tests. 
11. Older shoot cultures seem to be more susceptible to contamination and can also be 
a source of insect and pest contamination (i.e. mites/thrips) 
 9.6.1 Critical points 
 An overarching, quality control system is recommended for managing containment and 
contamination in IVAGs and IVBGs. 
 This should include routine, spot and process testing of cultures for covert and endophytic 
contamination using microbial indexing/wide-screening detection media.  
 For persistent infections, identification of organisms may be necessary to help target 
strategies for their elimination. 
 Antibiotics should be used judiciously as they can cause resistance problems. 
 All contaminated cultures should be removed immediately from MTS. 
 Contaminated cultures should only be discarded after autoclaving.  
9.7 Choosing minimal slow growth protocols  
The principle of slow growth storage is based on optimizing subculture extension 
without risking germplasm loss and compromising genetic stability through stressful 
treatments. It is good practice when selecting an MTS protocol to conduct, over time, a 
cost benefit analysis of savings for resources, time, energy costs and space. This may be 
equated with maximum-minimum and average recovery ranges for (genebank-
significant) numbers of accessions. The process may also be calibrated by exposing 
different genotypes to several cycles of growth retardants in order to establish robust 
performance and stability assessment criteria (see sections 6, 7 and 9.9). It is important 
to note that genotype response to growth limiting treatments can be highly variable 
(IPGRI-CIAT 1994; Pennycooke and Towill 2001). In vitro genebanks should therefore 
carefully consider the economic and efficiency benefits of optimizing standard slow 
growth regimes for storage-recalcitrant outliers. It is also important to note that low 
recovery in stress-sensitive genotypes may not be cost effective or good practice in the 
longer-term because of the risks of selection pressures and germplasm loss. These 
factors are also compounded by poor regeneration in field regeneration cycles, loss of 
trueness-to-type and the costs of performing genetic and epigenetic stability 
assessments (see section 10.9).  
9.8 Recovery, rejuvenation and recycling 
Recovery procedures for germplasm maintained in slow growth are critically 
dependent upon monitoring the health of stored accessions and their timely 
regeneration and rejuvenation. Timing of recovery is dependent on the species, 
accession, explants stored, media used and/or environmental conditions of storage. 
The processes of recovery, rejuvenation and recycling can help to reduce the risks of 
irretrievable losses, genetic instability and selection pressures.  
9.9 Stability  
Careful selection of donor germplasm and stringent optimization of storage conditions 
are required to minimize stress and selection pressures, therefore personnel should be 
aware of the precautions that minimize genetic and epigenetic changes, they include:  
 1. An awareness that some genotypes and accessions of asexually (clonally) 
propagated species are more likely to display genetic variation that is generated via 
tissue culture (i.e. as SCV) than are seed propagated species (Scowcroft 1984; 
Harding 2004) and that specific clonal genotypes may have a propensity for 
producing off-types and variants.  
2. Optimizing subculture intervals before field regeneration is important as 
prolonged culture increases frequencies of chromosomal aberrations, SCV and 
epigenetic changes (Scowcroft 1984). 
3. The possibility that in vitro selection pressure can potentially generate mutants. 
4. Recovery responses need to be sufficiently high to offset the problem of selection.  
9.9.1 Critical points 
 Minimal growth treatments can exacerbate abnormal morphogenetic responses. 
 Stability assessment is an important quality control measure. 
 Many different methods are currently employed for stability assessments (phenotypic, 
chromosomal, cytological, epigenetic, and genetic molecular tests, RAPD, DNA 
methylation, RFLP, AFLP) therefore careful choice and testing of analyses is required. 
 Molecular diagnostics mainly screen a very small part of the genome and some changes may 
not be detected.  
 Maintaining shoot and plantlet regeneration through preformed (original) meristems 
(apical and axillary buds) and avoiding adventitious shoots will greatly aid the maintenance 
of trueness-to-type and genetic stability and offset the risks of SCV. 
 Field trials are recommended to test for trueness-to-type and authenticate germplasm 
identity, particularly for genotypes that have a propensity for instability/off-types being 
generated. 
9.10 Problems, trouble-shooting and improvements 
The main factors limiting successful conservation in MTS are variable genotype 
responses, aberrant morphogenetic behaviour, hyperhydricity, necrosis, polyphenolic 
oxidation, covert, delayed and endophytic (systemic) contamination, poor rooting, in 
vitro senescence and stress-induced morbidity and mortality. Troubleshooting for 
causal factors should be a routine practice and based on timely use of performance 
indicators, methodical recording and careful interpretation of monitoring data. The 
interpretation of which should pinpoint those procedures and treatments that are the 
most limiting with the objective of optimizing or changing the strategy of growth 
limitation. Where possible, factors (e.g. temperature stress, nutrient deficiency, 
ethylene production) that predispose cultures in slow growth to genetic instability 
should be identified. Thereafter, risk management strategies and best practices should 
be applied to minimize the risks of instability and genetic selection (Scowcroft 1984). 
  
The objective of cryopreservation is the long-term storage of viable plant germplasm 
in LN, to a minimal temperature of -196°C in the liquid phase, or in the vapour 
phase. It is important to note that the temperatures of vapour phase LN can vary 
considerably (see Benson 2008 for a review) dependent upon the position of the 
sample in the storage vessel inventory system, the type, size and capacity of the 
cryotank, filling and top-up regimes and the ambient conditions in which the storage 
vessel is located. Hunt and Pegg (1996) advise that storage under liquid phase LN 
assures a constant temperature of -196°C, whereas they report differential subzero 
gradients of approximately 100°C for vapour phase storage. In the case of plant 
germplasm conserved in vapour phase storage it is important to ensure that a 
minimum temperature is achieved to enable the long-term stabilization of samples; 
this is highlighted by Walters et al. (2004) in their long-term study of cryopreserved 
plant germplasm. The criticality of vapour phase storage temperature is particularly 
important for vitrified samples (Angell 2002; Volk and Walters 2006; Benson 2008). 
Some manufacturers of cryogenic storage equipment recommend that the storage of 
cells must be performed below the water recrystallization temperature of -130°C 
(Nunc™ 2005, 2008). With the objective of preventing detrimental episodes of 
rewarming, that risk the stability of samples stored in vapour phase LN. The GPG2 
project’s CCTF propose that the vapour phase should be maintained at a minimum 
of ca. -170°C.  
These technical guidelines pertain to the different methods of cryopreserving 
shoot meristems from clonal crops (Schäffer-Menuhr 1996; Escobar and Roca 1997; 
Escobar et al. 1997; Panis et al. 2005; Sakai and Engelmann 2007; Benson 2008; 
Engelmann et al. 2008; Keller et al. 2008; Reed 2008a, b; Sakai et al. 2008; Panis 2009). 
Detailed technical guidelines should be produced on a crop-specific basis. Minimal 
requirements used for MTS are also applicable to cryostorage (see section 9); specialist 
cryogenic equipment and facilities are highlighted.  
This section has been numerated to four hierarchical levels (e.g. 1.1.1.1) to aid 
the readers’ navigation and cross-referencing to different sequences and combinations 
of cryostorage procedures.  
10.1 Cryopreservation terminology consensus  
Increasingly, different terms and their permutations are used to describe plant 
cryopreservation protocols and developing best practices for cryopreservation requires 
common consensus on storage terminology as used by different genebanks. Common 
meaning and use of terms is important for quality systems as it prevents 
misinterpretation and underpins: (1) safe, accurate and meaningful knowledge 
exchanges; (2) development of standard operating procedures; (3) inter-operability of 
 IT systems, knowledge bases, genebank inventories and tracking systems; (4) robust 
technology transfers/validation exercises and (5) facilitates training programmes.  
10.2 Sample type  
Inventories should be in place to document the type (wild species, cultivar, landrace, 
breeding lines) and nature of material used for cryobanking. For these guidelines, the 
explant usually comprises: (1) meristematic shoots from apical/axillary shoots of in 
vitro propagated cultures; (2) ex vitro tuber sprouts; (3) surface-sterilized shoot cuttings 
from field, shade or glasshouse-grown plants, and more generally, (4) dormant buds 
from field-grown woody species and somatic and zygotic embryos (e.g. Citrus).  
10.2.1 Shoot selection criteria  
Meristem type (i.e. apical, axillary, dormant bud, species morphology, size, number of 
leaf primordia) influences successful storage outcomes following exposure to LN. 
Genetic instability can arise in vitro and selecting original shoot meristems generated 
via direct development is preferred to using those of adventitious origin. Ideally, the 
same type of meristem should be selected systematically, unless it is proven that 
meristem origin has no significant effect on post-storage recovery. However, this 
option can be constrained by technical problems, efficiency and cost issues, in which 
case, proliferating adventitious meristems may, out of necessity be used. If this is the 
case, confirmation of genetic stability is prudent. The number of replicates processed 
per cryopreserved accession should anticipate expected recovery responses, 
regeneration frequency, potential for germplasm loss and the use of cryobanked 
materials. Where probabilistic tools based on known performance metrics for viable 
recovery are used (see Dussert et al. 2003), it is cautious to factor in potential losses 
incurred by contamination, delayed onset declines in recovery, genotype variability 
and a potential preponderance for instability and off-types.  
10.2.2 Physiological status 
Developmental and physiological status and source (i.e. field, glasshouse, shade 
house) of ex vitro donor plants can influence culture initiation, micropropagation and 
recovery after cryopreservation. For in vitro donors, culture age, subculture cycle, 
position of meristem, and shoot size can also affect recovery. Therefore, testing the 
effects of physiological condition on survival after cryopreservation is suggested, 
particularly for recalcitrant genotypes. Knowledge of cold hardiness is helpful for 
those species that naturally cold acclimate and seasonal screening for hardiness and 
freeze tolerance is recommended in order to determine which part of a life cycle 
provides buds that are more amenable to cryostorage.  
10.2.3 Basic assumptions 
Cryopreservation of clonal crops is critically dependent upon optimizing in vitro 
culture before and after cryogenic storage, therefore, culture regimes should be 
thoroughly tested before proceeding to cryopreserve germplasm. Recovery after 
storage may require different to standard culture media to facilitate survival and shoot 
  
regrowth. Donor explants and in vitro cultures should be thoroughly checked for 
health status as survival is compromised if tissues are already stressed, for example as 
may be the case for ageing cultures or materials that have been maintained under sub-
optimal growth conditions (see sections 6 and 7). It is assumed cultures and donor 
materials entering a cryopreservation process have been through stringent 
phytosanitary procedures. Covert contaminants and systemic, endophytic infections 
can become highly problematic following cryogenic treatment; bacteriological 
indexing before cryobanking is thus recommended.  
10.3 Cryopreservation procedures and protocols  
Cryopreservation methods are compiled as generic guidelines on which to develop 
crop-specific best practices. These are presented in the following sections (see sections 
10.3 to 10.5) as the basic sequential components (e.g. equipment/material requirements, 
pretreatments, meristem dissection techniques, cryoprotection regimes) which are 
applied in various combinations in specific protocols (e.g. ultra rapid/controlled rate 
cooling/freezing, droplet freezing/vitrification, Plant vitrification solution number 2 
(PVS2) vitrification, encapsulation combined with dehydration, evaporative 
desiccation and vitrification). These are described in section 10.6 in full, sequential 
technical detail, including cryostorage, rewarming and recovery. Critical points are 
highlighted for each procedure that comprises the different protocol steps. 
10.3.1 Basic materials and equipment 
Personal protective clothing and equipment (PPC and PPE) are required during LN 
handling which should be performed in a safe and regulated environment. Tissue 
culture preparation, cryoprotection and recovery should be undertaken aseptically in a 
laminar airflow bench, aseptic techniques should be applied throughout all 
procedures. The following checklist provides basic requirements for most 
cryopreservation protocols; critical points concerning the use of different materials and 
equipment are also highlighted.  
Standard culture media for micropropagation, meristem excision, pretreatments, 
loading solutions, cryoprotectants, unloading solutions and post-storage recovery are 
normally prepared in either liquid or solid culture media. They are usually dispensed 
into aliquots of ca. 25-50 ml.  
 Standard culture (micropropagation) media. 
 Media for pretreatments, pregrowth and preconditioning media (see sections 
10.3.2.2 to 10.3.2.4). 
 Loading and unloading solutions used for vitrification. 
 Media for sequential adjustment of osmotica on thawing/rewarming. 
 Recovery media. 
 These comprise different types, described as follows: 
 Colligative: e.g. DMSO, glycerol (permeability is species dependent). 
 Osmotic: mannitol, sorbitol, sucrose, ethylene glycol, polyethylene glycol. 
 Specialist: additives/agents/cryoprotectants used to confer enhanced tolerance 
or survival after cryogenic storage and/or applied in combination with other 
cryoprotective strategies; examples include proline, plant growth regulators, 
trehalose, bovine serum albumin (BSA), antioxidants, calcium-alginate beads, 
heat-activated silica gel.  
 Personal protective clothing: lab coat, safe (closed-toe) footwear, LN-resistant face 
shield, glasses, goggles, gloves and aprons. 
 Personal protective equipment: oxygen monitor with audio/visual alarm. 
 Cryotanks: automatic filler, low-level LN monitor with audio/visual alarm. 
 Safe/secure LN supply, (supplied by external contractor or by in-house generator). 
 Standard refrigeration: 4°C to 0°C; freezers -20°C, -80°C. 
 Cold acclimating rooms/growth chambers/incubators, usually minimal 4°C to 0°C 
or high sub-zero temperatures as required. 
 Dewars/tanks LN-approved resistant: 1-2 L capacity for airflow bench work, LN 
supply Dewars/tanks and pressurized supply tanks for automatic cryogen 
dispensing, long-term storage Dewars/tanks and inventory system.  
 Computer-controlled programmable freezer, passive cooling devices (Mr Frosty®). 
 Cryovials, cryocanes, cryoracks, cryodrawers, cryoboxes, cryosleeves. 
 15 mm x 5 mm sterile aluminium foils for droplet-freezing/vitrification. 
 LN-equipment, pressure systems: spares, replacement supplies of essential parts. 
 Pasteur pipettes. 
 Hypodermic needles and syringes. 
 Autoclave. 
 Filters for sterilization (e.g. Millipore®). 
 Petri dishes e.g. 90 mm and 50 mm. 
 Sterile filter papers, forceps, scissors, scalpels, micro-scalpels.  
 Heated magnetic stirrer. 
 Binocular dissecting microscope. 
 Water bath. 
 Thermometer, thermocouple and data logger. 
 pH meter. 
  
 Gilson or Eppendorf Pipettes, standard range (20, 50, 100, 500, 1000, 5000 μl) or 
similar, branded, automatic pipettes, with sterile tips. 
 Media bottles, dispensing bottles, culture bottles. 
 Sterile distilled (or sterile) filtered water. 
 Vitrification-based protocols do not usually require programmable freezers. 
 If LN supply is ensured, nitrogen generators are not essential; however, larger scale-
genebanks that have a high demand may wish to consider purchasing a generator for 
extending capacity and safeguarding cryobank security. 
 For safety purposes, cryogenic facilities and equipment require regular, expert maintenance.  
 It is a regulatory (sometimes statutory) health and safety requirement in some countries for 
pressurized LN equipment to be checked annually by both internal and external auditors in 
order to comply with government health and safety regulations. 
 For convenience a small Dewar (e.g. of 1 L capacity) can be used for the initial 
cryopreservation step (i.e. plunging in LN). For example, small Dewars may be located in 
the laminar airflow bench (for vitrification protocols) or near to the programmable freezer to 
allow rapid transfer from the intermediate hold temperature. Dry shippers may be used to 
transport safely vials to long-term storage cryotanks located in other parts of a facility. 
 It is important that vials are plunged immediately into LN at an appropriate point e.g. 
following cryoprotection or after they are removed from the programmable 
freezer/Mr FrostyTM unit.  
 The uncontrolled rewarming of samples during cryo-protocol transfer stages or 
transportation is detrimental to cryopreserved tissues.  
10.3.2 Basic procedures 
These comprise procedures that are common to most shoot meristem cryopreservation 
protocols; variations may be required for certain crops, species and genotypes.  
The objective of this procedure is to excise shoot meristems of an appropriate size and 
structure that are capable of surviving cryostorage, growing new shoots and forming a 
stable plant via non-adventitious development. Shoot meristems are usually excised: 
(a) directly from untreated plants; (b) from plants that have been pretreated, 
acclimated or preconditioned or (c) from nodal stem cuttings that have been 
pretreated, acclimated or preconditioned.  
See section 10.3.1.4 General supplies and equipment 
1. Meristem dissection is best achieved on a moistened, sterile filter paper (or other 
suitable sterile surface) that is placed in a 9 cm Petri positioned on the viewing 
platform of a dissecting microscope (x 20-40 magnification) that is placed in a 
 laminar airflow to maintain sterility. 
2. Remove shoots from the culture vessel and place on the sterile surface.  
3. Trim away any large leaves and roughly locate the meristematic area of the bud or 
shoot. 
4. With the aid of two hypodermic needles and/or micro-scalpels remove larger 
expanded leaves from the shoot tip region taking care not to damage the meristem 
a. It is important to be cautious at this stage to retain any partly expanded leaf 
primordia and a small amount of subjacent meristem tissue, before proceeding to 
dissect too vigorously as this will injure the meristem.  
5. Carefully progress with the meristem dissection to an optimal crop-specific size:  
a. Minimally dissected shoot meristems usually comprise a partially exposed 
translucent apical dome, surrounded by 1-3 unexpanded leaf primordia. 
b. Maximally dissected shoot meristems usually comprise the apical dome, 
several leaf primordia, partially expanded leaves and tissue subjacent to the 
meristem region. 
6. Trim the meristem to an optimal size [ca. 0.5 to 5 mm] dependent upon 
genotype/species. 
7. Immediately following dissection transfer shoot tips to one of the following: 
a. A holding solution, usually liquid medium or pretreatment solution. 
b. Filter paper bridges soaked with the holding solution in a Petri dish. 
c. A cryoprotective loading solution (LS). 
d. A post-excision recovery medium, this can include 1-5% (v/v) DMSO that is 
applied to improve recovery following dissection injury. 
 Standardize excision technique and optimize shoot tip/nodal cutting size by using meristem 
controls at all precryo steps before proceeding to test cryogenic treatments. 
 Shoot tip size and origin (apical, lateral, axillary) can influence post-storage survival. 
 Due to technical problems associated with excising original (i.e. non-adventitious) 
meristems, for some crops (e.g. Musa) adventitious, proliferating shoot cultures are used 
(Panis 2009).  
 Shoot tips rapidly dehydrate during dissection, therefore this manipulation is best 
performed on a moist surface; similarly, excised meristems rapidly succumb to desiccation 
and require immediate transfer to a suitable holding medium. This should be of an 
appropriate osmotic potential e.g. isotonic relative to the pregrowth/treatment/culture 
medium from which the shoots were originally removed. 
 Placing excised meristems in water or hypotonic medium during the dissection and post-
dissection process can negate protection afforded by osmotica applied during pretreatment 
or pregrowth. 
 Meristems may also be transferred to colligative or osmotic cryoprotectants and vitrification 
loading solutions (dependent upon crop specific method). 
  
 It is important to note that once the excised meristem is exposed to cryoprotectant solutions 
the process or loading sequence is already initiated and should be timed from this onset. 
 To standardize the cryoprotectant process, meristems should be excised in batches that are 
timed in known intervals from first (start) to last (completion) batch samples. 
 It may be necessary to determine if the timing of the meristem excision process and 
subsequent holding times are critical to survival and if they affect the reproducibility of a 
cryopreservation protocol. Meristems can be excised the day before cryopreservation and 
incubated overnight on sterile filter papers infiltrated in 50 mm Petri dishes with an 
appropriate culture or pretreatment medium.  
 Wounding of dissected meristems can sometimes be exacerbated by cryogenic stress. 
Pretreatment for 16-48 h in 1-5% (v/v) DMSO applied in a medium of appropriate osmotic 
potential can significantly enhance the recovery of meristems from some species that are 
especially vulnerable to physical dissection injury (Benson et al. 2007). 
 Personnel should demonstrate proven competence in achieving meristem survival following 
dissection before proceeding to use excised meristems for cryogenic purposes. 
 Meristem dissection is a highly skilled procedure; personal aptitude should be tested on a 
no-blame basis as not all staff acquires the required competency even after training.  
 
Cold acclimation (cold hardening) is a natural process in which exposure to low 
temperatures enhances resistance to much lower temperatures and freezing. Several 
options are available for acclimating plants, explants and shoot meristems prior to 
cryogenic treatments, these mainly exploit natural acclimation, in which case 
meristems are excised directly (see section 10.3.2.1) from cold acclimated buds. 
Alternatively, acclimation can be artificially simulated in vitro; the objective of both 
procedures is to enhance survival after cryopreservation.  
See section 10.3.1.4  
1. Optimize the protocol for natural field-acclimation by selecting mother 
plants/shoots at different stages of the seasonal life cycle, this is usually 
concomitant with maximum acclimation. 
2. Apply appropriate phytosanitary/surface sterilization procedures to the 
explants.  
3. Excise shoot tip meristems (see section 10.3.2.1). 
4. Test meristem survival through sequential in vitro/cryopreservation treatments. 
5. Select the optimal acclimation stage of the life cycle. 
 
 1. Optimize cold storage for donor material using refrigerator conditions.  
2. Apply phytosanitary and surface sterilization procedures as appropriate (e.g. 
for donor explants that have not been introduced in vitro prior to 
cryopreservation treatments). 
3. Excise shoot tip meristems (see section 10.3.2.1). 
4. Test meristem survival through sequential in vitro and cryopreservation 
treatments. 
5. Select the optimal acclimation regime for temperature and storage duration.  
 
1. Grow shoot cultures on a standard medium and transfer to cold-acclimating 
conditions in a suitable incubator at ca. midpoint in their previous subculture 
cycle or, at a suitable stage of development.  
2. Optimize cold acclimation procedure for the cultures. As a general guide, plants 
normally maintained in vitro at 20-25oC may be tested for a 1-4 week cold 
acclimation treatment using 8 h days at 15-22oC and 16 h nights at –1 to 4oC. 
Different alternating temperatures may also be tested.  
3. Excise shoot tip meristems from acclimated donor cultures (see section 10.3.2.1). 
4. Test meristem survival through sequential in vitro and cryopreservation 
treatments. 
 
1. In vitro shoot cultures are grown on standard medium and transferred to a 
medium containing a suitable additive. Transfers are undertaken ca. midpoint 
in their previous subculture cycle or at a suitable stage of development when 
the shoots are healthy and not senescent due to prolonged subculture; nodal 
stem segments can also be used. 
2. Optimize the procedure for axenic in vitro shoot cultures or nodal cuttings. 
3. Cold acclimation can be substituted for, or simulated (see Dumet et al. 2000) by 
sugars, for example sucrose applied within the range ca. 0.3 to 0.8 M, either as a 
single or stepwise treatment. In the latter, sucrose is sequentially increased to an 
appropriate concentration that is applied over 1-4 weeks.  
4. Excise meristems from acclimated cultures/nodal cuttings (see section 10.3.2.1). 
5. Test meristem survival through sequential in vitro and cryopreservation 
treatments. 
 Sucrose-simulated acclimation can be applied to chill sensitive genotypes of naturally cold 
acclimating species; abscisic acid, mannitol and polyols are also used in acclimation. 
  
 Different species and genotypes exhibit variable cold hardiness responses. 
 In the absence of a specialist facility it is possible to improvise cold hardening by using 
manual transfers between a refrigerator at the lowest setting, and a growth room. 
 Once acquired, cold hardiness is transient and acclimated donor materials should be 
maintained under acclimating conditions until they are required for meristem excision. 
 Removing donor plants/cultures from the acclimation cycle for extended periods during 
processing can negate the positive effects of the cold hardening treatment and contribute to 
variable recovery responses. 
 Logistically it is useful to programme the diurnal acclimation cycle for workday meristem 
processing to take place during the warm-light part of the acclimating sequence. 
This term can be used interchangeably with cold acclimation and may also describe 
the simulation of natural cold acclimation in vitro, by the application of sucrose, 
abscisic acid and other agents. Preconditioning treatments also involve: (1) changing 
light (high, low; dark/light) as well as temperature conditions prior to 
cryopreservation; (2) selecting plants at specific points during subculture and 
(3) manipulating cultures to produce plants/excised meristems at a specific 
developmental stage or morphogenetic type (e.g. proliferating shoots). For technical 
manipulations follow the same basic format as outlined in section 10.3.2.2 and 
adjust/optimize preconditioning treatments on a crop or genotype-specific basis.  
These measures enhance survival but do not usually confer total protection; generally 
pretreatment, preculture and pregrowth confer cumulative resistance to LN when 
used in conjunction with cryoprotectants. They are also used to enhance tolerance to 
cryoprotection stress, particularly by increasing resistance to dehydration and 
desiccation. The terms pretreatment, preculture and pregrowth are often used 
interchangeably, sometimes inclusive of preconditioning treatments. Currently there is 
no consensus as to their definitive use in different applications; for clarification in these 
guidelines preculture and pregrowth infer protective treatments applied to still-
growing in vitro plants or shoots. The sequential application of osmotic agents 
administered in the subculture cycle before cryopreservation is an example of a 
preculture or pregrowth treatment. In the literature, pretreatment is a more general 
term used to either: (a) encompass pregrowth and preculture, or (b) describe short 
treatments for which new growth is limited or ceases. It is helpful to qualify the use of 
terms when developing best practices in a specific context, facility or project. 
See section 10.3.1.4  
 Cultures optimally selected for cryopreservation. 
 Media comprising pretreatment additives dispensed as single or multiple additives 
of increasing concentrations/levels, selecting from: 
 o Osmotica: sucrose, mannitol, sorbitol (ca. 0.1 to 1 M or 1-10% [w/v]) applied 
singularly or at increasingly cryoprotective concentrations. 
o Colligative cryoprotectants: DMSO (ca. 1-5% v/v); glycerol (0.1 - 0.5 M) at non-
cryoprotective levels. 
o Growth regulators: abscisic acid (e.g. ranges of 1-10 mg/L; 1-75 μM); GA3 (to 
stimulate shoot expansion during recovery); cytokinins (to stimulate shoot 
development during recovery) or other additives as required. 
o Anti-stress compounds that are known to enhance protection against injuries 
and stresses incurred during cryopreservation treatments (e.g. proline, 
antioxidants). These are applied at appropriate concentrations which have been 
tested prior to their routine use. 
1. Various plant materials are transferred to pretreatment media as appropriate:  
a. shoot cultures, midpoint subculture or at a required stage of development;  
b. nodal stem segments;  
c. excised shoot meristems (see section 10.3.2.1). 
2. Optimize the pretreatment based on: (a) choice and combination of additive; (b) 
concentration and sequential applications of increasing additive concentrations and 
(c) duration of exposure.  
3. Select optimal treatment.  
4. Test the effects of the optimal treatment on survival after sequential 
cryopreservation treatments. 
5. Select the treatment that confers the highest level of protection and recovery.  
 In the context of these guidelines, pretreatments are generally defined as specialized media 
containing protective additives that are applied a few days before (24-72 h) or just prior (1-2 
h) to cryopreservation. 
 Pretreatment additives/solutions are usually prepared in standard semi-solid or liquid 
culture medium. In the case of osmotic additives, the cumulative level of any sucrose added 
to media (e.g. as an energy source in standard medium) should be confirmed.  
 It is advisable to check medium pH after incorporating pretreatment additives. 
 Heat labile pretreatment additives should be filter sterilized. 
 Additives applied in combination can act synergistically and reduce the toxicity of other 
additives. 
The objective of encapsulation is to encase excised shoot meristems in calcium alginate 
beads (Fabre and Dereuddre 1990; Benson et al. 1996; Engelmann et al. 2008). The 
procedure is undertaken either on untreated meristems, or on meristems excised from 
cold acclimated (preconditioned) and pretreated (pregrown, precultured) shoot 
cultures and nodal cuttings. When used in combination with other cryoprotective 
  
strategies encapsulation can precede various manipulations, including loading with 
colligative and osmotic cryoprotectants, evaporative desiccation, and vitrification 
solution applications (Sherlock et al. 2005; Benson 2008; Engelmann et al. 2008). 
Encapsulation greatly facilitates the handling of individual, excised shoot tips. 
See section 10.3.1.4  
 Excised shoot meristems.  
 Calcium-alginate solutions:  
a. Alginate solution: calcium-free, liquid culture medium, containing 3% (w/v) 
sodium alginate (SIGMA™, 2% low viscosity, 250 cps, sodium salt derived from 
sea Kelp) dispensed into small bottles as 20-30 ml aliquots (slowly dissolving 
alginate while stirring over time might be helpful before autoclaving the 
solution).  
b. Calcium solution: liquid culture medium containing 100 mM CaCl2 dispensed as 
20-30 ml aliquots in 50 ml conical flasks or beakers or culture bottles. 
 For dispensing alginate solutions use either: (a) 5 ml Gilson "Pipetteman" (or 
similar automatic pipette) fitted with a sterile replaceable tips or (b) 3 ml disposable 
plastic pastettes or similar Pasteur pipette. When using pipette tips, it is advisable 
to cut the tip at an appropriate place to allow a single drop of alginate to form a 
bead of an optimally-sized diameter.  
 A 250 - 500 µm mesh sieve. 
 Sterile tissues or pieces of filter paper. 
1. Transfer shoot tip meristems to 3% (w/v) alginate solution; gently swirl to assist 
tissue immersion, taking care not to form air bubbles.  
2. Using a 5 ml Gilson "Pipetteman" (or similar automatic pipette) or 3 ml plastic 
pastette, place the sterile tip in the alginate solution and gradually withdraw ca. 2 
ml solution, concomitantly capturing ca. 3-5 meristems, taking care to avoid air 
bubble formation.  
3. Hold the pipette/pastette vertical, to ensure spherical drops are formed, by 
delivering droplets at ca. one-second intervals into 0.1 M CaCl2 solution; gentle 
swirling of the CaCl2 solution helps to prevent the beads from sticking together.  
4. The alginate will form spherical 45-50 μl beads that encapsulate the meristems and 
with care, beads containing single shoot meristem can be easily obtained. The usual 
bead size is ca. 4 mm, although this can vary dependent upon the physiology, 
structure and size of the meristem, shoot and leaf primordia.  
5. Allow beads to polymerize in the calcium solution for ca. 15-20 min after the 
formation of the last bead. 
6. Pour the calcium solution and beads into a sterile sieve or Petri dish. 
7. Retrieve beads containing shoot tips. 
 8. The empty beads can be retained for moisture content (MC) assessments. 
9. Use the encapsulated shoots as required in cryopreservation protocols.  
 Solubilizing and autoclaving alginate to produce uniformly dispersed solutions can be 
technically challenging, therefore test the following options: (1) add the alginate to liquid 
medium on a magnetic stirrer, heat to boiling whilst agitating vigorously, dispense the 
alginate into appropriate vessels, and autoclave; (2) prepare the alginate solution be 
vigorously agitating (at ambient temperature) on a stirrer, autoclave in bulk, dispense 
and autoclave. Discard any solutions that contain flocculated ‘clumps’ of partially 
solubilized alginate after autoclaving. 
 Ensure alginate solubilisation is uniform, as variable concentrations will have variable 
cryoprotective properties and behave non-uniformly during dehydration and desiccation.  
 Prepare calcium-free standard liquid medium (Ca2+ salts of vitamins accepted) and add 
3% (w/v) sodium alginate (SIGMA™ 2% low viscosity kelp alginate, as the sodium salt). 
 Uniform bead size is critical for reproducible bead dehydration and desiccation so it is 
important to use an alginate dispenser that produces beads of a consistent size. 
 It is possible to adjust pipette tip diameters using a hot scalpel to cut the tips to 
accommodate larger structures; this standardizes the pastette used for aperture size, 
noting that manufacturers produce pipettes with different-sized apertures. 
 If undertaking technology transfers and validation exercises with other laboratories, it is 
advisable to ensure that an identical or equivalent type of pastette is used.  
 Size differences in beads leads to non-uniform desiccation, which can affect cryoprotective 
properties and reduce reproducibility; this variability can influence validation exercises.  
 The way in which the alginate drop is dispensed into the CaCl2 solution is important, 
delivering too low to the surface tends to give flat beads, whilst dispensing too high above 
the surface produces tear-dropped shaped beads. Keeping a uniform distance of the pipette 
above the CaCl2 and gentle swirling of the calcium solution helps to form uniform beads. 
 Osmotica and additives (activated charcoal) can be applied in the alginate mixture. 
 The brand and type of sodium alginate can have an influence on drying rates. 
10.4 Evaporative desiccation  
The objective of this procedure is to: (1) reduce the amount of water available for ice 
formation and (2) increase cellular viscosity to a critical point that ensures a stable 
glass is formed. Evaporative treatments are applied to non-encapsulated, naturally 
cold hardened buds and cuttings, and to alginate-encapsulated meristems after they 
have been osmotically dehydrated (see section 10.6.3). Desiccation is achieved in a 
sterile airflow or over activated silica gel. For desiccation tolerant germplasm, 
evaporative desiccation may be the only cryoprotective treatment required when it is 
combined with an effective pretreatment; it is unsuitable for dehydration/desiccation 
sensitive (i.e. recalcitrant) germplasm.  
  
10.4.1 Air desiccation 
Airflow desiccation can be achieved passively, for example under low relative humidity 
(RH) conditions in a cold room used to store non-axenic acclimated bud cuttings. 
Alternatively, it can be achieved using the sterile air of a laminar airflow cabinet (for 
alginate-encapsulated meristems, see sections 10.3.2.5 and 10.6.3) described as follows:  
See sections 10.3.1.4 and 10.3.2.5  
 Osmotically pretreated encapsulated meristems.  
 Laminar airflow bench (horizontal airflow direction). 
 Sterile 50 mm or 90 mm Petri dishes. 
See sections 10.3.2.1 and 10.3.2.5  
1. Remove alginate encapsulated meristems from the pretreatment solution. 
2. Blot beads dry on sterile filter papers to remove any surface moisture. 
3. Transfer the beads to the inner or outer surface of an open sterile Petri dish. In 
some laminar airflow systems using the inner surface of Petri dishes allows the 
rims to create air turbulence which can enhance the chances of non-uniform 
desiccation. The appropriate surface can be selected by checking the uniformity of 
bead desiccation in a particular airflow using MC status assessments.  
4. Locate the Petri dish (open to the air) at the back of the airflow bench.  
5. Air desiccate for an optimal period of time and use the beads as required. 
 Reproducibility is dependent upon uniform bead size and evaporation rates. 
 Ensure surface moisture is removed from beads before they are placed in the airflow. 
 Ensure beads are evenly spread in the Petri dish and that they are not touching each other, 
as this can cause irregular desiccation. 
 Desiccation profiles may vary between laminar airflow benches and/or laboratories. 
 For quality control, technology transfers and validation exercises record the temperature 
and RH in airflow bench at the onset and end of the desiccation period. This will help to 
ensure parity between cryo runs. 
 Where RH and ambient temperatures are variable it is advisable to substitute silica gel 
based desiccation and use empty ‘blank’ beads as controls to gravimetrically measure the 
water loss using an appropriate balance and drying oven (see Section 10.4.3). 
10.4.2 Silica gel desiccation  
Silica gel desiccation (Sherlock et al. 2005) is preferentially used under conditions 
where RH, airflow and temperature are variable, it is usually applied to alginate-
encapsulated meristems (see section 10.3.2.5) as follows: 
See sections 10.3.1.4 and 10.3.2.5 
  Osmotically pretreated encapsulated meristems. 
 Sterile 50 mm or 90 mm Petri dishes. 
 Heat activated silica gel.  
1. Dispense activated silica gel at a consistent weight into sterile glass 90 cm Petri 
dishes (e.g. 20 g/dish); alternatively metal boxes or mini-desiccators can be used.  
2. Dry heat-sterilize the system in an oven if the materials are heat resistant.  
3. Concomitantly this will heat-activate the silica gel. 
4. Remove the desiccator (or homemade system for containing silica gel) from the 
oven and seal air-tight with tape or a cap.  
5. Transfer the alginate encapsulated meristems into a sterile 50 mm Petri dish. 
6. Overlay the open dish on the silica gel layer, this provides a support and a sterile 
surface on which the encapsulated meristems can be placed. 
7. Desiccate for an optimal time and use as required e.g. for cryopreservation or 
moisture content (MC) calibration (see section 10.4.3) 
 Reproducibility is dependent upon uniform bead size and evaporation rates. 
 Ensure surface moisture is removed from the beads before they are placed in the desiccator. 
 Ensure beads are evenly spread in the Petri dish and not touching each other. 
 Desiccation profiles may vary if the silica gel has not been effectively heat activated. 
 Use a standardized system for type of container, quantity of silica gel and number of 
beads/container.  
10.4.3 Bead moisture calibration  
The objective of evaporative desiccation is to achieve a critical minimal MC that: 
(a) stabilizes glasses during cryopreservation, (2) ensures viability and (3) permits the 
regrowth of normal shoots. Ambient temperature, RH, variable laminar airflows and 
silica gel activation heat treatments all critically influence bead desiccation rates and 
thus the final MC achieved after the treatment. Calibrating bead MC profiles is 
important for quality control, validation and protocol optimization. 
See section 10.3.2.4 for pretreatments, general supplies and equipment. 
See section 10.3.2.5 for encapsulation supplies and equipment. 
See sections 10.4.1 and 10.4.2 for evaporative desiccation (airflow and silica) supplies 
and equipment. 
 Two ‘series’ of experimental materials for MC-viability calibrations: 
1. empty alginate beads for MC determinations;  
2. alginate beads containing meristems to assess recovery.  
 Batches of empty, dehydrated beads exposed to sequential concentrations of osmotic 
solutions e.g. 0.5 to 1.0 M sucrose for different durations of time (usually 16 to 72 h).  
  
 Batches of empty, osmotically dehydrated beads, evaporatively desiccated for 
different durations of time (usually 16 to 72 h) in either: (a) sterile airflow or (b) silica 
gel (usually for 3-8 h).  
 Duplicate bead batches containing meristems exposed to treatments (for recovery). 
 Non-treated controls (empty or meristem-containing beads) to determine MC status. 
1. Excise meristems as described in section 10.3.2.1. 
2. Encapsulate meristems as described in section 10.3.2.5. 
This calibration compares MC status and meristem recovery at each stage of the 
treatment: 
1. Prepare (as above) batches of alginate beads with and without meristems. 
2. Select an appropriate number of replicates (5-10 beads) for each protocol step. 
3. Transfer bead batches to sucrose dehydration media (e.g. 0.3 M, 0.5 M, 0.75 M, 1.0 M). 
4. Incubate for various times in the dehydration-media concentration series 
(e.g. overnight for 16, 24, 48, 72 h).  
5. Remove dual batches of replicate beads sequentially for: 
a. immediate MC determination;  
b. transfer to evaporative desiccation stage. 
6. Remove dual batches of beads from sucrose solutions. 
7. Blot the beads dry on filter papers. 
8. Desiccate, using sterile airflow/silica gel over a suitable time course (see sections 
10.4.1 and 10.4.2). 
9. Withdraw bead samples for MC determinations.  
10. In parallel, repeat treatments for beads with meristems. 
11. Transfer the meristems encapsulated in beads to recovery media at each treatment 
stage. 
1. Remove beads from treatments. 
2. Blot dry the beads on filter papers to remove residual surface water. 
3. Record bead fresh weight. 
4. Transfer the beads to an oven set at an appropriate temperature (e.g. 85oC to 105oC).  
5. Monitor weight loss due to water, to a constant weight to ensure consistency. 
6. Calculate the empty bead MC on the basis of:  
(a) % Residual MC  
100  
(g)ht fresh weig
(g) dry weight - (g)ht fresh weig
ht)fresh weig (% moisture Residual   
(b) g H2O g dry weight-1 
 1. Plot MC profiles against survival of shoot meristems recovered via the same process.  
2. Select the optimal conditions for dehydration/desiccation and maximum survival. 
3. Proceed to test these conditions for an optimal cryoprotective strategy.  
 In humid environments, transfer of samples to and from drying ovens should be 
undertaken over activated silica gel in a desiccator. 
 MC profiles can be constructed in various ways, by residual MC and/or sequential 
calculation of water loss at each individual stage of the process sequence from osmotic 
dehydration to evaporative desiccation 
 The final MC is usually ca. 20-25% on a fresh weight basis; or ca. 0.2 to 0.4 g water dry 
weight-1 dependent upon sucrose loading of alginate and the concentration of alginate. 
 Some protocols apply alginate at 5% (w/v) and supplement the alginate medium with 
sucrose (0.5 to 0.75 M); nutrient medium may be used at reduced or half strength or 
ammonia-free in both the alginate and CaCl2 solutions. Modification in the composition of 
alginate may alter the thermal, dehydration, desiccation and cryoprotective properties of the 
beads.  
10.5 Cryoprotectant solutions 
Following appropriate acclimation and pretreatments excised and/or encapsulated 
meristems normally require further cryoprotection before they can be successfully 
recovered from cryostorage. Cryoprotection usually involves applying solutions of 
single or multiple additives of which there are several types:  
 Colligative: penetrating chemicals that act as agents that protect cells from 
cryoinjuries caused by intracellular ice, dehydration, deleterious cell volume 
changes and damaging solution effects.  
 Osmotic: non-penetrating (non-colligative) chemicals that osmotically reduce the 
amount of water available for ice formation.  
 Combinations of colligative/osmotic additives: mixtures that act with synergistic effects.  
 Vitrification: different permutations of colligative and osmotic chemical 
cryoprotectants, encapsulation and evaporative desiccation/dehydration treatments 
that are applied to achieve a critical cell viscosity which on exposure to low 
temperatures cause a glassy state to be formed. This is characterized by the glass 
transition temperature (Tg). 
10.5.1 General preparation of cryoprotectants  
These are generic methods for pretreatments, cryoprotectants, loading and unloading 
solutions.  
See section 10.3.1 
  
 Standard cryoprotectants: dimethyl sulphoxide (DMSO), glycerol, mannitol, sorbitol, 
sucrose, ethylene glycol. 
 Special components: sodium alginate and calcium chloride solutions. 
 Occasional cryoprotectants and protective additives: polyethylene glycol (various 
molecular weights), BSA, proline, abscisic acid, antioxidants. 
 Appropriate semi-solid media used as a base and diluent for the cryoprotectant. 
 Appropriate liquid culture media used as a base and diluent for the cryoprotectant. 
 Millipore/micropore filters. 
 Sterile 20-50 ml bottles or similar small vessels used for dispensing aliquots of 
cryoprotectants and their associated solutions.  
1. Select, on a crop-specific basis an appropriate diluent usually: (a) standard or basal 
liquid medium and/or (b) standard or basal semi-solid culture medium. 
2. Prepare cryoprotective/loading solutions using an appropriate procedure: 
a. For (%)-based formulations dispense: 
i. volumetrically (v/v) by volume; or adjust volume for specific gravity (w/v);  
ii. gravimetrically (w/v) using scales to weigh both liquids and solids. 
b. For molar-based solutions dispense on a formula/molecular weight basis. 
3. Check pH after adding cryoprotectants. 
4. Dispense solutions as 10-50 ml aliquots into suitable vessels:  
a.  bottles, 25-50 ml conical flasks for solutions; 
b. 50 mm or 90 mm Petri dishes or culture vessels for semi-solid medium 
treatments. 
1. Check additives for heat sensitivity.  
2. Filter-sterilize heat labile constituents.  
3. For heat tolerant additives, prepare in standard liquid or solid media, dispense as 
10-50 ml aliquots in suitable vessels (McCartney bottles, 25-50 ml flasks or similar) 
and autoclave.  
4. For heat sensitive additives, prepare standard or basal liquid or solid medium, 
dispense as 10-50 ml aliquots into a suitable vessel autoclave and cool to a safe 
temperature (minimal critical temperature for heat labile substances). 
a. Add the filter sterilized additives, mix thoroughly and dispense into previously 
sterilized bottles, 25-50 ml flasks Petri dishes or culture vessels. 
5. Label and store appropriately.  
  Cryoprotectants and pregrowth additives should be of the highest purity. 
 Spectroscopic grade or similar is recommended for DMSO as lower grades can contain 
harmful contaminants. 
 See manufacturers’ Material Safety Data Sheets for information concerning cryoprotectant 
additive recommended storage and sterilizing temperatures. 
 Take care when interpreting protocols that use sucrose as a cryoprotective additive; the 
solution is made to the final concentration/level of sucrose advised for cryoprotective 
purposes i.e. not the cryoprotectant loading of sucrose plus the sucrose normally used for 
culture/growth purposes, unless otherwise specified. 
 Check medium pH after incorporating additives and before autoclaving (if possible); this 
may not be feasible when applying filter sterilized additives. 
 Cryoprotectant mixtures should be filter sterilized, when this is technically difficult e.g. for 
high viscosity solutions, autoclaving is the only practical option. 
 Lengthy autoclave hold times after the sterilization cycle should be avoided to prevent heat-
degradation and caramelization of sugars. 
 It is recommended that cryoprotectant mixtures are freshly made and used without prior 
storage, particularly those containing DMSO and complex biochemical additives 
(e.g. abscisic acid, BSA, proline, antioxidants).  
 Thermal and cryoprotective properties may change after a prolonged shelf life.  
10.6 Cryopreservation protocols 
This section describes how the various generic procedures and methods described in 
the previous section(s) are combined in specific cryopreservation protocols. 
Contemporary plant cryopreservation comprises various permutations of different 
pretreatments and cryoprotection strategies, these can be considered in terms of 
freezing, colligative cryoprotection and vitrification as follows: 
 Freezing with colligative and/or osmotic cryoprotection: 
o Ultra rapid freezing: 
 in cryovials, 
 in (μl) droplets of cryoprotectants (termed droplet freezing) dispersed on 
aluminium foils. 
o Controlled rate freezing: 
 in cryovials and using a computer-controlled programmable freezer (noting 
that some models do not use computer-based systems), 
 in cryovials and using a passive cooling unit ‚Mr Frosty®.‛ 
 Vitrification by various strategies: 
o osmotic dehydration/evaporative desiccation of non-encapsulated or 
encapsulated meristems, 
  
o using ‘cocktails’ of osmotic and colligative cryoprotectants at high 
concentrations, administered in 1-2 ml volumes in cryovials or in micro (μl) 
droplets (termed droplet-vitrification) dispersed on aluminium foils, 
o applying cocktails of osmotic and colligative cryoprotectants applied at high 
(Molar) levels to encapsulated meristems. 
 
Colligative cryoprotection is combined with controlled rate or ultra rapid freezing; 
this procedure involves the formation of extracellular ice, albeit some of the 
intracellular material may become partially vitrified. Vitrification is the creation of a 
metastable amorphous glassy state in highly viscous solutions; this is characterized by 
the glass transition temperature (Tg) which is the thermal point at which a glass is 
formed. Vitrification is a useful alternative to controlled rate freezing and it has the 
advantage that tissues remain ice-free; these protocols support the direct immersion of 
samples in LN without the need for programmable freezing equipment. However, 
glasses are thermally unstable and glass relaxation and devitrification can occur on 
rewarming and these events may risk ice formation. Therefore, glass stabilisation is 
critical, this is achieved by manipulating different cryoprotective additives, (e.g. glass-
stabilizing sugars) and the careful control of rewarming regimes.  
10.6.1 Ultra rapid freezing 
The ultra rapid freezing of shoot meristems can be achieved by direct immersion in LN 
of the colligatively/osmotically cryoprotected materials contained either in cryovials or 
cryoprotectant droplets. 
This protocol was first devised by Kartha et al. (1982) for cassava shoot tips and was 
later adapted for potato by Schäffer-Menuhr et al. (1996). These guidelines provide a 
generic droplet freezing method based on the technical protocol of Keller et al. (2008) 
and Schäfer-Menuhr et al. (1996) as developed for potato. 
See sections 10.3.1, 10.3.2.4 and 10.5.1 
 Optimally pretreated, excised meristems (see section 10.3.2.2 and 10.3.2.3).  
 Freshly prepared, filter sterilized 10% (v/v) DMSO (see section 10.5). 
 Sterile aluminium foil strips of 0.6 x 1.5 cm dimensions. 
 Cryovials.  
 Polystyrene float with holes of a suitable size to support the diameter of cryovials. 
 Polystyrene box for LN. 
 Water bath. 
 Recovery medium comprising 1% (w/v) agarose dispensed into liquid culture 
medium. 
 Standard culture medium for shoot propagation. 
 1. Dispense ca. 2-3 ml 10% (v/v) DMSO into a Petri dish containing a filter paper 
overlay. 
2. Transfer excised shoot tips onto the surface of a DMSO-soaked filter paper: 
a. with the aid of a hooked hypodermic needle/forceps,  
b. avoid causing physical damage to the meristem (see section 10.3.2.1).  
3. Cryoprotect for an optimal duration (ca. 30 min to 3 h) during which time prepare 
the following materials: 
a. label the cryovials ensuring that the ink/surfaces are LN-resistant/indelible, 
b. place the aluminium foils on a sterile Petri dish, 
c. fill the polystyrene box with LN, 
d. open the cryovials and place in the holes of the polystyrene float on the LN 
surface, 
e. fill the cryovials with LN. 
4. Dispense 5 x 2 μl droplets of 10% (v/v) DMSO onto the sterile aluminium foils. 
5. Transfer a single meristem to each 10% (v/v) DMSO droplet. 
1. Transfer the foils supporting the droplets to the open cryovials and plunge directly 
into LN. 
2. Submerge the foils for a few seconds until they have reached LN temperature.  
3. Refill the open cryovials with LN. 
4. Repeat the process to complete the batch of meristems. 
1. Close the cryovials, optionally transfer to cryo-canes, enclosed in a plastic LN-
resistant cryo-sleeve before transferring to: 
a. 1 L bench top Dewar used to transfer them to the cryotank,  
b. transfer to the cryotank directly,  
c. store appropriately in inventories, in either the vapour or liquid phase of LN. 
1. Warm agarose medium in a 70°C water bath, after it has melted set the bath to 
50°C, to ensure that the agarose does not set during subsequent manipulations. 
2. Label the liquid culture medium for each cryovial.  
3. Fill the polystyrene box with LN. 
4. Retrieve the cryovials from the cryostorage tank and place them in the holes of the 
polystyrene float which is overlaid on the surface of the LN in the polystyrene box.  
  
5. Remove the lids from the cryovials and using forceps retrieve the foils/meristem-
droplets, transfer immediately to bottles containing liquid culture medium. 
6. The meristems will thaw rapidly and float into the liquid culture medium. 
7. Repeat the process for the remaining meristems. 
8. To avoid cross-contamination use separate bottles for each cryovial. 
1. Dispense 5 drops of agarose solution onto the surface of an empty sterile 50 mm 
Petri dish. 
2. Retrieve the meristems from the thawing solution and place one in each agarose 
solution droplet. 
3. Repeat the process for the remaining meristems. 
4. To avoid cross-contamination, use a separate Petri dish for each recovery bottle. 
5. Allow the agarose to solidify for ca. 30-60 min. 
6. Dispense 2.5 ml of liquid culture medium in Petri dishes with agarose/meristems 
and seal the Petri dishes with Parafilm® or cling film. 
7. Recover under species-specific growth room conditions. 
8. Assess recovery for up to 6-12 weeks, dependent upon species/genotype. 
9. Once new shoots have developed transfer to standard culture medium.  
 Optionally, to improve survival after dissection injury and shoot regeneration after 
cryogenic storage 1-5% (v/v) DMSO may be added to the pretreatment solution and the 
meristems incubated overnight before they are cryopreserved (Benson et al. 2007). 
 The droplet freezing protocol may contravene health and safety regulations for some countries 
and institutions. This is because the use of cryovials outside manufacturers’ safety 
recommendations (i.e. purposeful filling and sealing of vials with LN); non-LN resistant 
vessels such as polystyrene boxes may not be compliant with the safe use of LN. 
 Due to the direct exposure of meristems to LN, this procedure is not contained and strict 
precautions should be taken to ensure that the germplasm has been through a stringent 
phytosanitary process and is confirmed free of covert or endophytic microbial infection.  
10.6.2 Controlled rate freezing 
Controlled rate freezing is used synonymously with the terms controlled rate cooling 
(using passive or computer-based cooling methods) and two-step freezing, for which 
there are a range of protocols. These guidelines present a generic method that is based 
on several standard procedures (Escobar et al. 1997; Benson et al. 2007; Reed and 
Uchendu 2008). Controlled rate freezing is usually preceded by cold acclimation, 
pregrowth and pretreatment of the donor tissues and/or their excised meristems.  
See sections 10.3.1, 10.3.2.4 and 10.5.1 
 Excised meristems (see sections 10.3.2.1, 10.3.2.2, 10.3.2.3 and 10.3.2.4).  
  Freshly prepared sterilized cryoprotectants (see section 10.5.1) examples include:  
Single colligative additives  
10% (v/v) DMSO (Benson et al. 2007) 
Multiple additives: colligative and osmotic cryoprotectants  
15% (v/v) DMSO and 3% (w/v) sucrose (Kartha et al. 1982) 
1 M sorbitol, 10% (v/v) DMSO and 4% (w/v) sucrose (Escobar et al. 1997) 
10% (w/v) each of polyethylene glycol (MW 8000) glucose and DMSO (Reed et 
al. 2001). 
 Ice, ice bath or bucket. 
 Controlled rate cooling apparatus: 
o Option 1. Computerized programmable freezer (see section 10.6.2.1) 
o Option 2. Passive freezer Mr Frosty™ (see section 10.6.2.2) 
o Option 3. Stirred methanol bath with cooling and heating elements.  
 Water bath set at 40-45C. 
 Bottles containing sterile-distilled water. 
 Antibacterial wash or 70% (v/v) alcohol. 
 Recovery medium. 
 Standard culture medium for shoot propagation. 
See sections 10.3.2.1, 10.3.2.2, 10.3.2.4 and 10.5.1 
1. Clearly label cryovials ensuring marker inks are LN-resistant and indelible.  
2. Dispense 1-2 ml of sterile cryoprotectant solution into a batch of 2-3 ml cryovials. 
3. Transfer shoot meristems as manageable batches to the cryovials.  
4. Choose one of two options for applying the treatment:  
a. cryoprotection on ice/ice-slush (0-4°C), which is the more usual option. 
b. cryoprotection at ambient temperatures (ca. 20-25°C) for germplasm that is 
sensitive to chilling. 
5. Cryoprotect for an accurately timed, optimal period (usually 30 min to 2 h). 
A programmable freezer is usually a computer-controlled instrument comprising: (1) a 
freezing chamber with a thermal event recording unit and thermo-couples for 
monitoring sample and chamber temperature; (2) a computer and printer and (3) a 
cooling system supplying the sample chamber which uses pressurized LN as the 
cryogen; in older instruments solvents are used as the coolant. A programmable 
freezer can be programmed with multiple options and it can usually store eight or 
more programmes dependent upon the manufacturers’ specifications. 
  
1. Preprogramming a computer controlled rate freezer according to the 
manufacturers’ instructions is optimized for a crop-specific programme, some 
examples of parameters are: 
o The start temperature which is appropriate to the cryoprotection incubation 
temperature: 
 0-4°C or 20-25°C. 
 A 5 min hold time to load the cryovials. 
o Cooling rate (-0.25 to -5C/min) 
 As required, an optional ‚ice seeding‛ stage is programmed, usually within a 
range of -5 to -15oC, followed by a hold of 5-20 min to allow for extracellular 
ice nucleation/initiation of the excursion of intracellular water. 
 Ice seeding can be achieved manually by touching cryovials with forceps 
chilled in LN vapour or, by the automated control of the programmable 
freezer (this is optional dependent upon the manufacturer). 
 A resumed cooling ramp to a terminal transfer temperature.  
o The terminal transfer temperature, usually at or around the temperature of 
homogeneous ice nucleation (ca. -40C). 
o A hold time ca. 30 to 45 min, usually programmed to allow the transfer of 
cryovials to LN from a constant temperature. 
2. Programmes are checked for entry accuracy by using the pre-run programme 
facility of the computer-controlled freezer unit. 
3. Programmes are saved and a print out is retained as a copy for reference and 
quality control purposes. 
4. Following manufacturer’s specific safety and operational instructions the LN is 
connected to the cooling line and the pressurized LN dispenser to the freezer unit. 
In the case of solvent-cooled freezers this step does not apply. 
5. The unit is pressurized to the manufacturer’s recommended level and the 
apparatus is checked for LN leaks. In the case of solvent-cooled freezers this step 
does not apply. 
6. The lid of the freezing chamber is checked for security. 
1. Place a reference cryovial containing cryoprotectant in the freezer chamber. 
2. Insert the instrument’s sample-temperature probe into the reference vial (this 
records sample temperature, ice nucleation and thermal events during the run).  
3. Transfer remaining cryovials (containing the meristems) to cryocanes or freezer 
racks and insert in the programmable freezer (this takes ca. 5-10 min).  
4. Complete the loading process before the end of cryoprotection incubation.  
 5. Ensure the lid of the freezing chamber is secure. 
6. Once the cryoprotection period is completed, press RUN.  
7. Check the real time progress of the programme on the computer and/or printout. 
8. On completion retain a hard and digital copy of programme prints out for quality 
control.  
9. On completing the programme an alarm will normally sound. 
1. Remove the freezer chamber lid and quickly transfer the cryovials to a small LN-
filled Dewar.  
2. This should be located by the side of the freezer to enable safe transfer, this 
procedure reduces the risks of un-controlled rewarming of the cryovials. 
3. Optionally, rapidly enclose the cryocanes in a plastic LN-resistant cryosleeve before 
transferring to: 
a. 1 L bench top Dewar used to transfer them to the cryotank,  
b. the cryotank directly,  
c. store as appropriate in inventories in either the vapour or liquid phase of LN. 
1. Transfer the bottles containing sterile-distilled water to the 40C to 45C water bath 
and allow a few minutes for them to stabilize at that temperature.  
2. Transfer the cryovials from the cryotank to a small LN-filled Dewar and transfer 
the Dewar to the side of the water bath.  
3. Rapidly transfer the cryovials to bottles containing sterile-distilled water (one 
vial/bottle), after the ice has melted remove them immediately to avoid over-heating. 
4. To remove excess and potentially contaminating water from the water bath, wipe 
the outside of the cryovial with a tissue soaked in an antibacterial/sterilizing 
solution or 70% (v/v) alcohol.  
5. Transfer the cryovials to a laminar airflow bench.  
1. Expel the vial contents onto sterile filter papers contained in a 50 or 90 mm Petri dish; 
the cryoprotectant can be removed by several options. These are described by Reed 
and Unchendu (2008), who comment that in the case of shoot tips exposed to 
cryoprotectants and controlled rate cooling it is possible to rinse with liquid medium. 
They also remark that for several protocols it is usual for standard liquid culture 
medium to be used to dilute and remove cryoprotectants. This may be due to the fact 
that additives applied in controlled rate cooling are colligative and penetrating, and 
as such do not expose the germplasm to the same degree of osmotic stress as non-
penetrating cryoprotectants. However, if osmotica are applied it may be necessary to 
take precautions in the rinsing stages and gradually reduce the osmotica or wash  
  
with a medium of similar osmotic strength (Benson et al. 2007), for example by:  
a. capillary action of the filter papers, 
b. rinsing in liquid culture medium, 
c. rinsing in a washing solution (e.g. sucrose) of the same osmotic strength as the 
cryoprotectant mixture.  
2. Transfer the shoot tips to recovery medium dispensed in Petri dishes and seal the 
Petri dishes with Parafilm® or clingfilm. 
3. Recover meristems under species-specific growth conditions. 
4. Assess recovery for up to 6-12 weeks dependent upon genotype-specific rate of 
recovery. 
5. Once new shoots have developed, transfer them to standard culture conditions. 
6. Morphologically normal shoots are regenerated prior to the final score of a 
successful outcome in order to confirm positive and sustained recovery.  
Mr FrostyTM is the trade name for a small (ca. 86 x 117 mm) portable freezing unit 
comprising a polyethylene/polycarbonate ‚cryochamber‛. It holds 18 to 20 cryovials 
(1 to 2 ml size) in foam insert. The tank, once filled with isopropanol cools at a 
controlled, but fixed rate of -1oC/min (Reed and Unchendu 2008). The terminal transfer 
temperature of the samples placed in the vials is dependent upon the freezer 
specifications (usually -20oC, -70 or -80oC). The rate of cooling in Mr FrostyTM is usually 
linear over the range of cooling from -10°C to -15°C, after which the sample 
temperature profile loses its linear cooling rate as it cools more slowly to reach 
equilibrium at -20°C (see Nalge Nunc International 2003). Plant materials, equipment, 
cryoprotection, thawing and recovery procedures are the same as those described for 
the programmable freezer protocol (see section 10.6.2.1)  
See sections 10.3.1, 10.3.2.4 and 10.5.1 
 NalgeneTM Cryo 1oC freezing container or a Mr FrostyTM. 
 Cryovials Nunc 377267 CryoTubeTM 1.8 ml Nunc internal Starfoot round 
(50/bag450/case) available from Nalgene or equivalent. 
 Isopropanol (C3H8O) sometimes abbreviated to ‚IPA‛. 
 Thermocouple or electronic thermometer (data logger) capable of accurately 
measuring and recording temperatures to -80°C and monitoring the stability of 
refrigerator/freezer temperatures (e.g. when applied overnight). 
 Cryoprotectant mixture. 
See sections 10.3.2.1, 10.3.2.2, 10.3.2.4 and 10.5.1 
 1. Fill the NalgeneTM Cryo 1°C freezing container or Mr FrostyTM unit with clean 
isopropanol (C3H8O) ‚IPA‛ to the 250 ml line on the freezing unit.  
2. Transfer the cryovials with cryoprotectant to the cooling unit. 
3. Insert a thermocouple into one of the cryovials and close the lid of the apparatus.  
4. The lead of the thermocouple should be sufficiently narrow to allow door closure. 
5. The temperature data logger should be placed external to the freezer.  
6. Place the Mr FrostyTM unit in a -70oC or -80oC freezer. 
7. The Mr FrostyTM unit will passively cool at -1°C/min.  
8. Record the timing of the thermal nucleation events on the temperature logger.  
9. Repeat the procedure at different places in the freezer.  
10. Identify any local temperature effects, changes in cooling/nucleation profiles and 
the timing of the thermal events.  
11. Calibrate cooling profiles of the Mr FrostyTM unit and determine consistency 
between freezing runs. 
12. Retain information for quality control and validation purposes. 
1. Fill the NalgeneTM Cryo 1°C Freezing Container or a Mr FrostyTM unit with clean 
isopropanol (C3H8O) ‚IPA‛ to the 250 ml line on the freezing unit.  
2. Transfer the cryovials to the cooling chamber.  
3. Insert a thermocouple in one of the cryovials, this is designated a surveillance vial 
which is used to check for temperature changes. 
4. Close the Mr FrostyTM unit (as above).  
5. Cool at -1°C/min and record the thermal events on the thermocouple/temperature 
logger.  
6. Based on the calibration information, cool to an optimized terminal transfer 
temperature/time. 
7. Hold at the terminal temperature (usually around the temperature of homogenous 
ice nucleation, -40°C)  
8. Based on calibration information of real time temperature, remove the unit.  
9. Rapidly transfer the vials to cryocanes or a suitable inventory system. 
10. Plunge into LN in a 1 L Dewar located next to the freezer.  
11. Then transfer to the cryotank.  
Proceed to thawing and recovery stages as for Programmable freezer section 10.6.2.1 
Critical cryogenic factors specific to controlled rate freezing are highlighted below; see 
previous and following sections for critical factors that are more generally relevant to other 
  
(e.g. vitrification and ultra rapid freezing) cryopreservation protocols and their associated 
procedures.  
 Excessive freeze-induced dehydration can lead to colligative damage that is caused by the 
harmful concentration of solutes and cell volume changes. 
 In the case of controlled rate freezing a penetrating colligative cryoprotectant(s) is thus 
required and is usually applied in combination with osmotic additives and pretreatments.  
 Colligative cryoprotectants are optimally used to reduce harmful solution effects, deleterious 
volume changes and osmotic stress. 
 Initiation, ‚seeding‛ or nucleation, of extracellular ice is a critical factor as it creates a 
water vapour deficit between the inside and outside of the cell, thus causing intracellular 
water to move outside the cell.  
 Nucleation thus results in cryoprotective freeze-induced cellular dehydration.  
 Optimized controlled rate cooling of tissues to an intermediate sub-zero freezing 
temperature helps to ensure that sufficient intracellular water moves to the outside of the 
cell, thereby reducing the water that is available to form ice inside the cell. 
 A ‚hold‛ is programmed at a fixed time and terminal transfer temperature, usually at, or 
around, the point of homogeneous ice formation, which is ca. -40°C. 
 Additional optional cooling ramps/hold times can be incorporated to optimize the freeze-
induced excursion of water from the cell. 
 Programmable freezers consist of a freezing chamber cooled by liquid nitrogen, temperature 
probes (connected to the sample and the chamber) are used to monitor precisely thermal 
history and by means of computer programming it is possible to investigate a wide range of 
cooling/freezing rate and hold time parameters.  
 With an appropriate output device (e.g. chart recorder/PC) the temperature at which 
extracellular ice is formed (the latent heat of crystallization) may be determined with 
reasonable accuracy. Albeit this is not always possible as it is dependent upon the 
capabilities of the freezing unit.  
 Ice nucleation can mark the onset of intracellular dehydration and, as such, it can be an 
important factor in developing a controlled-rate cooling method.  
 In the absence of external intervention, it is possible for extracellular ice nucleation to occur 
randomly (i.e. via heterogeneous ice nucleation), however, this may be problematic and can 
lead to variable freezing responses between different programmable freezers.  
 Some programmable freezers are fitted with a device, which initiates nucleation by 
mechanically agitating the cryogenic samples. It is also possible to induce nucleation by 
touching the outside of the cryovial with a liquid nitrogen-chilled instrument. 
 It is important that vials are plunged immediately into LN after they are removed from the 
programmable freezer or Mr FrostyTM unit; rewarming of the samples during this transition 
is detrimental to the tissues. For convenience a small Dewar (e.g. 1 L capacity) can be 
located near the programmable freezer and used to transport cryovials to the long-term 
storage site. 
 Qualified service engineers should service programmable freezers annually. 
  Mr FrostyTM provides a simple and cost effective alternative. 
 Used singularly Mr FrostyTM is not efficient for large batches of samples as only a few 
samples can be processed and using one rate of freezing. However, several Mr FrostyTM 
units may be used at the same time increasing the number of samples that can be batch-
processed. 
 It is recommended that between each new freezing run IPA is decanted from the 
Mr FrostyTM chamber which should be washed, dried, and stored at room temperature. 
 Manufacturers recommend that alcohol should be replaced after every fifth use of 
Mr FrostyTM. 
10.6.3 Encapsulation-dehydration  
Fabre and Dereuddre (1990) first developed this cryoprotective method for Solanum 
phureja, it involves encapsulating shoot meristems in a calcium-alginate bead (see 
section 10.3.2.5) followed by osmotic dehydration in sucrose, evaporative desiccation in 
sterile airflow, or over silica gel (see section 10.4.2) followed by direct plunging in LN. 
Encapsulation-dehydration is dependent upon achieving a critically low MC which 
supports the vitrification of the alginate bead and the entrapped meristem. This 
generic protocol is based on the method developed for potato by Fabre and Dereuddre 
(1990) and adapted by Benson et al. (1996), Keller et al. (2008) and Sherlock et al. (2005) 
for silica gel. Crop and genotype-specific modifications may be required when 
applying the method to a wider range of species (Engelmann et al. 2008).  
See sections 10.3.1, 10.3.2.4, 10.3.2.5 and 10.4 
1. For meristem excision and bead preparation see section 10.3.2.1  
2. For encapsulation see section 10.3.2.5 
3. For sucrose pretreatments see section 10.3.2.4 
4. For desiccation see sections 10.4.1, 10.4.2 and for MC calibration see section 10.4.3 
1. Place encapsulated meristems into a 0.75 M sucrose solution prepared in liquid 
medium. 
2. Incubate in a 50 ml conical flask overnight (16 h) on a reciprocal shaker. 
3. Remove, beads, blot dry on sterile filer paper. 
4. Desiccate in a laminar airflow or over silica gel for 3-8 h or for an extended 
duration which is dependent upon achieving an optimal exposure time.  
1. Remove beads, transfer to cryovials and dispense 5-25 beads/vial.  
2. Directly immerse the cryovials into LN in a cryotank. 
  
1. Remove cryovials from the cryotank.  
2. Warm the cryovials at ambient temperatures for 20-30 min. 
3. Wipe the exterior of the cryovials with a sterilant solution.  
4. Remove beads and either transfer to solid recovery medium or re-hydrate in 
standard liquid culture medium for 10-20 min (Reed 2008b).  
1. Transfer the beads to standard culture medium.  
2. Monitor for recovery for 6-8 weeks or longer as required. 
 Desiccation profiles may vary between laminar airflow benches and laboratories and 
alginate brands.  
 To monitor quality control between cryoruns record the temperature and RH in the airflow 
bench at onset/end point of desiccation period.  
 Where RH and ambient temperature are variable use silica gel based desiccation. 
 Some protocols recommend rewarming beads at 45°C for approximately 1 min.  
 Transferring beads to fresh medium during the first 1-3 days can aid recovery. 
 Some protocols recommend excising meristems from the beads during recovery (e.g. after 
one week, this involves cutting the bead in half with the cut on one side of the shoot tip and 
carefully excising the shoot meristem, alternatively the exposed shoot grows out of the cut 
end of the bead. 
 Encapsulation-dehydration has a proven efficacy for several crops/species that are 
unresponsive to controlled rate cooling, but it has the disadvantage of not being applicable 
to desiccation intolerant germplasm.  
10.6.4 Vitrification using PVS2  
Vitrification is the solidification of a liquid without crystallization and it is achieved by 
applying cryoprotectants that are sufficiently concentrated to create an amorphous 
glassy state on cooling. This is a thermal event punctuated by the glass transition 
temperature (Tg). Steponkus et al. (1992) describe plant vitrification in five steps: 
1. Loading: equilibration in a solution of permeating (colligative) cryoprotectants  
(e.g. DMSO, ethylene glycol and glycerol, albeit permeability may be cell specific). 
2. Dehydration: dehydration in a concentrated, osmotically active cryoprotectant(s)  
(e.g. sucrose). 
3. Rapid cooling: the germplasm is vitrified by direct plunging into LN. 
4. Warming: the germplasm is rewarmed either rapidly or by stepwise increases in 
temperature. 
5. Unloading: vitrification solution removal by dilution and/or washing. 
 
 In practice, loading and vitrification solutions comprise mixtures of penetrating 
and non-penetrating cryoprotectants; several have been used for plant germplasm, 
(Steponkus et al. 1992). PVS2 was devised by Sakai and colleagues; Sakai and 
Engelmann (2007) and Sakai et al. (2008) provide a history and summary of the 
different range of protocols that use PVS2 and other derivative methods that are 
termed PVS protocols. Sakai et al. (2008) report PVS3 as an alternative vitrification 
solution comprising (w/v) each of 40% sucrose and 40% glycerol (w/v) prepared in 
liquid medium. In the wider literature (Reed 2008a), PVS3 is reported to comprise 
50% (w/v) sucrose and 50% (w/v) glycerol. PVS2-based protocols are the most 
commonly used vitrification methods applied to the mandate crops for which these 
multi-crop guidelines are designed. The following generic method is described as a 
basic protocol, it may however require optimization for specific crops, genotypes and 
different types of germplasm. 
See sections 10.3.1, 10.3.2 and 10.5.1 
1. For meristem excision, see section 10.3.2.1 
2. For pretreatments, see section 10.3.2.4 
Using the methods described in section 10.5 prepare the following solutions in liquid 
culture medium. Sucrose is added to the final concentration required for cryoprotection. 
 Loading solution: usually 2 M glycerol and 0.4 M sucrose. 
 PVS2: 30% (w/v) glycerol, 15% (w/v) ethylene glycol, 15% (w/v) DMSO and 0.4 M 
sucrose (final level/concentration). 
 Optionally prepare a PVS2 dilution series: ca. 50, 60, 70, 80 % (v/v) PVS2/liquid 
culture medium as sequential loading of increasing concentrations may be required 
to avoid toxicity. 
 Unloading solution: 1.2 M sucrose (final concentration) in liquid culture medium. 
Prepare/excise meristems (section 10.3.2.1) apply a pretreatment as appropriate. 
1. Transfer meristems to 2 M glycerol and 0.4 M sucrose loading solution for  
20-25min at 25°C.  
Construct a toxicity trial for PVS2 based on testing the effects of solution concentration 
and duration of exposure on germplasm survival, as follows: 
1. Treat meristems with ice-chilled (PVS2 can for some species also be used at room 
temperature) 1 ml aliquots of PVS2 within the range of 50-80% (v/v) to a specific 
concentration and exposure time (e.g. 1-20 min). 
  
2. Remove almost all the vitrification solution, replace with intermediate increasing % 
solutions, stepwise to higher % levels of PVS2.  
3. Gradually increase the level of PVS2 until tissues are in a 100% solution. 
4. Remove the 100% PVS2. 
5. Replace with "unloading" solution containing 1.2 M sucrose in standard liquid 
medium.  
6. Wash 2-3 times in fresh unloading solution and maintain in this solution for up to 
30 min. 
7. Expel vial contents onto a sterile filter paper to soak away the liquid excess.  
8. Transfer meristems to recovery medium. 
9. Select the treatment which permits maximum survival and tolerance to 
cryoprotection.  
1. Apply optimal PVS2 treatments on ice as determined by the toxicity test applied to 
meristems (as described above).  
2. Once in 100% PVS2, transfer the meristems to cryovials (5-25/vial) to which 0.5-1 ml 
of fresh PVS2 has been added. 
3. Directly plunge the cryovials in LN contained in a 1 L Dewar. 
4. Transfer the vials to a cryotank for storage. 
1. Transfer bottles containing sterile-distilled water to a 45C water bath and allow a 
few minutes for them to stabilize at that temperature. 
2. Transfer the cryovials from the cryotank to a small LN-filled Dewar and transfer 
the Dewar to the side of the water bath. 
3. Proceed to rewarm using one of two options:  
a. rapidly transfer the cryovials to bottles containing sterile-distilled water (one 
vial/bottle) to the 45C water bath and agitate for 1-2 min, remove to avoid 
over-heating, 
b. hold the cryovials for 1 min at ambient (20 to 25°C) to allow for glass relaxation 
and to avoid fractures, then proceed to transfer to a 45C water bath and 
proceed as in (a). 
4. To remove excess and potentially contaminating water, wipe the outside of the 
cryovial with a tissue soaked in an antibacterial/sterilizing solution or 70% (v/v) 
alcohol.  
5. Transfer the cryovials to a laminar airflow bench.  
1. Remove the 100% PVS2 and replace with 1.2 M sucrose unloading solution.  
2. Perform 2-3 washes in fresh unloading solution. 
3. Maintain in the final rinse solution for 20 to 30 min. 
4. Transfer the meristems to a sterile filter paper and allow the solution to drain away 
 1. Place a sterile filter paper over the surface of a Petri dish containing solidified culture 
medium. 
2. Transfer the meristems onto the surface of the filter paper. 
3. After one day, transfer the meristems to a new filter paper/Petri dish with fresh 
medium. 
4. Continue this process for 1-3 days after which transfer the meristems to medium 
only. 
5. Monitor recovery regularly for 6-8 weeks or longer as required. 
 Ensure PVS2 contains sucrose at a final level  of 0.4 M. 
 Applying (w/v) DMSO, glycerol and ethylene glycol additives to liquid culture medium 
already containing 0.4M sucrose does not result in a final level of 0.4 M sucrose which 
volume per volume is diluted out by the other cryoprotectants. 
 A simple check test: on exposure to LN, correctly prepared PVS2 solution should be 
completely clear i.e. ‚glassy‛, some glass fractures (cracks) may be observed. 
  If the PVS2 becomes white/opaque on exposure to freezing temperatures it has not been 
prepared correctly as opacity indicates ice formation. In this event, the preparation of PVS2 
should be re-checked. 
 PVS2 is very viscous and takes some time to dissolve, therefore the gradual addition of 
cryoprotectants during vigorous agitation on a magnetic stirrer is recommended. 
 Adjust the pH of PVS2 after formulation. 
 Filter sterilization of small volumes of PVS2 is recommended. 
 Make fresh PVS2 for each use. 
 Pretreatments (pregrowth, preculture), acclimation and preconditioning are often critical to 
successful cryopreservation outcomes using PVS2. 
 Applying loading solutions prior to PVS2 improves survival of germplasm, most probably 
by enhancing tolerance to dehydration. 
 Optimizing the sequential application, dehydration and incubation steps of the PVS2 
protocol is similarly critical to successful outcomes. 
 Shoot tips may not survive direct (i.e. immediate) exposure to 100% PVS2, stepwise 
addition of an increasing concentration, e.g. in a range of 50-100% (v/v) of the 
cryoprotectant is best optimized by exposing to different time durations for different 
concentrations (e.g. usually 5-20 min, but can be longer). 
 Adding chilled PVS2 solutions on ice may reduce its toxic effects. 
 It may be possible to expose tissues to higher concentrations of PVS2 if applied at 0oC. 
 Due to glass relaxation events, larger volumes of PVS2 may fracture on rewarming, if this 
is harmful to meristems, a two-step rewarming procedure may be tested. This involves a 
brief 30-60 sec rewarming on initial removal from LN (either in vapour phase LN or at 
ambient [ca. 25°C]) temperatures to allow for safe glass relaxation, followed by rapid 
rewarming at 45°C. In these cases it is important to take care that the glass does not 
  
crystallize during devitrification; the process should proceed directly from glass to liquid 
without an intervening ice nucleation and thawing event. 
 Following vitrification, the shoots are initially recovered in an "unloading" solution which 
prevents osmotic shock by replacing the vitrification solution with 1.2 M sucrose. 
 PVS3 is an alternative vitrification solution comprising (w/v) each of 40% sucrose and 
40% glycerol (w/v) prepared in liquid medium (Sakai et al. 2008). Panis (2008) reports the 
use PVS3 for Allium meristem cryopreservation, albeit based on the original formulation of 
50% sucrose and 50% glycerol (w/v). PVS3 is similarly applied (as for PVS2) but in 
conjunction with an osmoprotection solution of 2 M glycerol and  0.4 M sucrose prepared 
in standard culture medium. 
 PVS2 vitrification has proved a very effective cryoprotectant for a wide range of crops and 
is particularly useful for cryopreserving tropical and recalcitrant germplasm. 
10.6.5 Droplet vitrification  
This approach is a modification of both the PVS2 protocol (above) and the droplet 
freezing protocol (see section 10.6.1.1) in which DMSO is replaced by PVS2 as the 
cryoprotectant. Pennycooke and Towill (2000) first tested droplet-vitrification for the 
cryopreservation of sweetpotato meristems; subsequently Panis et al. (2005) developed 
the method for Musa. Droplet-vitrification has been successfully applied to a range of 
genotypes and species (Sakai and Engelmann 2007). A generic protocol is presented, 
based on Panis (2008) and Panis et al. (2005). However, the basic method will require 
pretreatment, preculture and pregrowth optimization (see section 10.3.2.4) on a crop-
specific basis.  
See sections 10.3.1 and 10.3.2.4  
 Vitrification solutions as prepared as described in section 10.5. 
o Loading solution: 2 M glycerol and 0.4 M sucrose 
o PVS2: 30% (w/v) glycerol, 15% (w/v) ethylene glycol, 15% (w/v) DMSO, 0.4 M 
(final level) of sucrose in standard liquid culture medium. 
 Ice, ice bath or bucket. 
 Small 1L bench top Dewar, cryostorage tank or Dewar. 
 Recovery medium.  
1. For meristem excision, see section 10.3.2.1 
2. For sucrose pretreatments, see section 10.3.2.4 
1. After excision, transfer the meristems to a loading solution of 2 M glycerol and 
0.4 M sucrose in standard culture medium. 
2. Incubate for a minimum of 20 min. 
 1. Remove the unloading solution and replace with ice-cooled 100% PVS2. 
2. Cryoprotect in PVS2 on ice for 30-60 min. 
3. During which time, dispense 5-8 15 μl droplets of chilled PVS2 solution onto the 
surface of sterile aluminium foils placed in a sterile 50 mm or 90 mm Petri dish 
(5 x 20 mm).  
4. Transfer the foils/Petri dish to ice in a polystyrene icebox. 
5. Five to ten minutes before the end of PVS2 cryoprotection, transfer meristems 
(one per droplet) to the droplets on the surface of the aluminium foils. 
1. Pre-prepare labelled cryovials, ensuring the ink/surfaces are LN-resistant and 
indelible. 
2. Place aluminium foils on a sterile Petri dish. 
3. Fill a polystyrene box with LN, open the cryovials, place them in the holes of the 
polystyrene float, and place on the surface of the LN. 
4. Fill the cryovials with LN. 
5. With the aid of forceps, transfer the foils and droplets to the open cryovials and 
plunge them directly into LN, submerging the foils for a few seconds until they 
have reached LN temperature (i.e. the vapour has stopped boiling).  
6. Refill the open cryovials with LN. 
7. Repeat the process to complete the batch of meristems. 
1. Close the cryovials.  
2. Optionally transfer to a cryocane and enclose in a plastic LN-resistant cryosleeve. 
3. Transfer to a 1 L bench top Dewar before transfer to the cryotank. 
4. Alternatively, transfer to the cryotank directly. 
5. Store in appropriate inventories in either the vapour or liquid phase of LN. 
1. Remove lids from cryovials, using forceps retrieve the foils/meristems in droplets.  
2. Plunge directly into bottles containing 1.2 M unloading solution; incubate for 
ca. 15 min at ambient temperature.  
3. The meristems rapidly float into the solution. 
4. Repeat the process for the batch of meristems. 
5. To avoid cross-contamination use separate bottles of unloading solution for each 
cryovial. 
1. Place a sterile filter paper over the surface of a Petri dish containing solidified 
medium. 
  
2. Transfer meristems onto the surface of the filter paper. 
3. After 1-2 days transfer to a new filter paper/Petri dish with medium. 
4. After which transfer the meristems to medium only and culture under standard 
conditions. 
5. Monitor for recovery regularly for 6-8 weeks or longer as required. 
Also see critical factors for section 10.6.4  
 This protocol has proved effective for cryopreserving meristems from species that have not 
responded to the conventional PVS2 method. 
 Optimization of meristem excision/pretreatments may be required, particularly for 
problematic genotypes. 
 This protocol may contravene health and safety regulations for some countries and 
institutions for which the use of cryovials outside manufacturer’s safety recommendations 
i.e. purposeful filling of vials with LN and use of non-LN resistant vessels e.g. polystyrene 
boxes are not compliant with the safe use of LN. Small Dewars with larger openings are 
more effective containers. 
 Due to the direct exposure of meristems to LN, this procedure is not contained and strict 
precautions should be taken to ensure germplasm has been through a stringent phyto-
sanitary process, and is confirmed axenic and free of covert microbial infection. 
10.6.6 Encapsulation-vitrification 
This method usually combines encapsulation with the PVS2 vitrification protocol, 
although other vitrification solutions may be used. The original PVS2 protocol was 
developed to increase the technical efficiency of the standard encapsulation- 
dehydration protocol (see Sakai and Engelmann 2007). It involves encapsulation 
followed by treatment with PVS2 solutions and uses the basic preparative and bead-
making procedures for alginate and PVS2 (see sections 10.3.2.5, 10.5, 10.6.3 and 10.6.4). 
 For basic materials, see sections 10.3.1 
 For PVS2 solutions, see sections 10.5 and 10.6.4 
 For meristem excision and pretreatments see sections 10.3.2.1 and 10.3.2.4 
 For encapsulation see section 10.3.2.5 
1. Encapsulate meristems in calcium alginate as described in section 10.3.2.5. 
2. Transfer encapsulated meristems to a loading solution (see section 10.6.4) of 
0.4 M sucrose, or 2 M glycerol and 0.4 M sucrose (usually prepared in standard 
culture medium) and incubate for 1 h at 25oC (this may require optimization for 
temperature and exposure time). 
 3. Remove encapsulated shoot tip meristems and place in a 50-100 ml flask containing 
100% PVS2 solution (see sections 10.5 and 10.6.4). 
4. Place flask on a reciprocal shaker optimized incubation time (e.g. 60-100 rpm) for 
up to 1 h for different durations.  
1. Put the PVS2 into the cryovial first and then add the beads, this ensures that the 
beads are always immersed in PVS2 from the start to finish of the procedure. 
2. Remove beads, place in 1.8-2.0 ml cryovial (5-25 beads/vial) to which previously 
1 ml of PVS2 has been added. 
3. Directly immerse the beads and the vials into LN and transfer to a cryotank. 
1. On retrieval from storage, rewarm the vials in a water bath at 35-45°C for ca. 1 min. 
2. Swab the cryovials with a disinfectant.  
3. Drain away the PVS2, replace with 1.2 M sucrose unloading solution, and incubate 
for 10 to 30 min or optimize for different durations.  
1. Remove the beads and blot dry on filter papers to remove excess solution. 
2. Place on recovery medium. 
3. Monitor for recovery regularly for 6-8 weeks. 
 Optimization of acclimation, pretreatments and PVS2 incubation, loading, and unloading 
may be required on a crop-specific basis. 
 Initial recovery on ½ strength solidified medium for 1-2 weeks may aid regrowth. 
 The encapsulation-vitrification protocol is technically easier than the traditional 
encapsulation-dehydration protocols as it offsets the need for prolonged osmotic dehydration 
and evaporative desiccation of the beads. 
 This method has proved particularly successful for species/genotypes that are not amenable 
to either the traditional PVS2 or encapsulation-dehydration (Sakai et al. 2008). 
 Some studies indicate that the encapsulated shoot tips of certain species and genotypes can 
withstand up to 2 times longer PVS2 exposure than non-encapsulated shoot tips. 
 Encapsulated shoots may require longer pre- and unloading solution exposure times. 
10.7 Control of contamination in long-term storage 
Personnel should be aware of the special phytosanitary treatments, contamination and 
containment issues affecting germplasm held in LTS (Benson 2008) most of which are 
common to those for active in vitro culture and slow growth. Specific cryogenic 
contamination risks are associated with: (1) sterilization of cryoprotectants, 
particularly those that are filter-sterilized; (2) cryovial containment and the risks of 
contamination; (3) cross-infections during laborious cryogenic manipulations; 
  
(4) accumulation of adventitious microbial flora in long-term cryobanks during LN 
tank filling and (5) contamination on rewarming or when thawing in water baths. 
Morris (2005) provides experimental evidence for the accumulation of contaminants in 
cryotanks. 
10.8 Recovery 
Recovery of germplasm from cryobanks will need to be addressed on a crop and 
species basis, dependent upon the overall success of the protocol and its applicability 
across genotypes. Potential treatments that can improve recovery include: 
(1) optimization of unloading after vitrification (see section 10.6.4); 
(2) optimization/phasing of plant growth regulators to avoid adventitious 
development and callogenesis and encouraging normal shoot regrowth; (3) 
sequential and gradual removal of osmotica by frequent transfers to media with 
decreasing levels of additives; (4) initial recovery in low or no light to reduce 
photooxidation and (5) recovery in special media containing antioxidants and 
ethylene inhibitors (Mafla et al. 2004; Benson 2008).  
10.9 Stability 
In vitro genebank practices must ensure biological resources maintain their unique 
characteristics and that these are unchanged by tissue culture and cryogenic 
manipulations. Genetic variability is cautioned due to risks of in vitro-generated 
instability proceeding through somaclonal variation (SCV) which is defined as 
heritable genetic variability in plants generated by tissue culture (Scowcroft 1984). The 
genetic consequences of SCV are more significant for clonally propagated genetic 
resources as they manifest in the asexually regenerated plant. Ameliorating the 
potential risks of SCV resulting from in vitro manipulations connected to 
cryopreservation is thus important. Scowcroft (1984) recommends care should be 
taken in making critical technical decisions as to how in vitro germplasm is 
manipulated and maintained to avoid practices that increase genetic variation.  
Preferred practices are: (1) avoidance of germplasm propagated via dedifferentiated 
and adventitious routes of development and (2) selecting germplasm from young 
cultures as SCV increases and totipotency decreases during prolonged culture. Careful 
selection of donor plants and germplasm and the optimization of cryopreservation 
protocols are also required to minimize stress and selection pressure; these precautions 
are similar to as described for MTS. Mode of regrowth and regeneration is important 
for clonal crops that have a propensity for somaclonal variation. It is advisable that 
recovery, shoot regrowth and regeneration proceeds via normal routes of primary 
meristematic development. Stress-induced selection pressures may become problematic 
for low surviving genotypes.  
Stability testing after cryogenic storage should be a quality control measure and 
prioritized for species, crops and genotypes that: (1) have a known tendency to 
generate somaclones, off-types and are prone to genetic and epigenetic variability; 
 (2) low surviving genotypes; (3) cultures that have been maintained in vitro for 
extended periods before they are cryopreserved; (4) plants recovered via 
dedifferentiated or adventitious routes and (5) plants with abnormal characteristics.  
Stability assessments may be conducted at the cytological (ploidy/chromosomal 
assessments), genetic, epigenetic and phenotype levels and field regeneration studies 
permit true-to-type assessments using crop descriptors. Although a result may not be 
indicative of genetic instability or stability and molecular-based testing is best supported 
by trueness-to-type evaluations (Harding 2004). Testing can include: molecular, 
genotypic and phenotypic assessment of stability, developmental competence and field 
performance of clonal crops regenerated from in vitro storage. Specific procedures may 
comprise: long-term field performance trials, biometric analysis of phenotypes and their 
developmental competencies, microsatellite (SSRs) analysis, AFLPs, RAPDs, RFLP-
ribosomal RNA genes, DNA methylation, biosynthetic stability, secondary metabolite 
production, flow cytometry, ploidy assessments and evaluations of transgene stability, 
as well as the assessment of morphological and genetic stability in progeny. 
10.9.1 Critical points  
 Quality control stability assessment should be considered at phenotypic, epigenetic/ 
genotypic levels of assessment.  
 Methods currently employ phenotypic, chromosomal, cytological and molecular tests 
(e.g. RAPD, DNA methylation, RFLP, AFLP). 
 Molecular diagnostics mainly screen a very small part of the genome. 
 Field trials should be considered to assess trueness-to-type this procedure can run 
concurrent with germplasm authentication. 
10.10 Longevity 
Currently there is no notable evidence for cryopreserved germplasm deteriorating 
with time in storage per se. However, constantly maintained LN levels and carefully 
controlled deposits and retrievals from cryotanks are critical to good cryobanking 
practice. Inadvertent and unregulated warming of stored samples (particularly those 
that are vitrified) can put at risk their longevity. Periodic assessment of cryobanked 
germplasm and the use of sentinel cryovials may be prudent measures to build into 
standard genebank quality control operations. 
10.11 Problems, troubleshooting and improvements 
The main factors limiting successful cryopreservation are variable genotype responses, 
arrested shoot development, limited regrowth of surviving meristems, delayed decline 
in recovery, poor rooting in survivors, covert and endophytic contamination. One of 
the main limitations is developing cryostorage protocols that are applicable to wide a 
range of genotypes and the inefficiency of optimizing protocols. Applying the 
probability equations of Dussert et al. (2003) is a useful and necessary approach as they 
calculate the lowest recovery rates that allow a target number of regenerants to survive 
  
cryopreservation. It is important to caution that these equations do not take into 
account losses from contamination, genetic instability and selection pressures in low 
survivors. Improvements to cryopreservation protocols can be achieved by the 
optimization of generic protocols and the development of new approaches for 
recalcitrant genotypes based on both fundamental (e.g. proteomics) and applied 
research. Improved technology transfers and validation exercises that use critical point 
analyses will facilitate these approaches. Implicitly, this also means that the 
development of improved procedures and protocols in IVGBs will be facilitated by the 
continued development of quality systems and their associated best practices.  
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 Base collection: as defined by Genebank Standards (1994) for seed germplasm, base collections 
are a set of genetically distinct, different accessions as close, as is possible to the sample 
originally procured to establish the collection. The base collection is: (a) preserved for 
the long-term future and (b) not normally distributed from directly to users. Ideally, 
the base collection represents a comprehensive genepool of the crop or species. Because 
of the potentially extreme longevity of germplasm held in LN, cryobanks have become 
synonymous with base collections. 
Biorepository: a body/institute/laboratory/genebank that receives, stores, processes and 
disseminates organisms, organs, tissues, cells, cultures and other constituent biological 
materials. The term embraces infrastructures, documentation and all processes 
involved in the safekeeping stored biological resources and their dispatch to clients, 
end users and beneficiaries.  
Colligative cryoprotectant: the term ‘colligative’ refers to the properties of solutions and it is 
characterized by the amount of solutes that are dissolved in the solution. A colligative 
cryoprotectant is an additive that is able to penetrate the cell, it is applied to reduce or 
prevent the damage caused by excessive cell volume changes and the toxic 
concentration of solutes, both these injurious effects occur during cryopreservation. 
Colligative cryoprotectants also cause freezing point depression which is also 
protective, as when ice nucleation does occur, it is not as injurious as would be the case 
for ice formed at higher sub-zero temperatures.  
Controlled rate cooling: a cryopreservation protocol that controls the rate at which 
cryoprotected germplasm is cooled before it is finally plunged into LN (also known as 
2-step or stepwise cooling). The process involves various cooling rates, hold times and 
a terminal transfer temperature(s). Synonymous with controlled rate freezing. 
Controlled rate programmable freezers: computer-operated machines that deliver pressurized 
LN into a freezing chamber via a solenoid valve that is controlled by a thermal device 
responsive to the difference between the actual and desired temperature. The computer 
control unit is programmed with the desired temperature gradient, and holding points 
which allow the samples to be placed in, and withdrawn from the chamber. Controlled 
rate cooling requires the sample to be ‘seeded’ (the process by which ice nucleation is 
induced), some programmable freezers contain devices that allow automatic sample 
seeding.  
Core collections: a limited set of accessions, representing, with minimum replication, the 
genetic diversity of a crop species and including its wild relatives. A contemporary 
definition is an optimally representative range of genetic resources that meets the needs 
and requirements of the end users and genebank curator.  
Cross-contamination: the transfer of one part of a sample to another, or cross-infection with a 
sample that is contaminated by a microbial agent, pest or pathogen. 
Cryopreservation: the conservation of living cells, tissues, organs and organisms at ultra low 
temperatures, usually in LN or its vapour, to a minimum temperature of -196°C.  
 Cryoprotectant: an additive, mixture of additives or a process that allows living cells, tissues, 
organs and organisms to survive exposure to cryogenic temperatures (usually in LN 
and its vapour to a minimum temperature of -196°C).  
Cryoprotective dehydration: the removal of water by osmotic or evaporative means to allow 
survival after cryopreservation.  
Cryostorage tank: a specialist vacuum-insulated LN tank used to store cryopreserved 
germplasm; these tanks have the advantage of being independent of electrical power so 
long as the LN level is maintained.  
Droplet freezing: a cryopreservation protocol in which meristems are suspended in micro-
droplets of DMSO solution on aluminium foils and cooled at ultra rapid rates by direct 
exposure to LN. On rewarming, the foils/meristems are placed in unloading solutions 
and passively rewarmed at ambient temperatures.  
Droplet-vitrification: a cryopreservation protocol in which meristems are suspended in micro-
droplets of vitrification solution on aluminium foils and are cooled at ultra rapid rates 
by direct exposure to LN. On rewarming, the foils/meristems are placed in unloading 
solutions and passively rewarmed at ambient temperatures or at 45°C in a water bath. 
Dry shipper: a special IATA, safety-approved transport container used to transport 
cryopreserved germplasm at the temperature of LN vapour (see liquid nitrogen) by 
means of LN being adsorbed into a special material which prevents risks of spillage.  
Encapsulation-dehydration: a cryoprotective process in which meristems are encapsulated in 
calcium-alginate beads, osmotically dehydrated, evaporatively desiccated in a sterile 
airflow or, over silica gel, directly cooled in LN, and passively rewarmed at ambient 
temperatures.  
Encapsulation-vitrification: a cryoprotective process in which germplasm is encapsulated in 
calcium-alginate beads, osmotically dehydrated and/or loaded with cryoprotective 
additives, exposed to vitrification cocktails such as PVS2 and cooled in LN, placed in 
unloading solutions and either passively rewarmed at ambient temperatures or at ca 
45°C in a water bath. 
GPG2: the Collective Action for the Rehabilitation of Global Public Goods Phase 2. The 
Consultative Group on International Agricultural Research (CGIAR) project of the 
CGIAR-System-wide Genetic Resources Programme (SGRP). The practical aim of the 
project is the upgrading of genebank operations and facilities and guiding the CGIAR’s 
contribution in developing a global, secure plant genetic resources system. 
Ice nucleation: also termed ‘seeding’ is the point at which ice crystals are first initiated in a 
cryopreserved sample, usually during controlled rate cooling.  
In Vitro Active Genebank (IVAG): an in vitro collection of germplasm comprising accessions 
held in conditions (low temperatures, light, high osmotica) that limit culture growth in 
order to reduce costs and increase efficiency by extending subculture intervals. The 
process is also termed Medium Term Storage (MTS). The cyclic flow of material is the 
essential feature of the IVAG which is maintained by successive subculturing and 
recovery, allowing renewal of cultures for use and distribution.  
In Vitro Base Genebank (IVBG): as defined by Genebank Standards (1994) a base collection is 
preserved for the long-term future in cryobanks and not normally distributed to users. 
Because of the extreme longevity of germplasm in cryobanks, the process is called 
Long-Term Storage (LTS) and is synonymous with cryopreservation.  
 In Vitro Genebank (IVGB): a genebank dedicated to the conservation of genetic resources in 
vitro under active growth slow growth and cryopreserved conditions. 
Liquid Nitrogen (LN): a cryogenic coolant which is used to cool and store germplasm in either 
the liquid phase (at a temperature of -196°C) or vapour phase at variable temperatures 
(depending on how far the sample is from the liquid phase). See Liquid phase storage 
and Vapour phase storage.  
Liquid phase storage: cryopreservation in the liquid phase of LN at -196°C.  
Long-term storage (LTS): cryopreservation (cryobanking) usually in in vitro base genebanks. 
Also see In Vitro Base Genebank (IVBG). 
Medium-term storage (MTS): preservation using slow or minimal growth usually in in vitro 
active genebanks. Also see In Vitro Active Genebank (IVAG). 
PVS2: Plant Vitrification Solution number 2, comprising 30% (w/v) glycerol, 15% (w/v) 
ethylene glycol, 15% (w/v) DMSO and 0.4 M sucrose, developed by Akira Sakai and 
colleagues. 
PVS3: Plant Vitrification Solution number 3, PVS3 is an alternative vitrification solution 
comprising (w/v) each of 40% sucrose and 40% glycerol (w/v) prepared in liquid 
medium (Sakai et al. 2008). Panis (2008) reports the use PVS3 for Allium meristem 
cryopreservation based on the original formulation of 50% (w/v) sucrose and 
50% (w/v) glycerol.  
Seeding: the process by which ice nucleation is initiated in a cryopreserved sample, usually 
during controlled rate cooling.  
Vapour phase storage: cryopreservation in the vapour phase of LN at ca. temperatures of  
-130°C to -190°C (Hunt and Pegg 1996; Benson 2008). 
Vitrification: A process which increases cell viscosity to a critical point at which an amorphous 
glassy state is formed at a critical glass transition temperature, called the Tg (see Tg).  
Accident: an event or occurrence deviating from a best practice or regulated procedure that 
may potentially, or will deleteriously affect personnel, germplasm and quality 
genebank systems (e.g. diagnostics, storage, authentication) and the subsequent use of 
the genetic resource. Accidents should be formally recorded and investigated to ensure 
any deleterious outcomes are obviated, corrected or limited. 
Accreditation: the process by which an external auditor which is itself accredited by formal 
standards (endorsing the auditor is competent to undertake accreditation by quality 
assurance) awards a certificate of competency and procedures.  
Adverse outcome: a detrimental outcome as a result of an accident or incident.  
Aseptic technique: the special processing of materials, explants and germplasm in such a way 
that the potential for contamination with microorganisms and cross-contamination via 
other samples is prevented. 
Audit: a formally assessed documentation of personnel, procedures, records and protocols 
used to evaluate adherence to Best practices (BPs) and Standard operating procedures 
(SOPs) regulations and statutes.  
Authentication: proof and verification of correct identity. 
 Best Practice (BP): a protocol, technique, method or process that is the most effective in 
producing a particular outcome compared to any other approach that is used. The BP 
must operate within a process that has been: (1) properly checked and tested against 
compliance with specific and desired outcome(s) and (2) is achieved without 
complications, changes to the protocol or unforeseen problems. Best Practices are the 
most efficient (in terms of time, resources, facilities, costs) and effective (producing the 
best possible result) approach to undertaking a task. A BP is usually and ideally proven 
and tested by others such that it is capable of being repeated by others (also see 
Technology transfer, validation and verification).  
Biohazard: an organism, pathogen or substance that is a threat or harmful to personnel, 
germplasm, other organisms, crops and the environment.  
Biorepository core responsibilities: (1) purity: freedom from contaminating organisms; 
(2) authenticity: correct identity; (3) stability, including functionality and fitness for 
purpose. 
Clean room: a room especially equipped to maintain a clean environment, for aseptic 
processing, usually with restricted entry, working at positive pressure, fitted with air 
filters to remove dusts, particulates, microorganisms and operating to specific 
containment conditions and specifications (also see Controlled areas).  
Cold chain: a supply chain of a product, material or germplasm that must be maintained at a 
controlled low temperature defined by critical specific limits to preserve its stability 
(also see Glass transition temperature, Tg). 
Community of practice: a term used to describe shared activities that embrace people and 
their institutions with shared/common goals and that require coordinated interactions 
to strive for and satisfy these goals; the term is associated with biorepository sectors.  
Consignee: an institute or member of staff that takes receipt of materials and germplasm and 
who is responsible for their dispatch, storage in transit, tracking and deposition in 
genebanks. 
Containment: the complete demarcation or enclosure of a process or sample so that it does not 
come into contact with a boundary or border that puts it at risk to contamination or 
infection by mean of direct, adventitious or cross-contamination (also see Double 
bagging).  
Controlled areas: restricted areas coded with a defined level of security, only accessible to 
signed in, authorized personnel; they are usually alarmed and can be placed under 
camera surveillance.  
Critical point factor: a factor or issue that affects the successful outcome of a procedure or 
protocol.  
Custodian: the person responsible for the management of the germplasm held in the genebank 
and who works in cooperation with the donors, recipients, stakeholders, end users and 
beneficiaries. The custodian is responsible for ensuring the overall technical, regulatory 
and safe management of the genebank according to guidelines and best practices. 
Deviation: an unintended or intended departure from a normal or best practice, standard 
operating procedure or regulatory requirement that requires formal explanation, 
justification and documentation. 
Donor: the source of the biological material, explant or germplasm that can be designated as 
an institute, genebank, person or mother plant.  
 Double bagging: the secure, double-containment of germplasm stored in cryobanks to prevent 
leakage of LN into cryovials and cryobags, thus minimizing the risks adventitious 
contamination and cross-infection from other samples held in the cryobank.  
Environmental monitoring system: an automated surveillance and data logging system that 
monitors a controlled environment within critical specifications and that triggers an 
alarm if the environmental control system goes off limits or malfunctions.  
Error:  a departure from a best practice or standard operating procedure involved in any 
aspect of the IVGB activities that may be due to: technical and documented mistakes, 
miscalculations, mislabelling and that requires formal and documented corrective 
action to mitigate against current and potential deleterious consequences and may 
require re-call of samples and the re-writing of best practices.  
Exemplar: in the context of these guidelines, exemplar is used (in preference to the use of 
‘example’) to mean a typical (or generic) illustration of a process, technique, protocol or 
procedure (including reporting procedures). 
Hazard: anything or a process or procedure that can cause harm.  
Hazard analysis and critical control points: a systematic preventative approach used in food 
safety and the pharmaceutical industry to identify and control hazards based on the 
principles of: (1) hazard analysis; (2) identification of critical control points; and 
establishing (3) critical limits for each control point; (4) critical control point monitoring 
requirements; (5) stabilizing corrective actions; (6) record keeping procedures and 
(7) formulating procedures for ensuring a process is working properly. 
Incident: an unplanned deviation from a best practice, or safety protocol affecting a standard 
operating procedure (SOP) and which may put at risk personnel carrying out the 
procedure, the germplasm/sample/process and consequently requiring instigation of 
an incident response plan and report documentation (see also Accident).  
Institutional review: a panel, review board or committee formally appointed to review 
periodically the activities of an institute and a process that can be undertaken as part of 
an overarching quality review programme.  
International Air Transport Association (IATA): the regulatory body that oversees the safe 
aviation transport and the organization that requires IVGB complicacy with its 
regulations for the safe shipment of germplasm ad biological materials (see Dry 
shipper).  
International Treaty on Plant Genetic Resources: the objectives of the Food and Agriculture 
Organization’s Treaty are the conservation and sustainable use of plant genetic 
resources for food and agriculture and the fair and equitable sharing of the benefits 
arising out of their use, in harmony with the Convention on Biological Diversity (CBD), 
for sustainable agriculture and food security. 
ISO:  the logo and designation of The International Standard for quality management 
systems of the International Organization for Standardization, a body composed of 
representatives from a wide range of national standards organizations, setting 
standards of practices. 
Material Safety Data Sheets (MSDS): information sheets provided by equipment and 
chemical manufacturers and suppliers providing physical/chemical/biological 
properties; information on the hazards of their product with ratings related to their 
handling risks: first aid and fire fighting measures, accidental release contingencies, 
 exposure controls, Personal Protective Equipment (PPE) and Clothing (PPC), handling 
and storage controls, stability and reactivity, toxicological and ecological information, 
transport and disposal information and regulatory controls and procedures.  
Material Transfer Agreement (MTA): an agreement that controls the transfer of germplasm 
between two organizations, which specifies how the recipient will use the genetic 
resource or biological material. The MTA defines the rights and obligations of the 
donor/provider/recipient regarding germplasm use. The prefix standard specifically 
refers to the standard MTA (CGIAR-FAO) devised for plant germplasm.  
Preservation: the process by which germplasm, physical and biological materials, chemicals, 
and reagents are stored to ensure that they do not deteriorate, usually within a specific 
period notified by an expiry date, or as defined by long and short-term storage.  
Procedure: a series of consecutive steps designed to result in a specific outcome.  
Process(es): any of all the procedures in the IVGB involved in the overall security, safe 
management storage, dispatch and use of its genetic resources.  
Quality: confirmation of compliance with specific, predetermined standards.  
Quality Assurance (QA): Evidence of action confirming that work is done effectively using 
systematic accounting of actions related to the work, so that they give sufficient 
confidence that a process, product or service meets given requirements for quality. QA 
normally involves all activities in the process; including documentation and assures 
that the processes are fit-for-purpose. QA also includes failure testing, to anticipate a 
weakness or critical point in the process.  
Quality Assurance (QA) IVGB-specific: an integrated system for managing all aspects of a 
genebank’s activities to ensure that they are performed to the appropriate and required 
standard in full compliance with all regulatory obligations.  
Quality Management System (QMS) IVGB-specific: as for Quality Assurance. 
Risk:  the chance, high or low of harm being caused by a hazard. 
Risk assessment: identification of a risk, usually placed into unavoidable and avoidable 
categories, the former being outside operator control no matter what safety measures 
are put in place. These risks include ‘Force Majeures’, natural climatic disasters, armed 
conflict and terrorism. Avoidable risks are potential hazards resulting from routine 
and/or research operations that are not conducted with due care and vigilance. These 
are identified in a risk assessment and measures are taken to prevent them from 
happening. In the event that they can potentially occur, risk assessment includes 
protocols and procedures obviating or limiting their deleterious impacts and dealing 
with their consequences as effectively as possible. Risk assessment constitutes a 
systematic, recorded operation rationally foreseeing and mitigating against potentially 
adverse or damaging incidents. The assessment is usually based on information from a 
number of sources including: national regulatory authorities and it is administered in a 
no-blame culture. 
Risk management IVGB-specific: the processes and procedures involved in assessing and 
mitigating against hazards and risks in order to ensure the safety of personnel, 
samples, germplasm and genebanks and their freedom from harm.  
Seeding: an automatic or manual process that induces the formation or nucleation of ice 
crystals, during colligative controlled rate cooling protocols this is achieved manually, 
 by touching the cryovials with a cold instrument or, using a programmable freezer 
seeding programme.  
Shipping log: a formal written, processing, dispatch and receipt log for the safe, regulated 
shipment of germplasm and biological samples.  
Shipping manifest: a formal written description of the contents of a package shipped from the 
genebank. 
Slow growth: the process by which the growth of in vitro cultures is retarded to increase the 
length of the subculture cycle to increase the efficiency and reduce costs of their 
maintenance, it is usually applied in the IVAG.  
Standard Operating Procedure(s) (SOPs): a portfolio of standard procedures, methods and 
protocols that are technically detailed and formally validated and documented and that 
comprise the procedures used in common by all the genebank personnel in a 
repository. SOPs are an integral part of a Quality Management System.  
Sterility: an absolute term which is defined as the complete absence of detectable, viable, 
contaminating microorganisms;  it is usually achieved by validated, testing procedures 
that confirm the absence of microbial flora.  
Sterilization: an absolute process undertaken by chemical, filtration or heat treatments that is 
validated (i.e. fit-for-purpose) to destroy microorganisms.  
Storage: the preservation of biological and non-biological samples and specimens under 
specific conditions for their future use in the medium- (minimal, slow growth) or long-
term (cryopreservation) designated as MTS and LTS respectively. 
Technology transfer: the process by which the outcomes of scientific research are applied in 
practice, usually involving technology acceptance and implementation on a routine 
basis by its practitioners.  
Tg:  the glass transition temperature of vitrified, cryopreserved material.  
Tolerance limits: the limits that define the maximum and minimum range of acceptable values 
that are used to test the efficacy of a procedure or process or storage method, which if 
exceeded needs the implementation of corrective or emergency actions.  
Traceability: the ability to locate a germplasm sample or an accession during any stage of the 
biobanking/genebanking process, it is synonymous with the term ‘tracking’.  
Validation: a process by which a procedure is checked against a specific criterion, confirming 
that it meets the intended needs of users; it can also mean a declaration of fitness-for-
purpose. Validation may need to satisfy specific criteria that are regulated and defined 
by external standards. Validation is an indicator of how robust a protocol is within the 
constraints of its operational parameters.  
Validation exercises: a formal testing by different validators in a community of practice, of a 
protocol, procedure, analytical technique or diagnostic method so that it is 
demonstrated to consistently produce the expected results or outcomes based on 
performance indicators within predetermined and precise specifications.  
Verification: usually an internal quality process, ensuring a protocol, test or procedure is 
compliant with its required performance standard(s).  
 Accreditation 
ISO-International Organization for Standardization 
http://www.iso.ch/iso/en 
Benefit sharing 
General bibliography  
http://www.kew.org/conservation/access-benefit.pdf 
Leipzig Declaration 
http://www.fao.org/FOCUS/E/96/06/more/declar-e.htm 
The Convention on Biological Diversity, Bonn Guidelines  
http://www.cbd.int/doc/publications/cbd-bonn-gdls-en.pdf 
The International Treaty on Plant Genetic Resources for Food and Agriculture 
http://www.planttreaty.org/ 
Best practices  
CABRI 
http://www.cabri.org/guidelines.html 
ISBER 
http://www.isber.org/bp/index.cfm 
OECD Guidelines for Best Practices for Security in Biological Resources Centres 
http://www.oecd.org/dataoecd/6/27/38778261.pdf 
OECD Guidelines for Best Practices in Biological Resources Centres 
http://www.oecd.org/dataoecd/7/13/38777417.pdf 
National Cancer Institute Best Practices for Biospecimen Resources 
http://biospecimens.cancer.gov/global/pdfs/NCI_Best_Practices_060507.pdf 
Biorepositories and culture collections (General) 
European Culture Collection Organization (ECCO) 
http://www.eccosite.org 
UK National culture collections 
http://www.ukncc.co.uk/ 
International Society for Biological and Environmental Biorepositories  
www.isber.org 
World Federation for Culture Collections 
http://www.wfcc.info/ 
The OECD Biological Resource Centres 
http://www.oecd.org/dataoecd/55/48/2487422.pdf 
Biosafety and biotechnology 
Cartagena protocol  
http://www.cbd.int/biosafety/ 
SGRP Biosafety 
http://www.cbd.int/doc/external/mop-04/cgiar-bs-en.pdf 
 Consultative Group on International Agricultural Research  
www.cgiar.org 
CGIAR Virtual Information Centre 
http://www.cgiar.org/vic/index.html 
http://www.cgiar.org/publications/secretariat.html 
Convention on Biological Diversity 
www.biodiv.org 
Food and Agriculture Organization of the United Nations 
www.fao.org 
Genebanks (CGIAR’s clonal crop)  
Bioversity International (Musa) 
http://www.bioversityinternational.org/ 
https://sites.google.com/a/cgxchange.org/musanet/musa-collections/international-transit-center-itc 
International Potato Centre (potato, sweetpotato) 
http://www.cipotato.org/ 
(http://www.cipotato.org/publications/program_reports/99_00/20clonverif.pdf). 
International Center for Tropical Agriculture 
http://www.ciat.cgiar.org/ 
International Institute for Tropical Agriculture 
http://www.iita.org/ 
Genetic resources  
Common Access to Biological Resources and Information (CABRI) 
http://www.cabri.org 
Global Action Plan for Plant Genetic Resources 
http://www.fao.org/ag/AGP/AGPS/GpaEN/gpatoc.htm 
Global Crop Diversity Trust 
http://www.croptrust.org/main/ 
Guidelines: Technical crop-specific 
Musa (Bioversity) 
https://sites.google.com/a/cgxchange.org/musanet/documentation/technical-guidelines 
Material Transfer Agreements (Standard) 
International Treaty on Plant Genetic Resources Plant Material Transfer Agreement  
http://www.planttreaty.org/ 
Organization for Economic Cooperation and Development 
www.oecd.org/home/ 
Plant protection  
International Plant Protection Convention (IPPC) 
https://www.ippc.int/IPP/En/default.jsp 
 Plant Protection Health and Safe Movement of Germplasm 
http://www.musalit.org/pdf/IN960084_en.pdf 
WTO 
http://www.wto.org/english/tratop_e/sps_e/sps_e.htm 
Quality assurance  
OECD Guidelines for Quality Assurance in Molecular Genetic Testing 
http://www.oecd.org/dataoecd/43/6/38839788.pdf 
Regulations, codes and treaties 
Budapest Treaty 
http://www.wipo.int/treaties/en/registration/budapest/trtdocs_wo002.html 
Leipzig Declaration 
http://www.fao.org/FOCUS/E/96/06/more/declar-e.htm 
The Convention on Biological Diversity, Bonn Guidelines  
http://www.cbd.int/doc/publications/cbd-bonn-gdls-en.pdf 
The International Treaty on Plant Genetic Resources for Food and Agriculture 
http://www.planttreaty.org/ 
Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) 
http://www.cites.org/ 
Research projects (cryoconservation) 
Cost Action 871 CryoPlanet  
http://www.agr.kuleuven.ac.be/dtp/tro/cost871/Home.htm 
CRYMCEPT 
http://www.agr.kuleuven.ac.be/dtp/tro/crymcept/CRYMCEPT.htm 
http://ec.europa.eu/research/agriculture/projects/qlrt_2001_01279_en.htm 
CRYSTAL 
http://www.crystal-eu.org/ 
EURALIVEG 
http://euralliveg.ipk-gatersleben.de/home.php 
Safety and risk management 
Control of Substances Hazardous to Health (COSHH) 
http://www.hse.gov.uk/coshh/ 
Risk Assessment Guide 
http://www.hse.gov.uk/pubns/raindex.htm 
http://www.hse.gov.uk/pubns/indg136.pdf 
http://www.hse.gov.uk/pubns/bioindex.htm 
Guidance for Hazard Determination 
http://www.osha.gov/dsg/hazcom/ghd053107.html 
Personal Protective Equipment 
http://www.hse.gov.uk/pubns/ppeindex.htm 
Nunc™ 2008. Safety First: Nunc™ Cryopreservation Manual. 20.4.2008  
http://www.nuncbrand.com/en/frame.aspx?ID=608. 
BOC Industrial Cryogenic Gas Safety 
http://www.bocindustrial.co.uk/bocindustrial/product_information/Cryogenic_Products/safety/index.asp 
 System-wide Genetic Resources Programme (SGRP) 
http://www.sgrp.cgiar.org/ 
Transport  
International Air Transport Association (IATA) 
http://www.iata.org 
International Civil Aviation Organization: International Transport Regulations  
http://www.icao.int/ 
 
  
Appendix I comprises a series of bibliographies to support these guidelines, they each include 
a compilation of historical and contemporary information collated over the time course of the 
GPG2 project up to 2009. The general bibliographic section includes some representative 
literature relating to the development of quality systems and best practices across the wider 
biorepository and biobanking sector, including examples from medical and microbial 
communities of practice. The rationale for including these elements is based on the ‘lessons 
learnt’ approach that underpins GPG2 Activity 1.2 and the system-wide philosophy for 
managing genetic resources. The in vitro crop conservation bibliography is a collation of 
general and specific crop-by-crop literature pertaining to the in vitro conservation of 
CGIAR’S clonal crops. 
 
Biological resource centres  
OECD. 2001. Biological Resource Centres: Underpinning the Future of Life Sciences and Biotechnology. OECD, 
Paris, FR. 
Smith D. 2003. Culture collections over the world. International Microbiology 6:95-100.  
Smith D, Ryan MJ. 2001. Culture collections in the 21st century. The Biologist 48:125-128. 
Stacey GN, Day JG. 2007. Long-term ex situ conservation of biological resources and the role of biological 
resource centres. In: Day JG, Stacey G, editors. Methods in Molecular Biology. Vol. 368. Cryopreservation 
and Freeze Drying Protocols. (2nd ed.). Humana Press, Totowa, New Jersey, USA. pp. 1-14. 
Genetic resources and genebanks  
De Vicente M. 2004. The evolving role of genebanks in the fast-developing field of molecular genetics. Issues in 
Genetic Resources. No. 11. IPGRI, Rome, IT.  
Rao VR, Hodgkin T. 2002. Genetic diversity and conservation and utilization of plant genetic resources. Plant Cell 
Tissue and Organ Culture 68:1-19. 
Thompson R, Starzomski BM. 2007. What does biodiversity actually do? A review for managers and policy 
makers. Biodiversity and Conservation 16:1359-1378.  
van Hintum TH, Brown AHD, Spillane C, Hodgkin T. 2000. Core collections of plant genetic resources. IPGRI 
Technical Bulletin. No. 3. IPGRI, Rome, IT. 
Cost analyses 
Burstin J, Lefort M, Mitteau M, Sontot A, Guiard J. 1997. Towards the assessment of the costs of genebanks 
management: conservation, regeneration and characterization. Plant Varieties and Seeds 10:163-172. 
Epperson E, Pachio DH, Guevara CL. 1997. A cost analysis of maintaining cassava plant genetic resources. 
Crop Science 37:1641-1649. 
Harvengt L, Meir-Dinkel A, Dumas E, Collin E. 2004. Establishment of a cryopreserved genebank of European 
elms. Canadian Journal of Forest Research 34:43-55.  
Koo B, Smale M. 2003. Economic costs of genebank operation. A Guide to Effective Management of Germplasm 
Collections. (Engels JMM, Visser L, editors). IPGRI Handbook for Genebanks. No. 6. IPGRI, Rome, IT. 
 In vitro conservation  
Ashmore SE. 1997. Status report on the development and application of in vitro techniques for the conservation 
and use of plant genetic resources. IPGRI, Rome, IT.  
Benson EE, editor. 1999. Plant Conservation Biotechnology. Taylor and Francis, London, UK. 
Grout B, editor. 1995. Genetic Preservation of Plant Cells in Vitro. Springer-Verlag Heidelberg, DE.  
IBPGR. 1986. Design, planning and operation of in vitro genebanks. Report of the Subcommittee of the IBPGR 
Advisory Committee on In Vitro Storage. IBPGR, Rome, IT. 
IITA. 2004. Annual Report Programme A: preserving and enhancing germplasm and agrobiodiversity with 
conventional and biotechnological tools. IITA, NG. 
Normah MN, Narimah MK, Clyde MM, editors. 1996. In Vitro Conservation of Plant Genetic Resources. Plant 
Biotechnology Laboratory, Faculty of Life Science, Universiti Kebangsaan, MY.  
Razdan MK, Cocking EC, editors. 1997. Conservation of Plant Genetic Resources In Vitro. Vol. 1. General 
Aspects. Science Publishers Inc. Enfield, New Hampshire, USA. 
Reed BM, Engelmann F, Dulloo ME, Engels JMM. 2004. Technical guidelines for the management of field and in 
vitro germplasm collections. IPGRI Handbooks for Genebanks. No. 7. Rome, IT.  
Ruane J, Sonnino A. 2006. The role of biotechnology in exploring and protecting agricultural resources. FAO of 
the UN, Rome, IT. 
Volk GM, Walters C. 2003. The preservation of genetic resources in the national plant germplasm collections. 
Plant Breeding Reviews 23:291-344. 
Withers LA. 1980. Tissue culture storage for genetic conservation. IBPGR Technical Report. IBPGR, Rome, IT. 
Withers LA. 1985. Minimum requirements for receiving and maintaining tissue culture propagation material. FAO 
of the UN, Rome, IT. 
Withers LA. 1989. In vitro conservation and germplasm utilization. In: Brown AHD, Marshal DR, Frankel OH, 
Williams JT, editors. The Use of Plant Genetic Resources. Cambridge University Press. Cambridge, UK. 
pp. 309-334. 
Withers LA, Williams JT, editors. 1980. Crop genetic resources, the conservation of difficult material. Proceedings 
of an international workshop. 8-11 September 1980, University of Reading, Reading, UK.  
Practical tissue culture  
Beruto M, Beruto D, Debergh P. 1999. Influence of agar on in vitro cultures: I physicochemical properties of agar 
and gelled media. In Vitro Cellular Developmental Biology Plant 35:86-93. 
Beyl CA, Trigiano RN, editors. 2008. Plant Propagation Concepts and Laboratory Exercises. CRC Press, Florida, 
USA.  
Finer JE, Finer JJ. 2007. A simple method for reducing moisture condensation on Petri dish lids. Plant Cell Tissue 
and Organ Culture 91:299-304. 
Gaspar T, Kevers C, Penel C, Greppin H, Reid DM., Thorpe TA. 1996. Plant hormones and plant growth 
regulators in plant tissue culture: a review. In Vitro Cellular Developmental Biology Plant 32:272-289. 
George FF, Hall MA, De Klerk G-J, editors. 2008. Plant Propagation by Tissue Culture. Springer, Heidelberg, DE.   
Niedz RP, Evens TJ. 2007. Regulating plant tissue growth by mineral nutrition. In Vitro Cellular Developmental 
Biology Plant 43:370-381. 
Vasil IK. 2008. A history of plant biotechnology: from the cell theory of Schleiden and Schwann to biotech crops. 
Plant Cell Reports 27:1423-1440. 
Medium-term storage: slow growth  
Cha-um S, Kirdmanee C. 2007. Minimal growth in vitro culture for preservation of plant species. Fruit, Vegetable, 
Cereal Science and Biotechnology 1:13-25. 
Golmirzaie A, Toledo J. 1999. Non-cryogenic, long-term germplasm storage. In: Hall RD, editor. Methods in 
Molecular Biology. Vol. 111. Humana Press Inc. Totowa, New Jersey, USA. pp. 95-101.  
Grout BWW. 1995. Minimal growth storage. In: Grout B, editor. Genetic Preservation of Plant Cells In Vitro. 
Springer-Verlag Heidelberg, DE. pp. 21-28. 
 Ng SYC, Ng NQ. 1991. Reduced growth storage of germplasm. In: Dodds JH, editor. In Vitro Methods for 
Conservation of Plant Genetic Resources. Chapman and Hall, London. UK. pp. 11-39. 
Reed BM. 1991. Application of gas-permeable bags for in vitro cold storage of strawberry germplasm. Plant Cell 
Reports 10:431-434. 
Reed BM. 1992. Cold storage of strawberries in vitro: a comparison of three storage systems. Fruit Varieties 
Journal 46:98-102. 
Reed BM. 1993. Improved survival of in vitro-stored Rubus germplasm. Journal of the American Society for 
Horticultural Science 118:890-895. 
Reed BM. 1999. In vitro storage conditions for mint germplasm. HortScience 34:350-352. 
Reed BM. 2002. Photoperiod improves long-term survival of in vitro-stored strawberry plantlets. HortScience 
37:811-814. 
Reed BM, Aynalem H. 2005. Iron formulation affects in vitro cold storage of hops. ISHS Acta Horticulturae 
668:257-262. 
Reed BM, Paynter CL, DeNoma J, Chang Y. 1998. Techniques for medium- and long-term storage of Pyrus L. 
genetic resources. Plant Genetic Resources Newsletter 115:1-5. 
Reed BM, Okut N, D‟Achino J, Narver L, DeNoma J. 2003. Cold storage and cryopreservation of hops (Humulus 
L.) shoot cultures through application of standard protocols. CryoLetters 24:389-396. 
Long-term storage: cryopreservation  
Baust JM, Vogel MJ, Snyder KK, Van Buskirk RG, Baust JG. 2007. Activation of mitochondrial-associated 
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Springer, New York, USA. pp. 15-32. 
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 Examples are specific to the equipment and facilities required for in vitro storage using 
slow growth and cryopreservation, they do not include specialist phytosanitary, 
diagnostic and molecular equipment. The frequency of tests and calibrations are 
indicated where they generally advised by manufacturers, otherwise tests are 
undertaken based on the utility and frequency of use.  
(A) Safety and risk management  
Equipment Use  Maintenance Tests & 
calibration 
Procedures 
O2 Monitors  
cryogenic 
oxygen 
deficiency 
hazard (ODH) 
for personnel 
asphyxiation 
risks/safety   
Audio-visual alarms alert personnel to 
safety risks by monitoring oxygen 
depletion. These alarms are calibrated to 
critical minimal lack of O2 asphyxiation 
levels. They are used in closed or poorly 
ventilated areas and atmospheres 
holding larger volumes of LN  
 
 
 
 
 
 
Manufacturer 
service/local checks  
 
 
 
In house testing 
and re-calibrations 
using test gases 
(every 3-6 months) 
 
 
Personnel risk 
management 
Liquid Nitrogen  
low level 
alarms 
Audio-visual alarms alert low levels of 
LN in cryotanks and cryogen supply 
vessels.  
Calibration of 
alarms with critical 
LN levels  
Sample risk 
management 
Pressurized 
LN vessels 
and gauges 
LN Supply tanks, programmable 
freezers  
Manufacturers‟ services 
and local checks; in 
some countries 3rd party 
Health and Safety 
checks are 
mandatory/statutory 
legal obligations and 
cryogenic vessels have 
a designated finite 
lifetime after which they 
cannot be used  
Calibration of 
pressure gauges 
may be required 
Personnel and 
sample risk 
management 
 
 
LN Dewars 
 
 
Sample storage and supply  
Calibration of 
pressure gauges 
for automatic-fill 
vessels; calibration 
of LN burn-off 
 
Personnel and 
sample risk 
management 
Dry Shippers Safe transport of samples in LN Local checks for vessel-
LN charging and 
cleaning 
Calibration of LN 
burn-off, 
contamination 
checks 
Personnel and 
sample risk 
management 
Personal 
Protective 
Clothing/ 
Equipment 
(PPC) (PPE) 
 
Personnel protection 
Manufacturers‟ service 
and local checks of fume 
hoods, extraction 
equipment, PPC PPE 
cleaning. 
Fume hood- 
extractor airflow 
calibration particle 
count 
Personnel risk 
management 
 
 (B) Media and reagent preparation 
Equipment Use Maintenance Tests & calibration Procedures 
Balances Weighing of 
reagents, 
cryoprotectants and 
media  
 
 
 
 
 
 
 
Manufacturer and/or local 
service 
 
In-house testing and 
calibration of balances 
(annual or after re-location) 
Accurate 
dispensing of 
gravimetric 
weights and 
measures  
Gilson 
pipettes 
Volumetric 
dispensing of 
reagents, 
cryoprotectants and 
media 
In-house testing and 
calibration of automatic 
pipettes (annual) 
Accurate 
dispensing of 
volumetric 
measures 
pH Meters pH is critically 
important for 
biological 
processes and can 
be changed by 
cryoprotective and 
slow growth 
additives 
Test against 
manufacturers‟ standard 
test solutions (weekly) 
Preparation of 
media, buffers, 
reagents and 
cryoprotectants 
Water 
purification  
Production of 
purified and/or 
distilled water 
Manufacturer and/or local 
service of stills, ion exchange 
units, replacement of water 
purification filters  
Manufacturer-
recommended standard 
tests for conductivity 
(weekly) 
Preparation of 
reagents, 
cryoprotectants 
and media 
Washing 
machine 
Washing of 
glassware 
Manufacturer and/or local 
service 
Test for efficient cleaning 
and rinses with purified 
water  
Preparation of 
clean glassware 
for media 
preparation 
 
(C) Sterilization and aseptic procedures  
Equipment Use Maintenance Tests & calibration Procedures 
Autoclaves Sterilization of 
media, 
cryoprotectants and 
equipment 
Manufacturer and/or local 
service checks in some 
countries 3rd party Health and 
Safety checks are mandatory 
and autoclaves have a finite life 
In-house testing and 
calibration of temperature 
and pressure gauges, 
thermal indicator tests and 
contamination checks  
Sterile in vitro 
operations; media 
and cryoprotectant 
preparation 
Laminar flow 
cabinet 
Aseptic 
manipulations 
 
 
 
 
Manufacturer and/or local 
service 
 
In-house testing and 
calibration of airflow, 
particle count and 
microbial plate testing  
Sterile in vitro 
operations and 
autoclaved media 
dispensing  
Clean rooms Positive air pressure 
environments 
In-house testing and 
calibration of airflow and 
particle counts 
Clean room for in 
vitro operations 
 
 (D) Refrigerators and freezers 
Equipment Use Maintenance Tests & calibration Procedures 
-4°C, -80°C and 
 -20°C refrigerators 
and freezers 
Storage of thermo-labile 
reagents, biological 
samples  
 
Temperature check, 
defrosting and 
cleaning  
 
Testing and calibration  
of temperatures and at 
different locations in the 
freezer 
Cold storage  
-80°C freezers Passive controlled rate 
cooling using Mr 
Frosty™ units 
Testing and calibration of 
temperatures and at 
different locations in the 
freezer 
Cryopreservation 
Ice machines Production of ice for 
cryoprotection addition 
Defrosting and 
cleaning 
Contamination checks Cryopreservation  
 
(E) Thermal equipment  
Equipment Use Maintenance Tests & calibration Procedures 
Incubator Pregrowth and 
acclimation treatments, 
testing for microbial 
contaminants  
 
 
Manufacturer and/or 
local service, regular 
cleaning 
 
 
Testing and calibration of 
temperatures and at 
different locations in the 
thermal 
incubator/temperature  
controlled unit  
 
Cryopreservation  
Microbial culture  
Thermotherapy 
Water bath Thawing and rewarming 
of cryo-stored materials  
Cryopreservation  
Ovens Dry weight determination 
for critical point 
desiccation tolerance. 
Equipment sterilization 
Cryopreservation 
Sterilization 
 
(F) Temperature controlled environments  
Equipment Use Maintenance Tests & calibration Procedures 
Growth rooms Plant culture   
 
 
 
 
 
Manufacturer and/or 
local service 
 
 
 
 
 
Testing and calibration of 
temperatures, humidity, 
light and alarms and 
checks at different 
locations in the 
environmental control 
facility  
General culture 
maintenance, slow 
growth, recovery 
after medium-term 
and long-term 
storage  
Cold rooms Cold storage  Storage of cold 
acclimated/ 
hardened 
propagules and 
storage organs 
(tubers, bud 
cuttings) 
Air-conditioned 
laboratories 
Controlled operations  Cryopreservation, 
general analytical 
procedures  
  
 
